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ABSTRACT

The anti-cancer agent 4,4-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A007)
forms complexes with π-delocalized lymphangitic dyes that allow its penetration through the
skin effectively delivering it to a meta-stable type cancerous site. Previous in vitro studies,
combined with gas phase mass spectrometry studies, have shown that a stronger binding affinity
equates to a greater efficacy of the drug. For the determination of drug:dye complex binding
strength coefficients in solution, two methods have been developed by affinity capillary
electrophoresis (ACE), and cation exchange liquid chromatography (CELC). The methods
demonstrated that A007 non-covalent binding strength was greatest for methylene green,
followed by methylene blue, and lastly toluidine blue.
Bond dissociation energies and apparent reaction enthalpies for the fragmentation
pathways of lithiated acylglycerols were experimentally determined by collision activation in a
triple quadrupole mass spectrometer. A developed novel derived effective path length approach
for predicting bond dissociation energies (BDE) for electrostatic complex’s alkali metal adducts
(Li+), and halide adducts (Cl-) of acylglycerols was applied to the major fragmentation product
ions of a lithiated mono-acylglycerol, a 1,2-diacylglycerol, and a 1,3-diacylglycerol, to predict
the covalent bond dissociation energies involved in fragmentation pathways.

The model’s

calculated apparent reaction enthalpies are used in conjunction with the energy-resolved mass
spectrometry method of breakdown graphs to give a more complete quantitative aspect to the
interpretation of the fragmentation processes.
The dry eye condition affects millions of individuals world wide. The symptoms can be a
result of simple irritation to the eye or a serious disease state. A dry eye model was developed

xx

using rabbits in order to study the compositional makeup of the tear components in hopes of
identifying an underlying cause, or expressed effect of the dry eye condition. The major nonpolar lipids of the tear were identified by mass spectrometry as mono and diacylglycerols, with a
smaller extent of triacylglycerols. The major polar phosphorylated lipids were identified in the
tear extract revealing that sphingomyelin based species were being expressed in the dry eye
condition. The major proteins were determined to be the lower molecular weight lipid binding
proteins where two specific species were found to increase in expression for the dry eye
condition.

xxi

CHAPTER I: INTRODUCTION

1.1 Objectives and Aims
Previous work in measuring and identifying biological compounds from complicated
extracts has had difficulty in the ability to achieve detection, identification and quantitation of
the low nano to picogram levels that are found in tears. Also, specialized mass spectrometers that
are not readily available to most laboratories are typically used for complex biological compound
interactions. Therefore, the main objective of my work was to develop new and improved mass
spectrometric methods for the measurement of biological compounds and their complex
interactions using common mass spectrometer instrumentation. The specific aims of my work
were to develop advanced mass spectrometric methodology for: a) the measurement of complex
biological interactions in the solution-phase, b) the measurement of complex biological
interactions in the gas-phase c) the identity and comparison of nonpolar and polar lipids in a
rabbit dry eye tear model, and d) the identity and comparison of the major proteins in a rabbit dry
eye tear model.

1.2 Significance and Impact
The use of mass spectrometry has become a powerful analytical tool for gas phase
thermochemistry studies, for structural elucidation of organic compounds, and for composition
studies of complex biological samples. The high sensitivity of mass spectrometers has also
allowed the measurement of biological extracts that contain very low levels of the analytes of
interest such as tear film extracts. Previous investigations into molecular changes in tear film
structure have been hampered by the need to pool tears to make up a sample large enough to
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undergo analytical methods such as one- or two-dimensional electrophoresis. Another problem is
the requirement that the tear components be derivatized before they are subjected to gas
chromatography, mass spectrometry, or both. Finally, the total chloroform extract of the tear
layer constitutes a complex mixture of biological compounds that includes non-polar and polar
lipids and some lipoproteins. The polar lipid components make up a very small fraction of the
total extract, rendering their analysis difficult by mass spectrometry alone. Therefore, there is a
need to develop new methodology that combines optimized sample pretreatment in conjunction
with mass spectral instrumental analysis. In response to this, we have developed methodologies
for enhanced lipid and protein analysis that includes sample pretreatment such as clean-up
chromatography, cationizing agents, washing solutions, wax plating MALDI Voyager plates, and
enhanced MALDI matrices. The methodologies that have been developed have generated
significant improvements such as increased sensitivities, enhanced signal responses, and lower
detection limits.
The study of noncovalent bond dissociation energies by mass spectrometry has been
investigated for well over 25 years, generating very accurate and reliable values. However, the
type of mass spectrometer used is highly specialized and not readily accessible to most research
laboratories, and is primarily limited to small molecular weight systems such as solvent/metal
adducts. In response to this, we have developed a mass spectrometric method for the
measurement of bond dissociation energies for both small molecular weight systems such as
solvent/metal adducts, and larger molecular weight systems such as lipid/metal adducts. We have
also extended the method to calculate “covalent” bond dissociation energies as well as
noncovalent using a mass spectrometer that is fairly common in many research laboratories. This
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methodology in effect enables a broader scope to the measurement of dissociation energies by
mass spectrometry that is more accessible to researchers.
The analysis of the components of tears has been reported upon for more than 40 years
primarily using methods that required compositing samples, special pretreatment of samples, and
were not as sensitive as that needed for very low levels of analytes. With the advancements in
mass spectrometric instrumentation, ionization sources, and preparation techniques, there has
been a tremendous growth in applications towards the analysis of complex biological samples.
However, there are still many obstacles that are encountered when analyzing these complex
biological samples. For the tear composition studies, these included very low levels of lipids in
the nano to picogram levels that were suffering from suppression from other analytes present,
and proteins that have been challenging to compare a normal to a diseased state expression. The
developed methodology presented here shows for the first time the observance of single lipid
species in the tear thus allowing the observance of an expression differential. The developed
methodology has also allowed an expression study differential to be observed with the tear
proteins. These studies may be able to identify causes to, or signaling agents of the dry eye
diseased state.
In order to fully understand the results presented in Chapters III through VIII, it is
necessary to be familiar with some of the basic concepts of the applied methodologies used in
each study. Therefore, the following sections provide a brief introduction and overview of the
instrumental methods used in the research studies reported upon in this dissertation.
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1.3 Overview of High Performance Liquid Chromatography (HPLC) and Capillary Zone
Electrophoresis (CZE)
High performance liquid chromatography (HPLC), and capillary zone electrophoresis
(CZE) are two analytical separation techniques that have been used as individual approaches for
compound separations, and as complimentary approaches. HPLC is a separation technique that
utilizes a compound’s affinities for either a stationary phase, or a mobile phase, in order to
perform a chromatographic separation. In reverse phase HPLC (RP-HPLC), typically the
stationary phase is composed of a long chain non-aromatic, aliphatic hydrocarbon (e.g. C18, for
an 18-carbon chain) that is covalently bound to silica or polymer beads packed into a cylinder
stainless steel tube. The mobile phase typically consists of mixtures of H2O, methanol (MeOH),
and acetonitrile (ACN) that are all three completely miscible in all molar fraction ratios. The
sample is loaded onto the C18 column with a high H2O ratio in the mobile phase where the
affinity of organic compounds are greatest for the C18 stationary phase. The mobile phase is
changed in a gradient fashion where the organic solvent (MeOH or ACN) is gradually increased.
The affinity for the organic molecules now increases in the mobile phase which helps to carry
them along through the column. The separation of the individual organic constituents now takes
place due to their different affinities for the stationary and mobile phases.
Strong ion exchange high performance liquid chromatography works upon similar
principles as RP-HPLC, except that the compound of interest now has a strong ionic,
electrostatic, non-covalent affinity for the stationary phase. This approach works well for
compound that posses a permanent charge such as an acid in basic solution, or a base in acidic
solution. Strong cation exchange high performance liquid chromatography (SCEX-HPLC) uses
an organically bound sulfonic acid group that has a high affinity for compounds that contain
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permanent positive charges. Due to the aromatic backbone of strong cation exchange stationary
phases, there is also a slight reverse phase interaction that can also take place. For the
chromatographic elution of the compound of interest from the strong cation exchange column,
typically a salt gradient is used which displaces the analyte from the poly-sulfonic acid stationary
phase.
Capillary zone electrophoresis (CZE) is another very useful separation technique which
has traditionally been applied primarily to analytes of interest which also posses a permanent
charge, just as is the case with strong ion exchange chromatography. Unlike liquid
chromatography, capillary zone electrophoresis does not separate analytes according to their
respective affinities for mobile and stationary phases, rather the separation is achieved based off
of analytes electrophoretic mobilities in an electric field. In positive mode electrophoresis,
positively charged analytes move from the anodic (positive electrode) region of the separation
phase, to a cathodic (negative electrode) region of the separation phase, through a narrow bore,
short fused silica tube. In general, small highly charged analytes have the greatest mobilities,
followed by higher molecular weight similarly charged analytes, followed by neutrals, which
travel through the separation capillary due to a phenomenon known as electroosmotic flow
(EOF), and lastly, oppositely charged ions. The forces acting upon the analytes are vectors,
therefore they are additive, and result in the separation of analytes based upon their mass to
charge ratios. Electroosmotic flow results from bulk movement of the separation phase through
the fused silica capillary due to the charged silano groups of the fused silica wall. EOF can be
influenced through pH changes (high pH produces deprotonated, charged silano groups resulting
in higher EOF, while low pH results in protonated silano groups thus decreasing EOF), organic
modifiers in the separation phase (a higher organic modifier such as MeOH reduces EOF), and
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also through neutral coating of the fused silica wall such as with polymers, which can reduce or
eliminate EOF.
Since its early introduction(1-4), capillary zone electrophoresis is an analytical technique
that has become an indispensable tool in many modern laboratories, especially in the
pharmaceutical industry(5).

The application of capillary electrophoresis to the study of

complexes, known as affinity capillary electrophoresis (ACE), has recently experienced a large
growth. This methodology has been used to study the electrophoretic mobility and separation of
various complexes(6), complex electrostatic interactions(7), complex binding and disassociation
constants(8,9), and complex stoichiometry(10). In most studies, affinity CE ideally involves the
measurement of a complex that stays bound throughout the electrophoretic separation(11). The
complexes that were evaluated by this study involve a purely electrostatic binding between the
dye carrier compound, and the anti-cancer agent A007, which have estimated high disassociation
constants.

1.4 Overview of Electrospray Triple Quadrupole Mass Spectrometry
Electrospray ionization (ESI) is a process that enables the transfer of compounds in
solution phase to the gas phase in an ionized state thus allowing their measurement by mass
spectrometry. The use of ESI coupled to mass spectrometry was pioneered by Fenn et al.(12,13),
in 1985, by extending the work of Dole et al.(14) who demonstrated the production of gas phase
ions by spraying macromolecules through a steel capillary that was electrically charged, and
subsequently monitoring the ions with an ion-drift spectrometer. The process by which ESI
works has received much theorization, study, and debate(15-21), in the scientific community,
especially the formation of the ions from the Taylor(22) cone droplets and offspring droplets. The
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electrospray process is achieved by placing a potential difference between the capillary and a flat
counter electrode. The generated electric field will penetrate into the liquid meniscus and create
an excess abundance of charge at the surface. The meniscus becomes unstable and protrudes out
forming a Taylor cone. At the end of the Taylor cone a jet of emitting droplets (number of drops
estimated at 51,250 with radius of 1.5 µm) will form that contain an excess of charge. As the
droplets move towards the counter electrode, a few processes take place. The drop shrinks due
to evaporation thus increasing the surface charge until columbic repulsion is great enough that
offspring droplets are produced. This is known as the Rayleigh limit producing a columbic
explosion. The produced offspring droplets have 2% of the parent droplets mass and 15% of the
parent droplets charge. This process will continue until the drop contains one molecule of
analyte and charges that are associated with basic sites (positive mode). This is referred to as the
“charged residue model” that is most important for large molecules such as proteins. As the
droplets move towards the counter electrode a second process also take place known as the “ion
evaporation model.” In this process the offspring droplet will allow evaporation of an analyte
molecule from its surface along with charge when the charge repulsion of the analyte with the
solution is great enough to allow it to leave the surface of the drop. This usually takes place for
droplets with a radius that is less than 10 nm. This type of ion formation is most important for
small molecules.
In the ensuring years since its introduction, electrospray mass spectrometry has been used
for structural elucidation and fragment information(23-25), and non-covalent complex studies(26,27),
just to name a few recent examples of its overwhelmingly wide range of applications.
Electrospray(28-31) is an ionization method that is now well known to produce intact gas
phase ions with very minimal, if any, fragmentation being produced during the ionization
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process. In the transfer process of the ions from the condensed phase to the gas phase, several
types of “cooling” processes of the ions are taking place in the source: (1) cooling during the
desolvation process through vibrational energy transfer from the ion to the departing solvent
molecules, (2) adiabatic expansion of the electrospray as it enters the first vacuum stage, (3)
evaporative cooling, and (4) cooling due to low energy dampening collisions with ambient gas
molecules. The combination of these effects, and the fact that electrospray can effectively
transfer a solution phase complex to the gas phase with minimal interruption of the complex,
makes the study of non-covalent complexes from solution by electrospray ionization mass
spectrometry attractive.
The ESI source is coupled to a triple quadrupole mass spectrometer for detection of the
ions produced from the electrospray process. The triple quadrupole mass spectrometer is a
versatile tool in structural analysis of components of complex matrices. The instrument is
comprised of three quadrupoles, in tandem, which two (the first and third) have individual
detectors, while the middle quadrupole (actually a hexapole), known as the collision gas cell, is
RF only with no detector. Figure 1.2.4 shows the arrangement in space of the quadrupoles.
Having the quadrupoles aligned in tandem allows approaches to compound isolation, and
subsequent identification by using the quadrupoles as mass filters(32). A quadrupole is made up
of four rods that are placed precisely parallel to each other. One set of opposite poles have a DC
voltage (U) supply connected while the other two have a radio frequency (rf) voltage (V)
connected(33). Ions are accelerated into the quadrupole by a small voltage of 5 V, and under the
influence of the combination of electric fields, the ions follow a complicated trajectory path. If
the oscillation of the ions in the quadrupole have finite amplitude it will be stable and pass
through. If they are infinite, they will be unstable and the ion will collide with the rods. At a
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certain range of DC voltage U and radio frequency potential V, the ion of interest will have a
stable region. A plot of U versus V is used to scan mass to charge ratios (m/z) with the
quadrupoles allowing the measurement of a range of masses, typically up to 4000 Da. The slope
of the line is a fixed ratio of U to V. As U and V are varied, the scan follows the scan line and
subsequent m/z values are recorded. Due to this functionality the quadrupoles are called mass
filters, however, they are still dependent upon a mass to charge ratio. The mass spectrometry
methods used in the lipid analyses included single stage analysis (ESI-MS) where the first
quadrupole is scanned and the first detector is used. This is used for compound molecular mass.
A second method used was neutral loss scanning (NL). This is used to determine the initial
molecule that losses a certain neutral mass upon fragmentation induced in the central hexapole
collision cell. In this procedure the first and third quadrupoles are scanned at a differential equal
to the neutral loss value. For example, if the NL value is 50 then when Q1 is at 200 m/z, Q3 is
scanning at 150 m/z. When 150 m/z is registered by detector 2, the Q1 value is recorded along
with the intensity recorded with detector 2. A third method used was precursor ion scanning.
This is used to determine the initial molecule that produces a specific product ion. Here Q3 is
held static at the ion fragment m/z of interest and Q1 is scanned over an m/z range. When the ion
is detected by Q3 the m/z value in Q1 is recorded in conjunction with the intensity recorded by
detector 2. Finally, a fourth method used was product ion scanning(33). This is a scan for product
ions produced from a single precursor ion which is allowed to pass through Q1. This is used for
structural elucidation.
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1.5 Overview of Matrix Assisted Laser Desorption Ionization (MALDI) Time-of-Flight
(TOF) Mass Spectrometry
Matrix assisted laser desorption ionization (MALDI) is a process that enables the transfer
of compounds in a solid, crystalline phase to the gas phase in an ionized state thus allowing their
measurement by mass spectrometry(34-36). The process involves mixing the analyte of interest
with a strongly ultra-violet absorbing organic compound, applying the mixture to a surface and
then allowing it to dry. Examples of typical organic matrix compounds used are 2,5dihydroxybenzoic acid (DHB), 3,5-dimethoxy-4-hydroxy-trans-cinnamic acis (sinapic or
sinapinic acid), and α-cyano-4-hydroxy-trans-cinnamic acid (α-CHCA). There are many
techniques described for applying the matrix to the target such as the “dried droplet”
method(36,37), and the “thin film” method(38). The dried crystalline mixture “film” or “spot” is
then irradiated with a nitrogen laser (337 nm), or an Nd-YAG laser (266 nm). The strongly UV
absorbing species accepts energy from the laser and desorbs from the surface carrying along any
analyte that is mixed with it. The analyte is cationized in the plume above the crystalline surface
with, in the positive mode, either a hydrogen proton or a metal cation such as sodium.
The desorbed, ionized compounds from the matrix assisted laser desorption ionization
process are then introduced into a mass spectrometer for analysis. The most common mass
spectrometer that is coupled to MALDI is the time-of-flight mass spectrometer (TOF MS)(39,40).
The TOF mass spectrometer separates compounds according to their mass to charge ratios (m/z)
through a direct relationship between a compounds drift time through a predetermined drift
pathlength and its mass to charge ratio (m/z). Initially, all the ions have similar kinetic energies
imparted to them from the draw-out pulse (representing time zero) which accelerates them into
the flight tube. Because the compounds have different masses their velocities will be different
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according to the relationship between kinetic energy and mass represented by: KE = eV =
1/2mv2. From this expression, the mass to charge ratio is related to the ions flight time by the
following expression: m/z = 2vt2/L2. There is a high transmission efficiency of the ions into and
through the drift tube which equates to very low levels of detection limits which are in the
femtamole to atamole ranges. Theoretically, the mass range of the spectrometer is unlimited due
to the relationship of drift time for mass measurement. In practice though, the sensitivity needed
to detect a very slow moving large molecular weight compound limits the TOF-MS to 1 to 2
million Daltons or so.
The early designs of time of flight mass spectrometers suffered from poor resolution
which is the ability of the mass spectrometer to separate ions. This is usually expressed as
resolution = m/∆m where m is the mass of the peak of interest and ∆m is the difference between
this mass and the next closest peak. The poor resolution was due to nonuniform initial spatial and
energy distributions of the formed ions in the mass spectrometer’s ionization source. Due to the
distribution spreads the mass resolution was directly dependant upon the initial velocity of the
formed ions. Early work reported by Wiley et al.(41) reported upon the correction for initial
velocity distributions using a technique they described as “time-lag energy focusing” where the
ions were produced in a field-free region, then after a preset time a pulse was applied to the
region to extract the formed ions. They also reported upon a way to correct for initial special
distributions through a two field pulsed ion source. They demonstrated though that correction
can only be made for one of the distributions at a time. In MALDI, the spatial distribution spread
is not a significant problem, therefore “delayed extraction” of the ions from the field free source
region should correct for the initial energy distribution spread of the formed ions(42). With this
correction, the resolution should be directly dependent upon the total flight time ratioed to the
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error in the time measurement, thus an increase in the length of the flight path should equate to a
higher resolution. The resolution enhancement due to the delayed extraction initial energy
focusing and flight path was demonstrated in a study reported by Vestal et al.(42) using a
MALDI-TOF mass spectrometer.
A second modification of time of flight mass spectrometers involves time focusing of the
ions while they are in flight through the use of an electrostatic mirror at the end of the flight
tube(43,44). The electrostatic mirror focusing the ions with the same mass to charge ratio but
slightly different kinetic energies by allowing a slightly longer path for the higher KE containing
ion compared to a slightly lower KE ion thus allowing the ions to catch up to one another. The
electrostatic mirror also increases the flight path length of the mass spectrometer, thus providing
a double focusing effect. All recent TOF-mass spectrometers employ both delayed extraction and
the reflectron electrostatic mirror for analysis of compounds below 10 kDa. For compounds
greater than 10 kDa a linear mode is typically used where the electrostatic mirror is turned off.
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CHAPTER II: DETERMINATION OF RELATIVE BINDING CONSTANTS
BETWEEN π-DELOCALIZED LYMPHANGITIC DYES AND AN ANTI-CANCER AGENT
BY CATION EXCHANGE LIQUID CHROMATOGRAPHY AND AFFINITY CAPILLARY
ZONE ELECTROPHORESIS

2.1 Introduction
One of the major problems with anti-cancer therapy is the effective delivery of the anticancer agent to the tumor site. Skin permeability studies have demonstrated that the coupling of
the anti-cancer agent A007 with a carrier dye molecule (methylene green, MEG, methylene blue,
MEB, and toluidine blue, TB, see Figure 2.1 for structures) increases A007’s therapeutic
activity(1), with a rating from most effective, to least, as MEG>MEB>TB.

Electrospray

ionization tandem mass spectrometry(2-5) (ESI-MS/MS) has been used in our lab (results
unpublished) to study the characteristics and relative binding strengths of the three dyes MEG,
MEB, and TB, complexed with A007. The gas phase binding strengths of the three complexes,
determined by ESI-MS/MS, were ranked in the following order: MEG>MEB>TB, which
indicates that a stronger binding between the carrier and anti-cancer agent directly correlates to a
greater efficacy.

A high performance liquid chromatography (HPLC) method has been

developed for the determination of A007 in plasma(6), but not for the complexes that are formed
between A007 and carrier compounds. A cation exchange chromatography (CEC) method has
been developed in our lab (results unpublished) in order to rank the binding strengths of
carrier:A007 complexes. The CEC method determined binding strengths with the same trend as
was determined by ESI-MS/MS, namely MEG>MEB>TB. This effectively gave a “solution
phase” ranking of binding strengths.
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Figure 2.1. Structures of (a) 4,4’-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone
(A007)(1), (b) methylene blue (MEB), (c) toluidine blue (TB), and (d) methylene green (MEG).
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The ACE method developed ranked the binding strengths of the carrier:A007 complexes,
in the solution phase at an adjusted physiological pH (7.4), as MEG>MEB>TB. These results
are in agreement with the ESI-MS/MS, and cation exchange chromatography rankings that were
previously determined.

2.2 Experimental
The UV/VIS experiments were performed with a PC controlled CARY 500 Scan UVVis-NIR Spectrophotometer (Varian Australia Pty. Ltd.).
The fluorescence experiments were performed with a PC controlled Photon Technology
International Fluorometer (PTI, Canada).
The CE experiments were performed with a BioFocus 2000 Capillary Electrophoresis
System (BIO-RAD, Hercules, California) with a UV/VIS variable wavelength detector.
Uncoated fused-silica capillaries were used with a total length of 56 cm, effective length 50 cm,
and 50 um i.d. The capillaries were maintained at a temperature of 25 oC. The injection time
was 30 psi*sec pressure. All runs were made in a constant voltage mode with a running voltage
of 30 kV. The polarity was + to – (positive polarity mode where the negative pole is at the
capillary outlet). Between runs, the CE capillary was conditioned through a series of washes
comprised of 13 min. 1 M NaOH, followed by 13 min. of separation phase. The separation
phase consisted of (1) 50% MeOH/50% H2O buffered with 25 mM mono and dibasic hydrogen
phosphate at a pH of 7.4 (adjusted), or (2) 50% MeOH/50% H2O, 25 mM phosphate buffer at 7.4
pH (adjusted) and spiked with either MEG, MEB, or TB.
The HPLC experiments were performed with an 1100 Series HPLC (Agilent
Technologies, Palo Alta, CA) comprised of a vacuum degasser, a quarternary pump, and a diode
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array detector.

The column used was a 150 x 1.0 mm, 5 micrometer, 300-A,

PolySULFOETHYL A column (PolyLC, Columbia, MD). Instrumental parameters consisted of
a 0.1 ml per minute flow, 10 microliter injection loop, and ambient column temperature. Mobile
phases consisted of (1) 50% MeOH/50% H2O, buffered at 7.4 pH (adjusted) with 15 mM
triethylamine phosphate (TEAP), (2) 50% MeOH/50% H2O, buffered at 7.4 pH (adjusted) with
15 mM TEAP, and spiked with either 5x10-5 M MEG, 5x10-5 M MEB, or 5x10-5 M TB, or (3)
50% MeOH/50% H2O, buffered at 7.4 pH (adjusted) with 15 mM triethylamine phosphate and
0.5 M NaCl.
To mimic physiological conditions, all solutions are at a pH of 7.4, but adjusted due to
the change in H+ activity for a 50 % methanol and 50 % water mixture(18,19).

2.3 Results and Discussion
2.3.1 UV/Vis Study of the Compounds and Complexes
Figure 2.2 illustrates UV/Vis spectra of the complexes formed between the three dyes and
A007. What’s observed from the spectra is that each compound contains a unique absorbance
peak which can be used to detect and monitor the compounds and complexes without
interference. The three dyes used in the study, methylene green, methylene blue, and toluidine
blue, have unique absorbance maximums at 656 nm, 662 nm, and 630 nm, respectively. The
anti-cancer agent A007 has an absorbance maximum between 398 nm, and 405 nm. Both dye
and A007 peaks are found in the complexes, and the A007 max at 398 nm was used to detect the
complex for mobility calculations and migration times (ACE), and retention times (CELC).
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2.3.2 Flourescence Study of the Dye-A007 Complexes
The dyes used in the study naturally fluoresce at specific wavelengths. It was initially
felt that the complex between the dyes and the anti-cancer agent A007 enhanced this
fluorescence. Using the method of continuous variation(20,21), a fluorescence maximum was
obtained for each dye-A007 complex versus mole fraction. These dyes however are known to
produce dimers in the liquid phase(22), where the production of the dimer will quench the
fluorescence. Further spectroscopic experiments showed that only one species of complex was
being formed in solution between A007 and the dyes, but the enhancement in fluorescence was
attributable to the decrease in dye dimer only, and not to the formation of the A007:dye complex.

2.3.3 Cation Exchange Liquid Chromatography Results.
A binding coefficient (BC) equation (see equation 1) was derived based on the retention
times of the dyes, the A007:dye complexes, and the anti-cancer agent A007, in order to rank the
binding strengths of the A007:dye complexes. The scale spans a BC value from approximately
0.1, representing a weak binding, to 1.0, representing the strongest binding.

BC = (tdrug(carrier) – tdrug)/(tcarrier – tdrug)

(1)

Figure 2.3 contains the CELC chromatograms illustrating the retention times used for the
calculation of the binding constants. It is felt that this approach gives a direct measurement of
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Figure 2.2. UV/Vis absorbance spectrums of A007:Dye complexes illustrating
absorbance maximums of (a) 405 nm for A007, 662 nm for MEB, (b) 630 nm for TB, and (c)
656 nm for MEG.
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the binding strength between the dyes and A007. The binding method is achieved through a kind
of pseudo stationary phase that is produced in the cation exchange column between the dye in the
mobile phase, and the sulfoethyl A stationary phase. With a stronger binding between the dye
and A007, A007 will have a longer elution time, as is observed in the chromatograms contained
in Figure 1. The binding strength scale of the three dyes was determined to be methylene green
> methylene blue > toluidine blue, with calculated BC’s of 0.54 ± 0.05, 0.24 ± 0.02, and 0.18 ±
0.02, respectively (BC values are the average plus or minus one standard deviation of at least
three determinations).

2.3.4 Capillary Electrophoresis Results
Figure 2.4 illustrates the results of the change in mobilities of A007 versus increasing
concentrations of the dye ligands titrated into the separation phase. There are initial similarities
in the effective mobilities of A007 observed between the three systems at a dye ligand
concentration of 5x10-5 M (MEG dye A007 mobility of 14.9 cm2kV-1min-1, MEB dye A007
mobility of 14.3 cm2kV-1min-1, and TB dye A007 mobility of 14.9 cm2kV-1min-1). Following this
there is a subsequent decreasing mobility trend as the dye concentration is increased to 8x10-4 M.
This suggests that the change in mobility could be attributed to a decrease in the electroosmotic
flow with increasing background electrolyte(23-25). This type of effect is also observed with
increasing percentages of organic solvent in the separation phase(26-30). Salomon et al.(23) derived
an expression which describes the change in electroosmotic mobility as a function of buffer
(electrolyte) concentration:
µeo = (Q0/n(1 + Kwall[M+]))(d0 + 1/(K’([M+])1/2))
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(2)

Figure 2.3. Typical CELC chromatograms of A007 (Tdrug) at 5x10-5 M A007, A007:TB
Complex (Tdrug(carrier)) at 5x10-5 M TB and A007, A007:MEB Complex (Tdrug(carrier)) at 5x10-5 M
MEB and A007, A007:MEG Complex (Tdrug(carrier)) at 5x10-5 M MEG and A007, and Dye
(Tcarrier).
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The µeo is inversely proportional to both the ionic strength of the solution [M+], and to the
association of the cations to the silica wall (Kwall). An increase in either of these leads to a
decrease in the mobility.

The studies reported by Salomon measured the change in

electroosmotic mobilities for buffer concentrations ranging from approximately 2 mM to 40 mM.
The mobility change experiments performed on the A007:dye complexes reported here ranged
from 25.05 mM ionic to 25.8 mM ionic. This is a much lower change in ionic strength of the
separation phases suggesting perhaps a negligible contribution. The anti-cancer agent A007 at a
pH of 7.4 is neutral, therefore its mobility in buffer alone would represent the electroosmotic
flow of the system before titrating the separation phase with the dye ligand. A007’s mobility in
buffer alone was measured at 13.5 cm2kV-1min-1. This result is very similar to the mobilities
measured for A007 when 5x10-5 M dye (first data point, Figure 2.3) had been titrated into the
separation phases (MEG dye A007 mobility of 14.9 cm2kV-1min-1, MEB dye A007 mobility of
14.3 cm2kV-1min-1, and TB dye A007 mobility of 14.9 cm2kV-1min-1). Notice the slight increase
in mobility of A007 in separation phases containing 5x10-5 M dye versus the mobility of A007 in
buffer alone. The three dyes MEG, MEB, and TB are very similar in structure (see Figure 2.1),
and all possess a permanent positive charge. Therefore, the change in EOF due to increasing
concentrations of the dye ligands in the separation phase would be expected to be of similar
magnitude for the three systems, as was observed with the mobility of A007 with the titration of
5x10-5 M dye into the separation phases. As higher dye concentrations are titrated into the
separation phase, the mobilities of A007 are observed to decrease. This is attributed to the higher
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Figure 2.4. Plots of the mobility of A007 in increasing concentrations of methylene green,
methylene blue, and toluidine blue.
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background electrolyte effect described by eq 2. However, as the dye ligand is titrated into the
separation phase, the A007:dye electrostatic interaction is strong enough to produce a difference
in the mobility of A007 when comparing the three systems (e.g., A007 mobilities at 8x10-4 M
dye ligand: 4.03 ± 0.24 cm2kV-1min-1 for TB, 8.30 ± 0.76 cm2kV-1min-1 for MEB, and 9.04 ±
0.78 cm2kV-1min-1 for MEG). This illustrates that the dye ligand is playing an influential role in
the change in A007 mobilities through a direct electrostatic interaction in addition to EOF
changes due to high electrolyte background (see Figure 2.3).

It was at the 8x10-4 M

concentration of the dye ligand in the separation phase that the ranking of the relative binding
strength coefficients of the A007:dye complexes was calculated.
A binding strength coefficient (BC), eq 3, was derived based on the ratio of the
electrophoretic mobility of A007 in the presence of ligand, to that of the mobility of the free
A007. A BC of approximately 0.1 would indicate a weak binding, while a BC of 1 would
indicate the strongest binding. A similar ratio relationship was derived by Srinivasan et al.(31) to
directly calculate disassociation constants for noncovalent complexes between cyclodextrin and
barbiturates. The relationship derived and used for the BC ranking is as follows:
BC = µcomplex/µdrug

(3)

Figure 2.5 is a series of electropherograms illustrating the migration times of the dyes,
and A007 as sample in separation phases containing the dye ligands MEG, MEB, and TB. The
effective electrophoretic mobility, in the presence of electroosmotic flow, of component i was
calculated using the following equation(32):
ui = vi/E = vi⋅Lt/V [cm2⋅kV-1⋅min-1]

(4)

vi = vi(net) – veo = LD/ti – LD/teo [cm⋅min-1]

(5)

where:
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Combining equations 3 and 4 gives the standard mobility equation:
ui = (LD/ti – LD/teo)⋅LT/V [cm2⋅kV-1⋅min-1]

(6)

Equation (5) was further simplified, due to the absence of a measurable EOF, to:
ui = LDLTti-1V-1 [cm2⋅kV-1⋅min-1]

(7)

The calculated binding strength coefficients by ACE are listed in Table 2.1 along with the BC
values calculated from the CELC results.

________________________________________________________________________
Compound

ACE BC

CEC BC

Methylene green

0.67 ± 0.06

0.54 ± 0.05

Methylene blue

0.62 ± 0.06

0.24 ± 0.02

Toluidine blue

0.32 ± 0.02

0.18 ± 0.02

________________________________________________________________________

Table 2.1 Binding constant values for the methylene green, methylene blue, and toluidine blue
complexes with A007 by affinity capillary electrophoresis (ACE), and cation exchange
chromatography (CEC).
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Figure 2.5. Electropherograms of (a) the three dyes (co-migration), (b) the anti-cancer agent
A007, (c) A007:MEG complex, (d) A007:MEB complex, and (e) A007:TB complex.
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2.3.5 Comparison of Methods
As illustrated in Table 2.1, the ACE results show that MEG and MEB have very similar
binding coefficients, while TB was well differentiated. The ranking by CELC shows binding
coefficients that are more differentiated between the three, probably due to a much more direct
electrostatic binding strength determination than what is measured with the ACE approach.
The affinity capillary electrophoresis, ACE, method does have some general advantages
over the other two methods. The ES-MS/MS method describes a relative binding strength
between the complexes in the gas phase only. In general, gas phase binding strengths vary
greatly in agreement with solution phase binding strengths, always dependent on the system
being studied. In this work, a solution phase analytical method for binding strength
determination was needed. The cation exchange chromatography, CEC, approach gives a good
separation between the ranking values for the complexes, but the method requires considerable
column equilibration time with the changing of each mobile phase ligand (approximately 2 to 3
hours). In comparison the ACE method is fast (analysis completed between 10 to 30 minutes),
and requires little treatment between the changing of ligand separation phases (13 minute caustic
wash, followed by a 13 minute separation phase wash). A further advantage is that typical ACE
methods generally require samples in the nanomolar to micromolar concentration ranges, as
compared to millimolar levels as used in chromatographic methods such as the CELC method(33).
In general use, the ACE method would be utilized as a rapid screening determination of binding
strengths, while the CELC method would act as a more accurate, confirmation method.
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2.4 Conclusions
Affinity capillary electrophoresis has become a versatile tool in the study of many
descriptive parameters of complexes. Though this methodological approach has generally been
used for high affinity complexes, it can also be successfully used for complexes of low affinity,
or high disassociation, as demonstrated through the application to this dye-anti cancer agent
complex. The ACE method offers an alternative approach in the determination of binding
strength coefficients of complexes, with advantages over the other two methods studied, ESMS/MS and cation exchange liquid chromatography, respectively. The ACE method requires
less time for analysis, and also smaller sample sizes as compared to ES-MS/MS and CELC. The
cost for ES-MS/MS instrumentation can also be prohibitive for some laboratories. The ACE
method is robust, and can be applied as a general method for the determination of binding
strengths of non-covalent complexes. In its specific use for the dye:A007 system, the ACE
method would be utilized as a rapid screening determination of binding strengths, while the
CELC method would act as a more precise, confirmation method.
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CHAPTER III: DETERMINATION OF BOND DISSOCIATION ENERGIES USING
ELECTROSPRAY TANDEM MASS SPECTROMETRY AND A NOVEL DERIVED
EFFECTIVE REACTION PATH LENGTH APPROACH

3.1 Introduction
The measurement of the dissociation of gas-phase complexes by collision-induced
dissociation (CID) tandem mass spectrometry has been a useful approach in the study of
thermodynamic properties of complexes such as bond dissociation energies. Armentrout and
Beauchamp1 introduced an ion beam apparatus for the study of the bond dissociation energy
(BDE) of a cobalt carbene ion, and Armentrout et al. have since refined the measurement of noncovalent, collision-induced threshold bond energies of metal-ligand complexes by mass
spectrometry2-9. The array of uses of CID tandem mass spectrometry10 for the measurement of
thermodynamic properties of gas-phase complexes includes investigations of bond dissociation
energies11, gas-phase dissociative electron-transfer reactions12, non-covalent interactions10,13-15,
bond dissociation energies using guided ion beam tandem mass spectrometry2-9, critical energies
for ion dissociation using a quadrupole ion trap13, or a flowing afterglow-triple quadrupole14,15,
or an electrospray triple quadrupole16,17, and gas-phase equilibria18-20.
Electrospray21-24 is an ionization method that is well known to produce intact gas-phase
ions with minimal fragmentation during the ionization process. Thus, studies of gas-phase
thermochemical properties of species originating from solution are quite accessible by
electrospray mass spectrometry. MALDI is another “soft” ionization approach to gas-phase
ionic complex analysis, but the complex’s character in the solution phase can be lost during
crystallization with the matrix. However, Gidden et al.25 derived experimental cross sections for
a set of alkali metal ion cationized poly(ethylene terephthalate) (PET) oligimers using a MALDI
ion source coupled to a hybrid mass spectrometer.
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In this paper, we report on a mass spectrometry study of bond dissociation energies of
alkali metal (Li+) adducts, and halide (Cl-) adducts, of monoacylglycerol, 1,2-diacylglycerol, and
1,3-diacylglycerol lipids. The energies required for the dissociation of one acylglyceride from
lithium-bound dimers of monoacylglycerol, 1,2-diacylglycerol, and 1,3-diacylglycerol, were also
studied. The specific use of lithium adducts for ionization and structural analysis has been
reported for fast atom bombardment (FAB) of aryl 1,2-diols26 and fatty acids27, and ES
determinations of triacylglycerides28,29, and di- and tri-oligosaccharides30-33. Chloride ion has
also been reported to form adducts of diacylglycerols in liquid chromatography-negative
chemical ionization mass spectrometry34,35, and its adducts have been used for structural
elucidation employing ES-tandem mass spectrometry36-39.
In this work, all bond dissociation energies were measured using a “triple quadrupole”
(actually QhQ = quadrupole-hexapole-quadrupole) mass spectrometer using electrospray as the
ionization method. A new approach to the measurement of the dissociation of an alkali metal
ion, or a halide ion from ionic adducts of intermediate molecular weight lipids (316 Da to 596
Da) has been developed. An analogous model (differing only in input parameters used for
regression) to predict bond dissociation energies for low molecular weight cationic adducts such
as CH3OHLi+, C2H5OHLi+, ACNLi+, CH3OCH3Li+, etc., is also presented. The results obtained
from the mass spectrometry experiments were compared to both literature BDE values (when
available), and to computer generated BDE’s employing the Becke-style 3-Parameter Density
Functional Theory (B3LYP, using the Lee-Yang-Parr correlation functional, at the 6-31G*
level)40. The newly developed method does not require extensive calculations of degrees of
freedom, vibrational states, etc., which can be cumbersome for very high molecular weight
systems. It has been demonstrated to be applicable over a wide range of m/z values of the
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employed triple quadrupole, i.e. from the detection of the lithium ion at m/z 7, up to the 1stearin-2-palmitin diacylglycerol lithium-bound dimer ion at m/z 1199.

3.2 Experimental
Mass spectra were obtained using a “triple quadrupole” (actually quadrupole-hexapolequadrupole, QhQ) mass spectrometer (Quattro II, Micromass, Inc., Manchester, UK) equipped
with an electrospray source operating at solution flow rates of 2-4 µL/min. Nitrogen was used as
both nebulizing and drying gas. Cone voltages were 18 V for the low molecular weight lithiumsolvent adducts, and 40 V for lithium adducts of the higher molecular weight lipids. The ES
capillary voltage was set at 2.5 to 3.5 kV. Argon was used as collision gas during CID
experiments at pressures of approximately 1.3 x 10-4 mBar (measured externally to the central
hexapole collision cell) for single collision measurements. The hexapole offset energy values
range from 0 eV up to 250 eV with a minimum increment of 1.0 eV. MassLynx software
(Micromass) was used to acquire, process, and store mass spectral data.

3.3 Results and Discussion
3.3.1 Measurement of Collision Cell Path Length
In calculating thermochemical values such as the bond dissociation energy for a gasphase ionic complex by CID tandem mass spectrometry, the collision cell path length, or the
mean free path of reaction, are most often unknown. One approach to estimating this collision
path length would be to interject guesses into data reduction equations to iteratively test which
value results in a best fit. Chen et al41 presented a new model for determining bond energies for
holomyoglobin noncovalent gas-phase complexes where the collision cell path length is
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described as the average distance that ions travel before dissociating. In their method, estimated
values for the path length were iteratively used until a realistic fit was obtained. A second
approach would be to employ the actual measured dimensions of the gas cell, e.g., the central
hexapole. This is essentially the method used by Ervin et al.2, where the dimensions of their gas
cell are well-defined, but they also take into account the pressure profile of the collision gas
within the system to derive an effective cell length. The approach taken in our new method is to
measure the dissociation of standards with known BDE values to obtain IP/I0 values which then
can be related to the reaction path length according to the thin target limit equation2:
IP/I0 = IP/(IR + ∑ IP) = σPnl

(1)

where IP is the transmitted product ion signal intensity, IR is the transmitted reactant ion signal
intensity, I0 is the incident ion signal intensity, σP is the product cross section (cm2), n is the
number gas density (cm-3), and l is the collision cell path length (cm). In this approach, it is
assumed that the sum of the transmitted product peak intensities is equal to the incident reactant
ion peak intensity; the latter in actuality, is not readily measurable. Therefore, a “derived
effective reaction path length” is being obtained from the measurement of known standards. At
the thin target limit, the effective path length represents the average distance that the complex
travels before dissociation takes place (or the average distance of travel before one collision
resulting in dissociation occurs). According to the thin target limit (eq 1), the slope of a plot of
the IP/(IR + ∑ IP) ratio, versus number gas density, is related to the collision cross section2. The
number gas density, n, is calculated according to the ideal gas law42:
n = PL/RT = P/kBαT

(2)

where P is the pressure in atm, kB is the Boltzmann constant, α is a conversion factor of 9.869
cm3atm/J, and T is the temperature in kelvin. Figure 3.1 displays mass spectra obtained from
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lithium adducts of methanol, used as a standard for effective reaction path length determination,
and it depicts the emergence of the dissociation of the lithium cation from the precursor adduct.
For bond dissociation energy calculations, the supplied energy for the collision is converted from
the laboratory frame of reference to the center-of-mass frame of reference according to ECOM =
ELAB(m/(m + M)), where ELAB is the selected value of the offset for the central hexapole, m is the
mass of the stationary target Ar atom, and M is the mass of the precursor ion. Figure 3.1a shows
the measurement of the incident lithium adduct ion without the detection of the lithium cation at
0 eV offset value for the central hexapole. Figure 3.1b shows the emergence of the dissociated
lithium cation, at m/z 7, from the precursor methanol/lithium adduct at an offset value = 0.50 eV
(center-of-mass frame of reference, ECOM) for the central hexapole. This illustrates that the initial
dissociation of the adduct can be measured, but the spectra indicate an earlier threshold energy
value than what is expected from the known BDE of 1.596 eV9. Figure 3.1c is the spectrum
acquired at a 1.01 eV ECOM offset for the central hexapole. The ratio of the intensities of the
lithium cation peak to the precursor peak at 0.5 eV is 8.0 x 10-5, while at 1.0 eV the ratio is 2.5 x
10-4, demonstrating that the employed triple quadrupole possesses the required sensitivity to
perform gas-phase thermochemical bond dissociation energy measurements.
Figure 3.2a is a graph of the IP/(IR + ∑ IP) ratio versus number gas density for a dimethyl
sulfoxide (DMSO) lithium adduct standard. The values in the graph were obtained by acquiring
product ion mass spectra from CID of the DMSO lithium adduct at fixed collision energy (ELAB
= 10 eV) but increasing gas cell pressures; the latter equates to an increasing number gas density
of argon. The “zero point” collision cell gas pressure corresponds to the pressure measured in
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Figure 3.1. CID product ion mass spectra of the lithium adduct of methanol (m/z 39) illustrating
the appearance of the dissociation of the lithium cation (m/z 7, BDE = 1.596 eV12). (a) 0 eV, no
detection of lithium, (b) emergence of the dissociated lithium cation at 0.50 eV (ECOM), and (c)
1.01 eV (ECOM).
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the analyzer in the absence of argon, i.e., 7 - 8 x 10-6 mbar (1.7 - 1.9 x 1011 cm-3, expressed as
number gas density), representing a very small probability for collisions with nitrogen or other
ambient gas. The slope of the curve in Figure 3.2a, which is related to the product cross section
according to the thin target limit (eq 1)2 as slope = σPl, can be extracted from the plot and then
used to calculate the cross sections of the DMSO lithium adducts, and estimate l of the QhQ
mass spectrometer. For the initial cross section calculations using the thin target limit ratio
relationship σP = slope/l, we assign l = 1 cm. This assignment allows the simplifying
approximation that σP = slope, but also necessitates a subsequent correction of the derived
reaction path length, i.e., actual length l = 1 cm + correction. Figure 3.2b is a plot of the IP/(IR +
∑ IP) ratio versus ECOM for CID of the DMSO lithium adduct, at a fixed collision gas pressure of
1.3 x 10-4 mBar (number gas density of 3.14 x 1012 cm-3). The IP/(IR + ∑ IP) ratio is directly
related to the cross section according to the thin target limit (eq 1). Therefore, it is assumed that
at constant n and l values, the change in the IP/(IR + ∑ IP) ratio will be directly proportional to the
change in the cross section. From this assumption arises the basic premise of our method, i.e., the
magnitude in the change of the IP/(IR + ∑ IP) ratio can be used to predict the subsequent
decreasing cross sections, from the initial number gas density determined cross section, for
decreasing energies in the center-of-mass frame of reference.
Figure 3.2c shows the derived cross sections for the DMSO lithium adduct. Figure 3.2c is
generated by first evaluating the cross section from the number gas density plot of Figure 3.2a
obtained at the highest collision energy (ELAB = 10 eV) where the S/N of the product ion is
maximized. Then, each subsequent energy cross section at progressively lower energies is
calculated relative to this initial point, according to the magnitude of the change in the ratios
given in Figure 3.2b. The reference BDE value for the DMSO lithium adduct is 2.36 eV43.
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Taking this literature BDE value, the best fit of Figure 3.2b gives an IP/(IR + ∑ IP) ratio of 1.879
x 10-3, at a number gas density of 3.14 x 1012. The best fit of Figure 3.2c gives a cross section
value of 2.878 x 10-16 cm2, at 2.36 eV, and number gas density of 3.14 x 1012. These three values,
the number gas density of 3.14 x 1012, the IP/(IR + ∑ IP) ratio of 1.879 x 10-3, and the cross
section of 2.878 x 10-16 cm2, can then be used to calculate an experimentally derived corrected
effective reaction path length (initially set at 1 cm) using the thin target limit relationship,
namely l = 2.08 cm (see Appendix 1 for example calculations). This approach was also used
with lithium adducts of MeOH, DMF, and ACN to calculate an average effective reaction path
length of 1.95 ± 0.56 cm (using 7 individual determinations). This experimentally derived
effective reaction path length value was then used in all subsequent cross section calculations
and ensuing BDE evaluations.

3.3.2 Theoretical Calculation of BDE and Optimized Structures
There are now numerous bond dissociation energy values in the literature for many small
compounds that are adducted to lithium ion (ranging anywhere from 4 up to 30 atoms), but not
larger compounds such as the lipids which are described here (ranging from 40 to 119 atoms).
With no literature values available, in order to determine whether reasonable bond energy values
were obtained for the unknown lipids using the triple quadrupole mass spectrometer, theoretical
bond energy values were calculated using Becke-style 3-Parameter Density Functional Theory
computational methods (B3LYP, using the Lee-Yang-Parr correlation functional, at the 6-31G*
level). The computer modeling experiment consists of minimizing the potential energy of a
lithium-lipid adduct structure, and then sequentially altering the lithium ion distance to the lipid

37

(a)
0.07
0.06

Ip/(IR + ΣIp)

0.05
0.04
0.03
0.02
0.01
0.00
0

12

1x10

12

2x10

12

12

3x10

12

4x10

5x10

6x10

12

12

7x10

8x10

12

-3

Number Gas Density (cm )

(b)

Energy (eV, LAB)
0

2

3

0.0

0.5

1.0

5

6

8

9

11

1.5

2.0

2.5

3.0

3.5

0.003
0.003

Ip/(IR + ∑ IP)

0.002
0.002
0.001
0.001
0.000

Energy (eV, COM)

(c)

Energy (eV, LAB)
0

2

3

0.0

0.5

1.0

5

6

8

9

11

1.5

2.0

2.5

3.0

3.5

-16

5.0x10

-16

2

Cross Section (cm )

4.0x10

-16

3.0x10

-16

2.0x10

-16

1.0x10

0.0

Energy (eV, COM)

Figure 3.2. (a) Ratio of product ion abundances to incident ion abundances (the latter is
approximated by (IR + ∑ IP)), versus number gas density for the lithium adduct of DMSO at
constant collision energy (ELAB = 10 eV). The slope of the curve is related to the product cross
section (σP) of the lithium-DMSO cationic complex according to the thin target limit as σP =
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slope/l, (b) plotted results of IP/(IR + ∑ IP) ratio versus collision energy (ELAB, top) (ECOM,
bottom) for the dissociation of the DMSO-lithium adduct. The best fit gives an IP/(IR + ∑ IP)
ratio of 1.879 x 10-3, at 2.36 eV42, and a number gas density of 3.14 x 1012, used in calculating a
derived effective reaction path length, and (c) calculated cross sections for the DMSO-lithium
cationic adduct employing the σP = slope/l relationship from Figure 3.2a and the proportional
changes of the IP/(IR + ∑ IP) ratios with collision energy in Figure 3.2b. Using the 2.36 eV BDE
value, the best fit of Fig. 3.2c gives a cross section value of 2.878 x 10-16 cm2 and, by the thin
target limit relationship, a path length of l = 2.08 cm.

(i.e., assigning incrementally larger distances to the nearest neighboring atom via increases in the
“R” parameter of Gaussian 9840) while performing potential energy surface scans of the adduct
complex at each step. The obtained potential energies are plotted versus distance, and the
electrostatic bond dissociation energy can be calculated from the difference between the potential
energy obtained at the minimum, and the potential energy at complete dissociation, i.e., where
the charge on the lithium has reached +1 and does not change. Figure 3.3a illustrates an
optimized structure, and a plot of the potential energy surface scans versus distance for the
orientation is found for the lithium adduct of 1,3-dipentadecanoin, where the lithium cation has
oriented itself between the two carbonyl oxygens, and the oxygen atom of the hydroxyl group.
The distance between the lithium cation and the hydroxyl oxygen is 2.01 angstroms, and the
distance between the lithium cation and the two carbonyl oxygens is 1.88 and 2.00 angstroms.
For the lithium adduct of 1-stearin-2-palmitin diacylglycerol, the lithium cation was also found
to orient itself between the two carbonyl oxygens of the 1- and 2-position fatty acyl chains and
the oxygen of the hydroxyl group. The distance between the lithium cation and the hydroxyl
oxygen is 1.97 angstroms, whereas the distance between the lithium cation and the two carbonyl
oxygens is 1.88 and 2.04 angstroms.
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Figure 3.3.
Optimized structures and computer modeling results for the theoretical
determination of the electrostatic bond dissociation energies for: (a) The monopentadecanoin
lithium adduct. The lithium cation is initially located between the carbonyl oxygen at a distance
of 1.86 angstroms, and the 1-position hydroxyl oxygen at 1.96 angstroms. The distance to the 2position hydroxyl oxygen is 1.92 angstroms. The bond dissociation energy value is extracted as
the difference in the energy from the minimum of the potential well, to the electrostatic bond
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distance where the charge has reached unity for the adducted ion. The BDE was calculated to be
3.72 eV. (b) The monopentadecanoin chloride adduct. The chloride anion is between the 1position and 2-position hydoxyl hydrogens, each at a distance of 2.18 angstroms. The BDE was
calculated to be 1.56 eV.
The same approach was used for calculating the bond dissociation energies for chloride
adducts of the lipids: Figure 3.3b illustrates an optimized structure, and a plot of the potential
energy surface scans versus bond distance for the chloride adduct of monopentadecanoin. The
chloride anion is situated nearest to the 1-position and 2-position hydroxyl hydrogens at
distances of 2.18 angstroms and 2.18 angstroms, respectively, as would be expected due to their
higher acidities (more electropositive hydrogens) as compared to hydrocarbon hydrogen atoms.
Orientation of the chloride ion in close proximity to the lone hydroxyl hydrogen is found for the
optimized structures of the 1,2- and 1,3-diacylglycerols. For the 1,2-diacylglycerol-chloride
adduct, the distance between the hydroxyl hydrogen and the chloride ion is 2.09 angstroms,
while for the 1,3-diacylglycerol, the distance is 2.07 angstroms.

3.3.3 Mass Spectral Determination of Li+ and Cl- Lipid Adduct BDE’s
The first electrostatic complex that was measured using the newly proposed derived
effective path length approach was the cationic lithium adduct of monopentadecanoin. In order
to determine the thresholds for the endothermic CID reaction:
M+L

Ar (gas)

M+ + L

(3)

where M is the metal cation, L is the lipid, and Ar is the stationary target gas, the free metal
cation M+ (m/z 7) and the precursor ion M+L (m/z 323) signals are measured at increasing
collision energies, as are all other products formed via CID. Figure 3.4 shows the emergence of
the lithium cation (m/z 7) near the threshold energy for eq 3. Figure 3.4a is the CID product ion
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mass spectrum obtained at 2.75 eV (ECOM), where the lithium metal cation is present only at
noise level (S/N = 2). In Figure 3.4b, a significant peak at m/z 7 has emerged for the lithium
cation (S/N = 6) at 3.30 eV (ECOM) indicating that the threshold energy for eq 3 has been
acheived. The bond dissociation energy value for the lithium-monopentadecanoin adduct
calculated from the computer modeling results illustrated in Fig. 3.3a was 3.72 eV. This gives a
threshold energy value that is just below the ECOM value of 3.85 eV that was used to obtain the
CID product ion spectrum shown in Fig 3.4c.
The appearance of decomposition products at an energy lower than the threshold energy
for dissociation as calculated by computer modeling can be the result of a combination of factors
which contribute to error in the direct measurement of a threshold energy value for eq 3. The
magnitude of uncertainty in potential energy calculations at the B3LYP 6-31G* level has been
estimated to be 3.9 kcal•mol-1, or 0.17 eV44 (mean absolute deviation).
Uncertainty in mass spectrometrically estimating dissociation energies has been
attributed to: (1) initial internal energy content which may lead to metastable decompositions
(resulting in underestimation of BDE’s), (2) non-neglible translational energy at 0 eV (ELAB)
collision energy (underestimation of BDE’s)15,16, (3) collisions outside of the reaction cell (e.g.,
in Q1)15,16 (underestimation of BDE’s), (4) instrumental bias against observation of “slow
kinetics” reactions (overestimation of BDE’s)45, and (5) deposition of energy in competitive
vibrational excitation modes (overestimation of BDE’s)46. Some competitive fragmentation
reactions were observed in most of the product ion mass spectra, as illustrated in Figure 3.5.
Figure 3.5a is the CID spectrum obtained for the decomposition of lithium adducts in the
reaction threshold range at 3.85 eV (ECOM), illustrating a small contribution to the relative error
in the measurement of the BDE if only the intensity of the lithium cation is used as ∑ Ip instead
of using the actual sum of the products as ∑ IP in calculating I0 = IR + ∑ IP. If the intensities of
the “extraneous” products are much smaller than the precursor, then the product ion intensities
that are not being monitored can be neglected when applying eq 12. However, in this study it
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Figure 3.4. Product ion mass spectra illustrating the appearance of the lithium cation upon CID
of the lithium-monopentadecanoin adduct near the threshold energy for dissociation. ECOM
energies: (a) 2.75 eV, (b) 3.30 eV, (c) 3.85 eV, threshold area, and (d) 4.40 eV.
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was observed that many of the lipids yielded other CID fragment ions, in addition to the loss of
the lithium cation, at abundances that could not be considered much smaller than the precursor.
Therefore, in evaluating cross sections for each precursor adduct displayed in Fig. 3.5, product
ion abundances for all fragmentation pathways were summed along with the transmitted
precursor abundance when applying eq 1.
Figure 3.5b is the product ion spectrum of the Li+ adduct of another lipid, i.e., 1-stearin,2palmitin diacylglycerol at 3.10 eV (ECOM). The spectrum shows a considerable number of lower
abundance products formed during CID, in addition to the lithium cation.

Figure 3.5c also

shows product ions in addition to the lithium cation for the CID of a third lipid, 1,3dipentadeacoin lipid, at 3.74 eV (ECOM). In both the chloride adduct studies and the dimer
dissociation studies, competitive product fragment ions were not observed and posed no problem
as contributors to error in estimating I0. Furthermore, the use of electrospray as the ionization
method helps to reduce error, as only a minimal amount of internal energy is imparted to the
complex during ionization, owing to the soft nature of the ES process (no physically imparted
desorption/ionization energy such as laser flux or heat in MALDI). In addition, cooling collisions
in the source region, and relaxation of the complex through the desolvation process, help to
dissipate the low amount of internal energy initially present.
According to the simplified version of Rice-Ramsperger-Kassel-Marcus (RRKM)
theory47, the rate of a unimolecular decomposition is approximated by:
k(E) = ν(E – E0/E)n-1

(4)

where n is the number of vibrational degrees of freedom, ν is the frequency factor, E is the
kinetic energy, and E0 is the threshold energy for reaction. Eq 4 is directly related to the
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Figure 3.5. Competitive fragmentation reactions in CID of product ion mass spectra of lithiumlipid adducts illustrating a contribution to error in the measurement of BDE’s. (a) Lithium adduct
of monopentadecanoin in the reaction threshold range (3.85 eV ECOM). (b) Lithium adduct of 1stearin,2-palmitin diacylglycerol at 3.10 eV (ECOM). (c) Lithium adduct of 1,3-dipentadeacoin at
3.74 eV (ECOM). All three show a considerable array of fragmentation products.
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activated complex’s populated energy states. The theoretically derived mathematical function
used to obtain a best fit of the experimentally determined cross sections, according to the
transient energy states of the decomposing ion at the time of the dissociating collision is1,9:
σ(E) = σ0∑gi(E + Ei – E0)n / Em

(5)

where E and E0 remain as above, Ei represents the individual reactant states (electronic,
rotational and vibrational) with populations gi, σ0 is a scaling factor, and n and m are adjustable
parameters. According to the thin target limit relationship of the reaction cross sections (σp) to
the measured intensities in eq 1, the cross sections for the determination of the threshold energy
for eq 3 can be calculated for each of the lithium adducts in Figs. 3.5a, b, and c. Figure 3.6a
shows the results of these cross section calculations at increasing collision energies, covering an
activation energy range approximately three times that of the threshold energy region, for
decompositions of the lithium adduct of monopentadecanoin. The cross sections (right axis) are
related to the ratio of abundances of the product ions over all ions (left axis) through eq 1.
Consistent with the mathematical forms of equations 4 and 5, curve fitting of the cross sections
obtained from the mass spectrometric measurements of the BDE’s for the lithiummonopentadecanoin electrostatic adduct, as well as all the other adducts measured, was
empirically observed to fit an exponential growth equation of the following form:
σP(E) = σ0exp(ECOM/α) + y0

(6)

where σP(E) is the experimentally determined cross section in cm2, σ0 + y0 is the y-intercept of
the fit in cm2 (for multivariate regression, y0 is insignificant enough to be neglected, see
multivariate regression bond energy prediction section below). This equation effectively relates
the product cross section to the system energy (supplied by the central hexapole offset) in the
center-of-mass frame of reference. The suitability of a single exponential equation is
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serendipitous in that the ensuing multivariate regression entails fewer independent variables (as
compared to higher order equations), allowing relative ease in deriving the polynomial equation
used to estimate BDE values. The solid line in Figure 3.6a shows the fit of the experimentally
determined cross sections in the threshold region of the dissociation of the lithiummonopentadecanoin adduct, calculated using eq 6. Figure 3.6b shows the results of single
exponential curve fitting of the cross section vs energy for the chloride adduct of
monopentadecanoin.

Analogous calculations were made for the other two lipids, i.e., the

diacylglycerols 1-stearin,2-palmitin diacylglycerol, and 1,3-dipentadecanoin introduced in Figs.
3.5b and 3.5c, respectively. Figure 3.7a shows the cross sections for the lithium adduct of 1stearin,2-palmitin diacylglycerol, and Figure 3.7b is a plot of the cross sections for the chloride
adduct of 1-stearin,2-palmitin diacylglycerol, each versus collision energy. Figures 3.8a and
3.8b are plots of the cross sections versus collision energy for the lithium and chloride adducts,
respectively, of 1,3-dipentadecanoin diacylglycerol. The curves shown in Figs. 3.6-3.8 will be
used to apply the derived effective reaction path length method to deduce BDE values for each
compound in the following section.

3.3.4 MULTIPLE REGRESSION MODEL FOR PREDICTING BDE’s
3.3.4.1 High molecular weight BDE predictive model
The general multivariate growth curve model (GCM-Polynomial Regression)48 was used
to create a predictive model for bond dissociation energies involving the relatively high
molecular weight lipid standards, using the cross section results obtained for the ES triple
quadrupole mass spectrometer. Single exponential cross section vs energy curves, derived as
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Figure 3.6. (a) Plot of the ratio of abundances of the dissociated lithium cation to the total
product ions (IP/(IR + ∑ IP), left y-axis) in an energy range that is approximately 3 times greater
than the expected dissociation threshold energy of 3.72 eV predicted by computer modeling.
The reaction cross sections for the lithium adduct of monopentadecanoin, illustrated on the right
y-axis, are calculated from the experimentally obtained ratios according to eq 1. The solid line is
the best-fit of the experimental data using eq 6. The bond dissociation energy for CID of the
lithium cation was experimentally determined to be 3.69 ± 0.29 eV (ECOM). The theoretical value
was calculated to be 3.72 eV. (b) Cross sections of the chloride adduct of monopentadecanoin.
The bond dissociation energy was experimentally determined to be 1.65 ± 0.05 eV (ECOM) for
CID of the chloride anion. The theoretical value was calculated to be 1.56 eV.
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Figure 3.7. Cross section vs collision energy for: (a) the lithium adduct of 1-stearin,2-palmitin
diacylglycerol, with a growth curve model predicted BDE of 3.59 ± 0.18 eV (theoretical
predicted value: 3.98 eV), (b) the chloride adduct of 1-stearin,2-palmitin diacylglycerol, with a
growth curve predicted BDE of 1.26 ± 0.03 eV (theoretical predicted value: 1.37 eV).
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Figure 3.8. Cross section vs collision energy for: (a) the lithium adduct of 1,3-dipentadecanoin
diacylglycerol, with a growth curve model predicted BDE of 3.78 ± 0.39 eV (theoretical
predicted value: 3.52 eV), (b) the chloride adduct of 1,3-dipentadecanoin diacylglycerol, with a
growth curve predicted BDE of 1.63 ± 0.23 eV (theoretical predicted value: 1.48 eV).

50

outlined in the previous section for each lithium and chloride adduct of the monopentadecanoin,
dipentadecanoin, and 1-stearin,2-palmitin diacylglycerol standards, were used to create a
multivariate curve polynomial expression that can be used to calculate BDE values for unknown
complexes. To create the polynomial expression, the independent parameters of eq 6, σ0 and α,
are regressed with the dependent variable represented by the BDE values (obtained from DFT
computational methods) for each experimentally evaluated complex that had generated a single
exponential cross section vs energy curve. Analysis of the variance gave an adjusted regression
factor of 0.928, and a probability factor of < 0.0001, demonstrating the statistical significance of
the multivariate growth curve model. The model resulted in the following general second order
polynomial descriptive equation that was subsequently used to predict the bond dissociation
energies of the higher molecular weight (e.g., m/z 300 to 700) adducts:
BDE (eV) = 0.78051 – 1.7180x1013σ0 + 1.4627α - 0.16327α2

(7)

To use this equation to predict a BDE for an unknown complex, it is first necessary to generate a
single exponential cross section vs energy curve that will provide values for the σ0 and α
parameters. Table 3.1 is a compilation of the results obtained from the newly developed single
exponential cross section vs energy method, juxtaposed against the theoretical computer
modeling method, and where applicable, the “50% dissociation of dimers” method (see “Mass
Spectral Determination of Li+ Lipid Dimer Adduct BDE’s” section below). Also included in the
table are the theoretical charges and closest electrostatic bond distances of either the lithium ion,
or the chloride ion, for the computationally optimized structures of the complexes. The cationic
lithium adducts, the anionic chloride adducts, and the dimers are relatively large systems,
spanning molecular weights from 323 Da to 603 Da, that contain substantial numbers of
vibrational degrees of freedom. This is reflected in the magnitude of observed coefficients of
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variation (CV) for the studied systems such as 7.6% for the lithium adduct of
monopentadecanoin, 10.5% for the lithium adduct of dipentadecanoin diacylglycerol, and 4.8%
for the lithium adduct of 1-stearin,2-palmitin diacylglycerol. Overall, excellent agreement is
observed between the theoretical BDE’s obtained from computational molecular modeling, and
those obtained by the multivariate growth curve fitting method using one second order
polynomial (eq 7) to evaluate all three types of complexes (Table 3.1). The relative uncertainty
of the experimentally determined bond dissociation energies using this method is approximated
to be ± 7%, while absolute uncertainties are estimated to range between 10 and 20%. Rodgers et
al.8, reported cross section absolute uncertainties of ± 20%, and relative uncertainties of ± 5% for
their guided ion beam mass spectrometer. The variation in their cross section measurements was
attributed to errors in gas cell pressure measurements, and errors in estimating interaction region
lengths. In the method reported here, gas cell pressure uncertainty still exists, but the calculation
of an effective reaction path length is believed to reduce the magnitude of the path length error’s
contribution to uncertainty in BDE estimations.

3.3.4.2 Low molecular weight BDE predictive model
The general multivariate growth curve model (GCM-Polynomial Regression) was used to
evaluate bond dissociation energies of adducts of relatively low molecular weight solvent
standards, using the ES triple quadrupole mass spectrometer cross section results according to
the procedure outlined above. It was found that the regression and probability factors were much
improved when high molecular weight compounds were regressed separately from low
molecular weight compounds. For this reason, a separate general second order polynomial
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Adduct

Theoretical

Measured BDE

Charge

Electrostatic

BDE

(eV)

on

bond Distance

Li+ or Cl-

of

(eV)

Li+ or Cl(angstroms)
Li+ monopentadecanoin

3.72

3.69 ± 0.29

+0.628

1.9

Cl- monopentadecanoin

1.56

1.65 ± 0.05

-0.777

2.2

Li+ monopentadecanoin Dimer

NAc

1.43 ± 0.04 (exp)a

+0.527

NAc

or
1.31 ± 0.32 (50%)b
Li+ 1,3-dipentadecanoin

3.52

3.78 ± 0.39

+0.669

1.9

Cl- 1,3-dipentadecanoin

1.48

1.63 ± 0.23

-0.845

2.1

Li+ 1,3-dipentadecanoin Dimer

NAc

1.43 ± 0.01 (exp)a

+0.595

NAc

or
0.90 ± 0.09 (50%)b
Li+ 1-stearin-2-palmitin

3.98

3.59 ± 0.18

+0.579

1.9

1.37

1.26 ± 0.03

-0.836

2.1

NAc

1.38 ± 0.01 (exp)a

NAc

NAc

glycerol
Cl- 1-stearin-2-palmitin
glycerol
Li+ 1-stearin-2-palmitin
glycerol Dimer

or
1.16 ± 0.07 (50%)b

a

Experimental BDE obtained from the newly developed single exponential cross section vs

energy method.
b
c

Experimental BDE obtained from 50% dissociation as illustrated in Figure 3.10.
NA: Not analyzed, computational BDE not reported.

Table 3.1. Calculated (theoretical) BDE values, charges on Li+ or Cl-, and distances obtained
using the Becke-style 3-Parameter Density Functional Theory. The measured BDE values were
extracted from the plotted results of cross sections versus center-of-mass energies, obtained by
tandem mass spectrometry.
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descriptive equation was used to predict the bond dissociation energies of the low molecular
weight (e.g., m/z 30-100) adducts:
BDE (eV) = -4.22589 – 9.83647x1015*σ0 + 14.3319*α +2.20399x1031*σ02 – 7.43328*α2
(8)
Table 3.2 is a compilation of the results obtained from the newly developed single exponential
cross section vs energy method using eq 8 to predict the BDE’s. Overall, excellent agreement
between the literature BDE’s and the single exponential cross section vs energy method is
observed for the low molecular weight complexes studied, as illustrated in Table 3.2.

Adduct

Reference BDE

Model Fit BDE

(eV)

(eV)

1.596 (0.083)9

1.57 ± 0.08

ACNLi+

1.46843

1.60 ± 0.15

DMSOLi+

2.3643

2.44 ± 0.12

DMFLi+

2.4343

2.20 ± 0.09

C2H5OHLi+

1.70 (0.08)9

1.72 ± 0.06

CH3OCH3Li+

1.71 (0.11)9

1.68 ± 0.18

CH3OHLi+

Table 3.2. Comparison of the model fitted results for the low molecular weight lithium adduct
standards versus the measured BDE calculated from growth curve multivariate regression
models from the single exponential cross section vs energy method, obtained by ES triple
quadrupole tandem mass spectrometry. Parentheses represent uncertainties in the BDE values.

3.3.5 Mass Spectral Determination of Li+ Lipid Dimer Adduct BDE’s
The primary method used for the CID tandem mass spectrometric determination of BDE
values for dimers is to equate the point of 50% dissociation, measured as ML/(ML + M2L), to the
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center-of-mass collision energy11,39. All of the lipids that were used in the current study (i.e., the
monoacylglycerol, the 1,2-diacylglycerol, and the 1,3-diacylglycerols), have been observed to
form lithium-bound noncovalent dimers of the form [M2Li]+. Using the high molecular weight
growth model developed for our triple quadrupole, the energy for the dissociation of the
monopentadecanoin dimer was measured to be 1.43 ± 0.04 eV. Figure 3.9a shows the results of
the mass spectrometric determination of the BDE for the lithium-bound monopentadecanoin
dimer in the range of the threshold energy for dissociation. Figure 3.9b plots the experimentally
determined cross sections versus collision energy for the dissociation of the 1,3-dipentadecanoin
lithium bound dimer. The growth curve model yields a dissociation energy of 1.43 ± 0.01 eV for
the 1,3-dipentadecanoin lithium-bound dimer. Figure 3.9c presents the results of the 1-stearin,2palmitin diacylglycerol lithium-bound dimer dissociation with an estimated BDE value of 1.38 ±
0.01 eV.
Figure 3.10a is a plot of the ratio of the product ion abundance (from the dissociation of
the monoacylglycerol dimer) over the total ion abundance (to approximate the precursor ion
abundance), MLi+ / (MLi+ + M2Li+). The BDE’s for the different dimer systems were obtained
by fitting 4th order polynomials to the MLi+ / (MLi+ + M2Li+) ratio data versus collision energy,
setting the fitted polynomial equal to 0.50, and then solving for the roots. Inspection of the roots
always gave an obvious choice as to the BDE for the dimer system being studied. For 50%
dissociation of the monopentadecanoin dimer an ECOM of 1.31 ± 0.32 eV was experimentally
required (growth curve model predicted a BDE = 1.43 ± 0.04 eV). Figure 3.10b is a plot of the
ratio of the product ion from the dissociation of one of the 1,3-diacylglycerol dimers over the
parent ion intensity, MLi+ / (MLi+ + M2Li+). For 50% dissociation, an ECOM of 0.90 ± 0.09 eV
was needed (growth curve model predicted a BDE = 1.43 ± 0.01 eV). Figure 3.10c is the plotted
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results of the 1- stearin,2-palmitin diacylglycerol lithium bound dimer, with a 50% dissociation
ECOM value of 1.16 ± 0.07 eV (growth curve model predicted a BDE = 1.38 ± 0.01 eV). The
experimentally obtained energy values corresponding to 50% dissociation are fairly close to the
growth curve model predicted BDE’s (Table 3.1). The former may be slightly lower owing to
specific issues leading to underestimation of BDE’s as previously discussed.

3.4 CONCLUSIONS
An important aspect of accurately determining bond dissociation energies by CID mass
spectrometry is the measurement of a gas-phase reaction cell path length. The newly developed
“derived effective reaction path length” method described here does not require extensive
calculations of degrees of freedom, vibrational states, etc., which can be quite cumbersome for
very large molecular weight systems.

Unlike previous approaches, the method bases the

determination of the reaction path length on data obtained from the CID reactions of known
standards. Moreover, it can be implemented on standard commercial tandem mass spectrometers
such as the triple quadrupole. By deriving an effective reaction path length using known
standards, an empirically “error corrected” collision cell length is made available for use in the
ensuing cross section/BDE calculations, and the error associated with reaction path length
assignment is decreased. This reduction in uncertainty combined with the fact that electrospray
can effectively transfer a solution phase complex into the gas phase with minimal energy uptake
and perturbation of the complex, make the study of adducts by the derived effective reaction path
length approach attractive. We have further built upon the derived effective reaction
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Figure 3.9. Cross section vs collision energy for: (a) the lithium-bound monopentadecanoin
dimer. The BDE of 1.43 ± 0.04 eV (ECOM), for dimer dissociation was obtained from the
exponential growth curve model, (b) the lithium-bound 1,3-dipentadecanoin dimer. The growth
curve model yielded a dissociation energy of 1.43 ± 0.01 eV, (c) the lithium-bound 1-stearin,2palmitin diacylglycerol dimer, yielding a BDE value of 1.38 ± 0.01 eV.
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Figure 3.10. Ratio of MLi+ to (MLi+ + M2Li+) for the CID of lithium-bound dimers of: (a)
monopentadecanoin. The BDE extracted from the point of 50% dissociation gives a value of
1.31 ± 0.32 eV ECOM (exponential growth curve model predicted 1.43 ± 0.04 eV). (b) 1,3dipentadecanoin. At 50% dissociation, the BDE was measured to be 0.90 ± 0.09 eV (growth
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curve model predicted 1.43 ± 0.01 eV). (c) 1-stearin,2-palmitin diacylglycerol with a 50%
dissociation energy value of 1.16 ± 0.07 eV (growth curve model predicted 1.38 ± 0.01 eV).
path length and introduced a single exponential cross section vs energy method to enable the
estimation of BDE’s for relatively high molecular weight compounds. While the newly
developed methodology has been rigorously tested on a triple quadrupole that uses a central
hexapole collision cell, we see no reason that the method could not be applied to a Q-ToF, or any
other instrumental configuration employing a floated collision cell under user control.
Density functional theory calculations of BDE’s allowed a comparison with BDE’s
obtained using the derived effective reaction path length approach and subsequent curve fitting
procedures; excellent agreement was observed for all of the lipid adducts and dimers studied.
The monoacyl, 1,2- and 1,3-diacylglycerols, had very similar bond energies for the adducted
lithium (3.5 eV to 4.0 eV), and adducted chloride (1.4 eV to 1.6 eV) ions.

This study

demonstrates that the derived effective reaction path length approach can be used for cationic
and anionic adducted compounds, for dimers, and for larger molecular weight complex systems
such as lipids.
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3.6 APPENDIX 1
Derived effective path length calculation
Using the three following values for the BDE determination of the lithium adduct of DMSO:
number gas density, n = 3.14 x 1012 cm-3
IP/(IR + ∑ IP) = 1.879 x 10-3
product cross section, σP = 2.878 x 10-16 cm2
The unit cell path length can be calculated using the following thin target limit relationship:
IP/I0 = IP/(IR + ∑ IP) = σPn l
rearranged into the form:
l = [IP/(IR + ∑ IP)]/σPn
l = (1.879 x 10-3)/( 2.878 x 10-16 cm2)( 3.14 x 1012 cm-3)
l = 2.08 cm
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CHAPTER IV: DETERMINATION OF APPARENT THRESHOLD ENERGIES OF
LITHIATED ACYLGLYCEROLS USING TANDEM MASS SPECTROMETRY AND A
NOVEL DERIVED EFFECTIVE REACTION PATH LENGTH APPROACH

4.1 Introduction
Electrospray [1-3] tandem mass spectrometry (ES-MS/MS) is a well established and
powerful analytical tool for compound identification and structural elucidation [4-6].
Employing collision-induced dissociation (CID) [7] tandem mass spectrometry, a wide range of
mass spectrometers have been used to study thermochemistry in the gas phase such as that of
non-covalent receptor-ligand complexes by electrospray triple quadrupole [8-10], non-covalent
bond dissociation energy studies by guided ion beam tandem mass spectrometry [11-19], critical
energies for ion dissociation by quadrupole ion trap [21] or flowing afterglow-triple quadrupole
[22, 23], reaction enthalpies and ion-ligand bond energies by electrospray triple quadrupole [24,
25], and binding energies from gas phase ion-equilibrium [26] studies by electrospray triple
quadrupole [27-28]. For structural elucidation by triple quadrupole tandem mass spectrometry,
the precursor ion of interest is isolated by the first quadrupole acting as a mass filter, subjected to
collision induced dissociation in the rf-only second quadrupole (actually hexapole), and finally
the product ions are scanned in the third quadrupole. Typically, collision energy and collision
cell gas pressure are chosen to achieve 20 - 70% attenuation of the precursor ion abundance, and
the products from the collision induced fragmentation are thereby formed under multiple
collision conditions. However, in energy-resolved mass spectrometry studies [29-36] where the
specific kinetics of the fragmentation pathways are of interest, single collision conditions (~10%
attenuation of precursor) are employed in the triple quadrupole, and multiple spectra are obtained
at increasing activation energies controlled by the energy offset of the central hexapole. During
energy-resolved mass spectrometry studies, a wealth of information is being collected which can
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be used to qualitatively describe the unimolecular fragmentation pathways through the use of
breakdown graphs, where the percentage of the total abundance for each product ion is plotted
versus collision energy. One quantitative aspect of the breakdown graphs is the comparative
abundances of the product ions at specific collision energies. A higher relative product ion
abundance, expressed as the percentage of total ions measured, equates to a more favored
reaction pathway at that energy as compared to other product ions under the same condition.
The collection of spectra at incrementally increasing energy offset allows for the calculation and
graphing of branching ratios [37], and product cross sections. The product cross sections of
unimolecular reactions are directly related to the activation energies required for dissociation
according to the Rice-Ramsperger-Kassel-Marcus (RRKM) theory [38] of unimolecular
reactions which occur during fragmentation studies employing CID. Our previous work, taking
advantage of the thin target limit relationship to collision cross sections [12], resulted in the
development of a predictive model for bond dissociation energies of alkali metal or halide ion
adducts [39], where only the simple dissociation of the alkali metal cation or halide anion was
considered. In the current work, we have extended this new model by applying it to the
description of covalent bond dissociation energies (apparent threshold energies, ∆E0) involved in
the unimolecular fragmentations of lithiated acylglycerols.

4.2 Experimental
4.2.1 Materials and Methods
Methanol and chloroform solvents were of HPLC/spectroscopy grade and were
purchased from EM Science (Darmstadt, Germany).

Monopentadecanoin and 1,3-

dipentadecanoin were obtained from Nu-Chek Prep, Inc. (Elysian, MN), with stated purities of >
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99%. 1-Stearin-2-palmitin diacylglycerol was purchased from Larodan Fine Chemicals AB
(Malmo, Sweden), with stated purity of 99%. Lithium chloride was ACS grade in granular form
from J. T. Baker Inc. (Phillipsburg, NJ). All standards were used as received without further
purification.

4.2.2 Instrumentation
Mass spectra were obtained using a “triple quadrupole” (actually quadrupole-hexapolequadrupole, QhQ) mass spectrometer (Micromass, Inc., Manchester, UK, model Quattro II)
equipped with an electrospray source operating at typical sample solution flow rates of 2-4
µL/min. Nitrogen was used as both nebulizing and drying gas. Typical cone voltage was 40 V
for CID of the lithium adducts of the acylglycerols. The ES capillary voltage was held at 2.5 to
3.5 kV. Argon was used as collision gas during CID experiments at collision gas pressures of
approximately 1.3 x 10-4 mBar (measured externally to the central hexapole collision cell) to
obtain the single collision conditions employed in all experiments. The hexapole offset energy
values range from 0 eV up to 250 eV with a minimum increment of 1 eV (ELAB). MassLynx
software (Micromass) was used to acquire, process, and store mass spectral data.

4.2.3 Apparent threshold energy predictive model
A typical experiment consists of collecting a product ion spectrum at 0 eV (ELAB), as set
by the energy offset of the central hexapole, followed by sequentially collecting spectra at
increasing offset values in 1 eV (ELAB) increments. Most experiments employed collision energy
values ranging from 0 eV up to 200 eV (ELAB). The supplied energy for the collision is converted
from the laboratory (LAB) frame of reference to the center-of-mass (COM) frame of reference
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according to ECOM = ELAB(m/(m + M)), where ELAB is the measured offset for the central
hexapole, m is the mass of the stationary target Ar atom, and M is the mass of the analyte. Using
the thin target limit relationship [12]:
IP/I0 = IP/(IR + ΣIP) = σPnl

(1)

where IP is the transmitted product ion abundance, IR is the transmitted reactant ion abundance, I0
is the incident (precursor) ion abundance, σP is the product cross section (cm2), n is the number
gas density (cm-3), and l is the collision cell path length (cm), individual product cross sections
can be obtained for each product ion at a specified collision energy. The product cross sections
are plotted versus the collision energy, in the center-of-mass frame of reference, and the
following exponential growth equation:
σP(E) = σ0exp(ECOM/α) + y0

(2)

is fit to the data in the threshold activation energy range for product ion formation, between
approximately 0.06 - 4 eV (ECOM). The parameters of the fitted curve are then used in the
following general multivariate growth curve model (GCM-Polynomial Regression) [40]
developed for the triple quadrupole in our laboratory [39]:
BDE (eV) = 0.78051 – 1.7180x1013σ0 + 1.4627α - 0.16327α2

(3)

to calculate the apparent bond dissociation energy from unimolecular fragmentation for that
particular product ion.

4.3 Results and Discussion
4.3.1 Apparent threshold energies for lithiated mono-pentadecanoin
The first monoacylglycerol that the derived effective reaction path length approach for
the measurement of apparent threshold energies was applied to was the lithium adduct of mono-
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pentadecanoin.

Figure 4.1a is a product ion spectrum of the collisionally activated

monopentadecanoin lithium adduct, collected at 40 eV (ELAB) under single collision conditions,
showing the major fragments produced during unimolecular dissociation. There are four major
product ions produced, and their assignments are presented in Figure 4.1b. The m/z 99 product
ion is the result of the neutral loss of the C15 fatty acyl chain as a ketene from the precursor ion,
and it is the most abundant ion in the spectrum. The m/z 81 and m/z 63 ions are produced from
one water loss, and two water losses, respectively, from the m/z 99 product ion. The m/z 57 ion
is the result of LiOH loss from the m/z 81 ion, as depicted in Figure 4.1b, with a potential minor
contribution from the fragmentation pathway which produces the hydrocarbon series CnH2n+1+ (n
= 4). Over a wide range of collision energies, the “% Total Ion Abundance” of the four product
ions follows the trend: m/z 99 > m/z 81 > m/z 63 > m/z 57, as is visually apparent in the
breakdown graph presented in Figure 4.2.

For these energy-resolved determinations, CID

spectra acquired were under single collision conditions; therefore the % Total Ion Abundances
for the product ion fragments are very low. The precursor % Total Ion Abundance was also
plotted (but note the discontinuity in the y-axis) to further contrast the precursor vs product ion
abundances during these experiments.
It is known from the theory of unimolecular ion decompositions [38] that the bond with
the lowest critical energy for dissociation is not always the one to rupture at each respective
internal energy state. This arises due to kinetic considerations in enthalpy driven reactions where
the energy barrier required to cleave a given bond may be lowered due to simultaneous
formation of new bonds during the fragmentation process, thus resulting in a more abundant
product ion at a certain internal energy state. Moreover, fragment ions produced from a “loose
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Figure 4.1. (a) Product ion spectrum of the collision activated monopentadecanoin lithium
adduct, collected at 40 eV (Lab). Major fragments produced: (1) m/z 99 from the neutral loss of
C15 fatty acyl chain as ketene, producing lithiated glycerol, (2) m/z 81 produced by water loss
from m/z 99, (3) m/z 63 produced by two water losses from m/z 99, and (4) m/z 57 formed by
loss of LiOH from m/z 81, and from part of the CnH2n+1+ hydrocarbon series from the fatty acid
acyl chain. (b) Fragmentation pathways, structures, apparent threshold energies, and % Total Ion
Abundance for the four major product ions formed from CID of lithiated mono-pentadecanoin.
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The m/z 99 ion is the result of the neutral loss of C15 fatty acyl chain as ketene from the
precursor ion, and is the most abundant ion in the spectrum, at an apparent threshold energy of
2.87 ± 0.14 eV (ECOM). The m/z 81 and m/z 63 ions are produced from one water loss, then two
water losses, respectively. The m/z 81 ion has the lowest threshold energy at 1.74 ± 0.27 eV
(ECOM). The m/z 57 ion is formed primarily by LiOH loss from the m/z 81 ion.

complex” state are often observed at higher threshold energies than those formed from “tight
complexes” because the later more often benefit from stabilization of the transition state owing
to new bond formation. But decomposition reactions that proceed through “tight complexes”
have unfavorable entropic factors, hence, they are disfavored in cases where substantial amounts
of excess energy are present, and insufficient time is available for the tight complex to form.
Our predictive model for calculating apparent threshold energies for the fragmentation
pathways from the energy-resolved mass spectral data gives a new quantitative aspect to describe
the product ions produced from CID experiments. As can be deduced from Figure 4.1b, the %
Total Ion Abundance calculated at a given collision energy (at saturation, i.e. 7 eV, ECOM) are not
inversely related to the apparent threshold energies (∆E0). This indicates that some of the
product ions are produced through secondary or competitive processes. If a closer look is taken
at the apparent threshold energies, it can be noted that the production of the m/z 81 ion, ∆E0 =
1.74 ± 0.27 eV (ECOM) is the most enthalpy favored process compared to the other three product
ion pathways. This is followed by the m/z 63 ion at ∆E0 = 2.10 ± 0.36 eV (ECOM), the m/z 57 ion
at ∆E0 = 2.24 ± 0.13 eV (ECOM), and finally the m/z 99 ion at ∆E0 = 2.87 ± 0.14 eV (ECOM).
Clearly from a % Total Ion Abundance of 15.52%, the m/z 99 product ion has a much greater
rate of formation than the other three product ions at elevated collision energies, suggesting that
the m/z 99 product ion is the most entropically favored fragmentation pathway.
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Figure 4.2. Energy-resolved breakdown graph for the dissociation of the lithiated monopentadecanoin diacylglycerol. The % Total Ion Abundances are very low due to collection under
single collision conditions. The precursor % Total Ion Abundance is included in the plot to
illustrate the small percentage losses during these experiments. % Total Ion Abundances appears
to follow the trend of m/z 99 > m/z 81 > m/z 63 > m/z 57.

From the breakdown graph an additional interesting pathway description is observed. At
lower collision energies, the m/z 63 product ion is slightly favored compared to the m/z 81
product ion, suggesting a very initial favored pathway (due to stearic arrangement?), but is
quickly overcome by the m/z 81 product ion, which has a considerably lower apparent reaction
enthalpy, overall.
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4.3.2 Apparent threshold energies for lithiated 1-stearin,2-palmitin diacylglycerol
The lithium adduct of diacylglycerol 1-stearin,2-palmitin was the next to be studied using
energy-resolved mass spectra. The product ion spectrum of the collision induced dissociation of
1,2-diacylglycerol is shown in Figure 4.3a, at a collision energy of 50 eV (ELAB). The spectrum
shows a number of lower molecular weight fragment ions from approximately m/z 43 to m/z
123, and higher molecular weight product ions ranging from m/z 257 to m/z 365. The latter
higher molecular weight range contains 7 product ions, which are assigned in Figure 4.3b. All 7
of these higher mass product ions appear to have plausible fragmentation pathways that do not
arise from consecutive dissociations. The proposed mechanisms each constitute a single
dissociation involving one H-transfer in concert with cleavage to produce the array of product
ions listed in Figure 4.3b.
In contrast to the product ions of the lithium adduct of mono-pentadecanoin presented,
the product ions from 1-stearin,2-palmitin diacylglycerol dissociations appear in % Total Ion
Abundances have that are inversely related to the apparent threshold energies. Table 4.1 is a
listing of the apparent threshold energies versus % Total Ion Abundance, which more clearly
shows the inverse relationship. For this set of fragmentation pathways, except for a slight
anomaly for the last ion (m/z 365), a lower threshold energy equates to a higher % Total Ion
Abundance.
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Figure 4.3. (a) Product ion spectrum of the collision induced dissociation of lithiated 1-stearin,2palmitin diacylglycerol, at collision energy of 50 eV (Lab). Lower molecular weight fragment
ions appear from approximately m/z 43 to m/z 123, primarily representing the hydrocarbon
series CnH2n+1+ from σ-bond fatty acyl chain cleavage. Higher molecular weight product ions
ranging from m/z 257 to m/z 365 produced from single cleavage reactions of fatty acyl loss in
several forms (fatty acyl chain as ketene, lithium fatty acetate, and fatty acid). (b) Fragmentation
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pathways, structures, apparent threshold energies, and % Total Ion Abundance for the high
molecular weight range product ions produced from the CID of 1-stearin,2-palmitin, ranging
from m/z 257 to m/z 365. Paired products include the neutral loss of C18 and C16 lithium fatty
acetate at m/z 313 and m/z 341, and neutral loss of C18 and C16 fatty acid at m/z 319 and m/z
347. M/z 365 is formed by the neutral loss of C16 fatty acyl chain as ketene. Fragmentation
ranking of: loss of lithium fatty acetate > loss of fatty acid > loss of fatty acyl ketene.

Product ion

% Total Ion

Apparent

Cross Section

(m/z)

Abundance

Threshold Energy

(cm2)

(%)

(∆E0, eV)

313

4.74

1.35 ± 0.13

7.74 x 10-13

341

3.23

1.60 ± 0.13

5.28 x 10-13

319

2.38

1.66 ± 0.15

3.90 x 10-13

347

1.77

1.79 ± 0.16

2.90 x 10-13

263

1.01

1.97 ± 0.26

1.65 x 10-13

291

0.99

2.26 ± 0.01

1.62 x 10-13

365

0.82

2.02 ± 0.11

1.34 x 10-13

Table 4.1. % Total Ion Abundances, apparent threshold energies, and cross sections of high
molecular weight product ions for the lithium adduct of 1-stearin,2-palmitin diacylglycerol.

Figure 4.4a is the breakdown graph of the higher molecular weight product ions, which also
illustrates that each fragmentation pathway increases in product ion intensity, in a roughly
similar pattern, with increasing collision energy, i.e., little curve crossing occurs. The fact that
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curves in Fig. 4.4a do not cross indicates that the relative importance of entropic vs enthalpic
factors which govern the rates of decomposition for each process, does not change substantially
as higher internal energy uptake is achieved.

The m/z 313 product ion has the greatest

abundance as seen in the breakdown graph, followed by the m/z 341 ion. As illustrated in Figure
4.3b, the structures of these two product ions are related in that both have lost a neutral lithium
fatty acetate molecule. As has been observed previously in our laboratory [41], the loss of the 1position substituent giving rise to the m/z 313 product ion is the favored pathway, a conclusion
which the current studies also support. As noted above, the m/z 313 product ion has the lowest
apparent threshold energy at 1.35 ± 0.13 eV (ECOM), followed by the m/z 341 product ion at 1.60
± 0.13 eV (ECOM).
In summary then, for the losses involving the fatty acid substituents from this
diacylglycerol, the pair of product ions with the highest abundances, and lowest apparent
threshold energies, are from the neutral loss of the lithium fatty acetates at m/z 313 and m/z 341.
The next most abundant pair, with somewhat higher apparent threshold energy product ions
observed are from the neutral loss of the fatty acid substituent (acid form) at m/z 347 and and
m/z 319. Third in this fatty acid loss series, with the lowest abundance, and highest apparent
threshold energy, is the neutral loss of the fatty acyl chain as ketene at m/z 365, suggesting the
following favored fragmentation pathway neutral loss ranking of: loss of lithium fatty acetate >
loss of fatty acid > loss of fatty acyl chain as ketene.
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Figure 4.4. Breakdown graph of: (a) the higher molecular weight product ions from CID of 1stearin,2-palmitin. Fragmentation pathways arise primarily from losses of fatty acid substituents
in the form of fatty acyl chain as ketene, lithium fatty acetate, and fatty acid. All increase in
product ion intensity in a similar pattern for increasing collision energy.
(b) The lower
molecular weight product ions from CID of 1-stearin,2-palmitin. Peak series m/z 43, m/z 57, m/z
71, m/z 85, m/z 99 result from alkyl chain fragmentation through σ-bond cleavage of the fatty
acid hydrocarbon chains producing the series CnH2n+1+.
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The breakdown graph of the lower molecular weight product ions is illustrated in Figure
4.4b; the corresponding apparent threshold energies are listed in Table 4.2. Often, low molecular
weight product ions in the m/z 43 to 127 region are the result of alkyl chain fragmentation
through σ-bond cleavage of the fatty acid hydrocarbon chain producing the series CnH2n+1+. In
the product ion spectrum in Figure 3a, the hydrocarbon series from σ-bond cleavages of the fatty
acid alkyl chain consists of m/z 43, m/z 57, m/z 71, m/z 85, and m/z 99. The m/z 57 product ion
has the highest % Total Ion Abundance at 15.96%, and the lowest apparent threshold energy at
1.35 ± 0.26 eV (ECOM). Analogous to the fragmentation of the mono-pentadecanoin acylglycerol
in Figure 4.1b, the m/z 57 product ion may also be formed through a multi-step process requiring
first, losses of both fatty acyl chains to form m/z 99, then loss of water, followed finally by loss
of LiOH. Thus, two processes may be responsible for formation of the m/z 57 product ion
resulting in the observance of a greater abundance, and lower apparent threshold energy. Also
included in the low molecular weight series are the m/z 81 and m/z 63 product ions from the
losses of one, and then two waters, respectively, from the lithiated glycerol backbone, in a
manner analogous to the pathways illustrated in Figure 4.1b.

4.3.3 Reaction enthalpies for lithiated 1,3-dipentadecanoin
Figure 4.5a is a product ion spectrum for the collision induced dissociation of lithiated
1,3-dipentadecanoin, acquired at 60 eV (ELAB). Similar to the 1-stearin,2-palmitin diacylglycerol
CID spectrum, the 1,3-dipentadecanoin produces low molecular weight product ions ranging
from m/z 29 to m/z 99 by the same processes that were
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1-stearin,2-palmitin
Mono-pentadecanoin

diacylglycerol

1,3-dipentadecanoin

Product ion

Abund.

∆E0

Abund.

∆E0

Abund.

∆E0

(m/z)

(%)

(eV)

(%)

(eV)

(%)

(eV)

43

-----

-----

3.54

1.78 ± 0.03

2.36

1.87 ± 0.30

57

1.13

2.24 ± 0.13

15.96

1.35 ± 0.26

8.16

1.69 ± 0.10

63

2.24

2.10 ± 0.36

5.43

1.71 ± 0.03

3.30

1.68 ± 0.19

71

-----

-----

10.24

1.55 ± 0.09

5.08

1.53 ± 0.07

81

3.50

1.74 ± 0.27

3.54

1.87 ± 0.18

5.07

1.51 ± 0.26

85

-----

-----

7.46

1.70 ± 0.05

3.34

1.70 ± 0.15

95

-----

-----

3.63

1.88 ± 0.05

1.48

1.65 ± 0.35

99

15.52

2.87 ± 0.14

1.84

2.07 ± 0.35

2.16

1.62 ± 0.15

Table 4.2. % Total Ion Abundance and apparent threshold energy for the lithium adduct of
mono-pentadecanoin acylglycerol, 1-stearin,2-palmitin diacylglycerol, and 1,3-dipentadecanoin.
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∆E0 = 1.66 ± 0.24 eV
% Total Ion Abund = 3.13%
∆E0 = 1.79 ± 0.21 eV
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Figure 4.5. (a) Product ion spectrum of the collision induced dissociation of lithiated 1,3dipentadecanoin, collected at 60 eV (ELAB). Low molecular weight product ions ranging from
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m/z 29 to m/z 99 expressed by the hydrocarbon series CnH2n+1+ produced from σ-bond fatty acyl
chain cleavage. Higher molecular weight range of m/z 249 to m/z 323 produced from single
cleavage reactions of fatty acyl loss in several forms (fatty acyl chain as ketene, lithium fatty
acetate, and fatty acid). (b) Fragmentation pathways, structures, apparent threshold energies, and
% Total Ion Abundance for the high molecular weight range product ions produced from the
CID of 1,3-dipentadecanoin, ranging from m/z 249 to m/z 323. Neutral loss of fatty acyl chain as
ketene at m/z 323 contains the highest abundance, and lowest threshold energy. This is followed
by neutral loss of lithium fatty acetate at m/z 299, then neutral loss of the fatty acid at m/z 305.
Fragmentation ranking of: loss of fatty acyl ketene > loss of lithium fatty acetate > loss of fatty
acid. The m/z 289 product ion is produced from the consecutive neutral losses of H2O followed
by C15:1 alpha-beta unsaturated fatty acid.
discussed above. In the higher molecular weight range of m/z 249 to m/z 323, 5 principle
product ions are observed. Similar to 1,2-diacylglycerol described above, these product ions also
are formed primarily through single cleavages of a fatty acid substituent with concomitant Htransfer resulting in the losses of various neutrals, such as loss of the fatty acyl chain as a ketene,
loss of lithium fatty acetate, and loss of fatty acid (acid form). Figure 4.5b depicts assignments
for the product ions along with their respective % Total Ion Abundances and apparent threshold
energies.

Similar to the 1-stearin,2-palmitin diacylglycerol example there is an inverse

relationship observed between % Total Ion Abundance and apparent threshold energy, as listed
in Table 4.3. Among the competitive decomposition processes, the product ion with the highest
abundance, and lowest threshold results from the neutral loss of the fatty acyl chain as a ketene at
m/z 323. The next highest abundance, slightly higher threshold energy product ion observed is
from the neutral loss of lithium fatty acetate at m/z 299. Third in this fatty acid loss series, with
the next highest abundance, and even higher reaction threshold, is the neutral loss of the fatty
acid substituent at m/z 305, suggesting the following ranking favored of fragmentation pathways:
neutral loss of fatty acyl chain as ketene > neutral loss of lithium fatty acetate > neutral loss of
fatty acid. The m/z 289 product ion is produced from the consecutive neutral losses of H2O
followed by C15:1 alpha-beta unsaturated fatty acid (this order was established by precursor scan
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inspection of m/z 289 [41]), thus resulting in the lowest % Total Ion Abundance, and highest
apparent threshold energy up to this point. Figure 4.6a is the breakdown plot for formation of
the higher molecular weight product ions which graphically illustrates the observed % Total Ion
Abundances vs collision energy.

Product ion

% Total Ion

Apparent

Cross Section

(m/z)

Abundance

Threshold Energy

(cm2)

(%)

(∆E0, eV)

323

3.13

1.66 ± 0.24

5.11 x 10-13

299

2.06

1.79 ± 0.21

3.37 x 10-13

305

1.25

1.97 ± 0.21

2.05 x 10-13

249

0.91

2.10 ± 0.44

1.49 x 10-13

289

0.82

2.30 ± 0.33

1.34 x 10-13

Table 4.3. % Total Ion Abundances, apparent threshold energy, and cross sections of high
molecular weight product ions for the lithium adduct of 1,3-dipentadecanoin

The low molecular weight product ions range from m/z 43 to m/z 99, produced primarily
from a mixture of the CnH2n+1+ hydrocarbon series (m/z 43, m/z 57, m/z 71, m/z 85, and m/z 99),
and product ions arising from the glycerol backbone (m/z 63, m/z 81, and m/z 99). Table 4.2
shows the % Total Ion Abundance and apparent threshold energies for the 1,3-dipentadecanoin
diacylglycerol, as compared with the mono-pentadecanoin acylglycerol, and the 1-stearin,2-
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Figure 4.6. Breakdown graphs for: (a) high molecular weight product ions produced from CID
of 1,3-dipentadecanoin, and (b) low molecular weight product ions produced from CID of 1,3dipentadecanoin. M/z 57 product ion is the favored fragmentation pathway due to joint
production by glycerol backbone water loss, and fatty acyl chain hydrocarbon cleavage. M/z 43
product ion rapidly increases, as the collision energy is increased, produced from σ-bond
cleavage of the fatty acyl hydrocarbon chain and the glycerol backbone [C2H3O]+, appearing to
be a favored pathway at increasing collision energies.
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the other product ions, as the collision energy is increased. The m/z 43 product ion is produced
through two processes: σ-bond cleavage of the fatty acyl hydrocarbon chain, and a two carbon
species from the glycerol backbone [C2H3O]+.

4.3.4 Computational Reaction Enthalpies versus Predicted Apparent Threshold Energies
Computational methods for surface potential energies were obtained by Gaussian 98 [42]
to create a benchmark to evaluate the derived effective reaction path length approach for
predicting the apparent threshold energies of covalent dissociations arising from CID of the
acylglycerols. For all of the monopentadecanoin CID products listed in Fig. 4.1b, surface
potential energies were calculated along with those of the respective neutral molecules formed
concomitantly. For the pathway producing the m/z 99 lithiated glycerol product and the neutral
fatty acyl chain as ketene, the computational reaction enthalpy (∆H0rxn) was determined to be
2.19 eV. The magnitude of uncertainty in potential energy calculations at the B3LYP 6-31G*
level has been estimated to be 3.9 kcal·mol-1, or 0.17 eV [42] (mean absolute deviation). The
apparent threshold energy (∆E0) was experimentally determined to be 2.87 ± 0.14 eV. This is
illustrated in Figure 4.7a where the ground state surface potential energy of the precursor m/z
323 monopeantadecanoin lithium adduct has been set to a value of 0 eV. The three product ions
m/z 81, 63, and 57 (m/z 57 not shown), are observed to have lower ∆E0 values than the m/z 99
product ion (Fig. 4.1b). For the three product ions m/z 81, 63, and 57 an inverse relationship
between the % Total Ion Abundance and the apparent threshold energy ∆E0 is observed.
However, these three product ions are produced by consecutive decompositions after the first
step of loss of the fatty acyl chain as a ketene yielding the m/z 99 ion which initially requires a
∆E0 of 2.87 ± 0.14 eV.
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Figure 4.7. Energy diagrams for: (a) production of the m/z 63, 81, and 99 product ions from the
monopentadecanoin lithium adduct, (b) production of the m/z 63, 81, and 99 product ions from
the monopentadecanoin lithium adduct including the high energy pathways.
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The pathway for the production of the m/z 99 product involves a single hydrogen transfer. If a
consecutive loss is assumed for the production of the m/z 81 ion, two hydrogen transfers are
involved suggesting a higher energy barrier. For the production of the m/z 81 ion:
CID
M/z 323

m/z 81 + ketene + H20

(4)

the ∆H0rxn was determined to be 0.66 eV (by the Gaussian 98 method), and the ∆E0 was
determined to be 1.74 ± 0.27 eV (by the derived effective reaction path length approach). The
production of the m/z 81 ion may be passing through the initial ketene loss mechanism which
produces the m/z 99 product ion, thus requiring an activation energy of 2.87 ± 0.14 eV. Or,
alternatively the m/z 81 product ion may be produced through a separate pathway requiring the
1.74 ± 0.27 eV predicted by the derived effective reaction path length approach. Figure 4.8
illustrates a proposed mechanism for the production of the m/z 81 product ion from the m/z 323
precursor ion. In order to ascertain the production of the m/z 81 ion, the product ions m/z 99, 81,
63, and 57 that are also produced in the CID of the 1,2- and the 1,3-diacylglycerols can also give
information concerning the fragmentation pathways involved. As can be seen in Table 4.2, the
experimentally derived ∆E0 for the m/z 99, 81, 63, and 57 of the 1,2- and the 1,3-diacylglycerols
are all lower than 2.2 eV (most are much lower around 1.6 to 1.7 eV). Ratio plots of m/z 81, 63,
and 57 to m/z 99 are shown in Figure 4.9 for the three acylglycerols. As illustrated in the plots,
the mechanisms for the production of the m/z 81, 63, and 57 product ions are different for the
monoacylglycerol (Fig. 4.9a) as compared to the 1,2- (Fig. 4.9b) and the 1,3-diacylglycerols
(Fig. 4.9c). For the 1,2- and the 1,3-diacylglycerols, the m/z 81, 63, and 57 product ions increase
in production as the internal energy uptake of the system increases, whereas for the
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Figure 4.8. Proposed pathway for the direct production of the m/z 81 product ion from the m/z
323 precursor ion.

monoacylglycerol, the m/z 81, 63, and 57 product ions decrease in production as the internal
energy uptake of the system increases. This suggests that the m/z 81, 63, and 57 product ions for
the monoacylglycerol have pathways of formation that are competitive with the m/z 99 product
ion at lower internal energies, and could have lower activation energies than the m/z 99 product
ion as is reflected in the lower ∆E0 values predicted by the derived effective reaction path length
approach. An energy diagram describing the three pathways for the production of the m/z 99, 81,
and 63 ions from the m/z 323 precursor is illustrated in Figure 4.7a. The energy diagram
represents low energy pathways that do not require initial production of m/z 99. However, the
apparent threshold energies that are being calculated represent the weighted average of all
pathways that result in these product ions. Near the threshold region this is most likely to
correspond to a single or predominant pathway to for a given m/z ion. The 1,3-dipentadecanoin
lithium adduct was also modeled by Gaussian 98 for potential energy surfaces for the prediction
of ∆H0rxn values for the production of the m/z 323 product ion through the neutral loss of a fatty
acyl chain as a ketene. For the production of the m/z 323 product ion the ∆H0rxn was determined
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to be -0.42 eV (indicating an exothermic process), and the ∆E0 was determined to be 1.66 ± 0.24
eV. The lower ∆E0 for the initial ketene loss from the 1,3-dipentadecanoin compared to the
ketene loss from the monopentadecanoin (1.66 ± 0.24 versus 2.87 ± 0.14 eV) is reflected in the
lower energy state of the m/z 323 monopentadecanoin’s ∆H0rxn of –0.42 eV. Though the
mechanism for the dominant fatty acid substituent loss from the 1,2-diacylglycerol (loss of
lithium fatty acetate forming m/z 313, ∆E0 of 1.35 ± 0.13 eV) is different from that from the 1,3diacylglycerol, i.e. loss of fatty acyl chain as ketene forming m/z 323, ∆E0 of 2.87 ± 0.14 eV,
(see Table 4.1 and Figure 4.3b) indicates an even lower stability of the 1,2-diacylglycerol as
compared to the 1,3-diacylglycerol (and the monoacylglycerol). As illustrated in Fig. 4.7a, at low
energies the production of the m/z 81 and m/z 63 ions appear to be from channels that
circumvent m/z 99, and their apparent threshold energies are lower. However, at higher collision
energies the predominant pathway for the production of the m/z 81 and m/z 63 product ions
appears to occur by consecutive decompositions of the m/z 99 product ion as is illustrated in
Figure 4.7b. The breaks in the higher energy pathways illustrate that the second threshold for the
production of the m/z 81 and 63 product ions is unknown, and the current methodology cannot
predict these.

4.4 Conclusions
The newly developed derived effective reaction path length approach for predicting
BDE’s with the triple quadrupole in our lab has demonstrated an effective use in fragmentation
pathway studies as an enhancement to traditional energy-resolved mass spectrometry studies. By
combining the calculated apparent threshold energies with the % Total Ion Abundance
breakdown graphs, a more extensive quantitative description of fragmentation pathways is
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Figure 4.9. Ratio plots of m/z 57, 63, and 81 to m/z 99 for: (a) monopentadecanoin lithium
adduct, (b) 1-stearin,2-palmitin diacylglycerol lithium adduct, and (c) 1,3-dipentadecanoin
lithium adduct.
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possible. The use of the derived effective reaction path length approach to calculate apparent
threshold energies for the unimolecular fragmentation reactions of lithiated acylglycerols, by
triple quadrupole, enabled unique interpretation of the product ion results. The observance of an
inverse relationship between % Total Ion Abundance versus apparent threshold energies for the
dissociation of the fatty acid substituents of the 1,2- and the 1,3-diacylglycerols suggests simple
cleavage mechanisms that are competitive on the basis of activation energy. Also revealed by
the calculated apparent threshold energies are the dissociation rankings of the form of the neutral
loss of the fatty acyl substituent for the 1,2- and the 1,3-diacylglycerol. For the 1-stearin,2palmitin diacylglycerol, the following favored fragmentation pathway was observed: loss of
lithium fatty acetate > loss of fatty acid > loss of fatty acyl chain as ketene, and for the 1,3dipentadecanoin diacylglycerol, the following favored fragmentation pathway was observed: loss
of fatty acyl chain as ketene > loss of lithium fatty acetate > loss of fatty acid. Coupling the
interpretative results for the mono-pentadecanoin fragmentation pathways and product ions, the
high abundance, low apparent threshold energy observed for the production of the low molecular
weight m/z 57 ion in the CID of the 1,2- and the 1,3-diacylglycerols was explained through two
production mechanisms. In general, the derived effective reaction path length approach for
apparent threshold energy determinations is relatively fast, straightforward, and easy to use, and
has demonstrated itself to be applicable to both non-covalent, and covalent bond dissociation
studies, making it versatile and general in gas-phase thermochemistry applications.
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CHAPTER V: IDENTIFICATION, QUANTITATION AND COMPARISON OF MAJOR
NON-POLAR LIPIDS IN NORMAL AND DRY EYE TEAR LIPIDOMES BY ES-MS-MS

5.1 Introduction
Millions of humans are afflicted with keratoconjunctivitis sicca (KCS, also known as
“dry eye”), which can be associated with aging, disease, smoke, surgery, or any form of irritation
of the eye. The National Eye Institute’s (NEI) definition of dry eye states that KCS is a disorder
of the ocular tear film layer usually caused by a tear deficiency, or excessive evaporation of the
aqueous layer, resulting in damage to the ocular surface and symptoms of discomfort(1). Some
forms of dry eye may be physiologically related, perhaps from the breakdown of the eye tear
layer, or to hormones, as demonstrated in a hormone replacement study by Schaumberg, et.al.(1).
In two separate demographic studies, it has been estimated that 11% of Europeans (Copenhagen
criteria), between the ages of 30 and 60 years suffer from dry eye symptoms(2), and that 14.6% of
Americans over the age of 65 years (approximately 4.3 million people) also suffer from dry eye
symptoms(3). Although their symptoms are similar, the underlying causes are often unknown and
no practical method for evaluating the composition of tears from such patients exists.
Therapeutical approaches for the treatment of dry eye include application of artificial tear drops
for wetting and lubrication(4,5), corticosteroids (anti-inflammatory agents), anti-biotics and
immunosuppresants such as cyclosporin(6). The widely used dry eye drops consist of various
solutions containing electrolytes, organic additives, etc., but are primarily composed of water
(97-99%)(4).
The structure of the ocular tear film is generally divided into three layers: the innermost
corneal layer, an intermediate aqueous-mucin layer(7,8), and an outermost lipid layer(9). One of
the functions of the outer lipid layer is to retard the evaporation of the inner aqueous layer. The
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lipids are supplied to the tear film through the meibomian gland. The chemical composition of
the human meibomian gland liquid secretions is a complex mixture of cholesterol and wax
esters, triglycerides, free fatty acids, diesters, free cholesterol, hydrocarbons, and polar lipids(1014)

, with water composing 98-98.5%(4). Some forms of dry eye may be related to the breakdown

of the eye tear layer.
Electrospray(15-17) tandem mass spectrometry (ES-MS/MS) is a powerful analytical tool
for compound identification(18-20). In this paper, we use this method to develop a standard lipid
component profile of normal tears and identify specific component differences in the tears from a
dry eye model. Through the development of this technology to provide specific information
concerning the lipid profile of a healthy person’s tear, it may be possible to identify a defective
lipid profile, something which has been suggested to be a major contributor to the dry eye
syndrome(21). The mass spectrometric analysis of acylglycerides, which are comprised of mono-,
di-, and triglycerides, has been reported using various approaches such as derivative gas
chromatography-electron ionization mass spectrometry GC-EI-MS(22-24), positive chemical
ionization(22), negative chemical ionization(25-27) (NCI) of chloride adducts, ES-MS/MS(28,29)
including ES-MS/MS of ammonium adducts(30,31), MALDI-TOF(32,33), fast atom bombardment
(FAB)(34), atmospheric pressure chemical ionization (APCI) mass spectrometry(30,35), and APCI
liquid chromatography/mass spectrometry(36-38) (LC/MS). Quantifying triglycerides using ratios
of diacylglyceride fragment ions vs parent ions and fragmentation schemes has been reported for
single-stage APCI-MS experiments(39-42). Saturated acylglycerides do not readily form
protonated molecules, even in acidified solutions, so alkali metal salt (Na+), and ammonium
acetate (NH4+), have been used as additives in chloroform:methanol for both ES, and APCI
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LC/MS. It has also been reported(36) that APCI LC/MS is not sensitive enough to detect even
moderately low amounts (about 2.5 mg/mL) of monoacylglycerides under standard solutions.
In our mass spectrometry work involving the identification of lipid fractions in tear
samples, Li+ was chosen as the alkali metal for adduct formation for both the non-polar lipids
such as the acylglycerides and wax esters that, to our knowledge, have not appeared in the
literature, and for the more polar phosphorylated lipids, which have previously been reported(43).
The specific use of lithium adducts has been reported for FAB-MS-MS, and ES-MS studies of
oligosaccharides(44,45),

for

the

ES

ionization

and

structural

determination

of

triacylglycerides(29,46), for ionization of aryl 1,2-diols by fast atom bombardment(34), and for FAB
ionization and structural identification of fatty acids(47). In this paper, we present a detailed
description of the major fragments produced from ES-MS/MS studies employing collisionally
induced dissociation (CID) of lithium adducts of monoacylglycerides, and 1,2- and 1,3diacylglycerides, which can produce informative product ion spectra for the identification of
complex biological extracts.

5.2 Experimental
5.2.1 Instrumentation
Mass spectra were obtained using a triple quadrupole mass spectrometer (Micromass,
Inc., Manchester, UK, model Quattro II) equipped with an electrospray interface operating at
typical flow rates of 2-4 µL/min. Nitrogen was used as both nebulizing and drying gas. Argon
was used as collision gas during collision induced dissociation (CID) experiments, at collision
cell pressures of approximately 3.0 x 10-4 mBar (measured external to the cell). The typical
“cone” voltage setting was 40 V, and the ES capillary voltage was held at 2.5 to 3.5 kV. For
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quantification of the lipids, internal standards having similar structures to the lipids
(monopentadecanoin, dipentadecanoin, triheptadecanoin, and palmityl behenate) were employed
to minimize differences in ionization efficiencies(53). MassLynx software (Micromass) was used
to acquire, process, and store mass spectral data.

5.2.2 Rabbit Dry Eye Model
The rabbit dry eye model was created in female New Zealand white rabbits by two
sequential surgical procedures. First, the main lacrimal gland was removed from the
experimental eye; the contralateral eye was used as the control. Approximately 2 weeks later, the
accessory lacrimal gland and nictitating membrane were removed from the experimental eye.
Tear breakup time (TBUT, measured by slit lamp with a Tearscopetm) was measured daily. When
the TBUT of the surgical eye was half or less that of the control eye, the surgical eye was
considered to be ‘dry’. Baseline tears (representing tears produced under non-irritating
conditions) were collected daily from the normal and surgically induced dry eyes using 5 µL
silanated microcapillary pipettes.48–50 The usual volume obtained from a normal eye was 3 µL
each, whereas only 1 µL was typically obtained from a dry eye. The tear samples were
immediately placed in Eppendorf tubes and preserved by storage at –70 °C. The non-polar lipid
fractions were extracted from tear samples with a simple chloroform solvent modification
procedure51,52 and reconstituted in 9 : 1 methanol–chloroform solutions containing 2 mM LiCl.43

5.2.3 A Note on Stereochemistry of Acylglycerides
All vicinal diacylglycerides in this report have unknown stereochemistries at the chiral
carbon. Differentiation between 1,2-diglycerides and 2,3-diglycerides is not possible, and for
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convenience these are all designated as 1,2-diglycerides in the text.

Similarly, 3-position

monoglycerides are not distinguishable from 1- position monoglycerides, and the 1-position is
used to describe both. Moreover, 1,3-diglycerides cannot be distinguished from their enantomers
and the 1-position is arbitrarily assigned to the largest alkyl chain.

5.3 Results and Discussion
It was observed that, in the positive mode, mass spectral signal intensities of the lithiated
adduct species (upon addition of 2 mM LiCl) were more reproducible than those of the
corresponding protonated lipid molecules, or mass analysis of the deprotonated lipid species in
the negative mode. Upon decomposition, the lithium adducts were also observed to form
product ions that were characteristic of the lipid being analyzed, as will be described below.
Comparison of ES-MS spectra for normal human tear and normal rabbit tear, obtained in
our laboratory, have shown close similarities where the total chloroform extractables from
normal rabbit tears match quite closely those from human tears. This suggests that the rabbit
tears are quite close in composition to human tears, which would allow extrapolation of findings
from one species to the other. Secondly, it was noted that there was not a readily observable
difference in major components when comparing normal tears with dry eye tear total chloroform
extractables, though changes in the fatty acid fragments of the non-polar, and polar lipids have
been reported by Sullivan, et. al.(54-57) for people suffering from dry eye due to an androgen
deficiency caused by Sjogren’s syndrome, menopause, and aging.

95

5.3.1 MS of Lipid Standards
5.3.1.1 Product Ion Spectra
Figure 5.1a is the product ion spectrum of the lithiated adduct of triheptadecanoin. The
characteristic informative peaks include the C17:0 acylium ion at m/z 253 [C17H33O]+, the
lithium adduct of heptadecanoic acid at m/z 277 [C17H34O2Li]+, the neutral loss of heptadecanoic
acid, then the neutral loss of a C17:1 alpha-beta unsaturated fatty acid, to give the m/z 317
product ion [MLi - C17H34O2 - C17H32O2]+, the parent ion minus lithiated heptadecanoate at m/z
579 [MLi – C17H33O2Li]+, and the parent ion minus the neutral loss of heptadecanoic acid at m/z
585 [MLi – C17H34O2]+. The m/z 579 product ion from the neutral loss of a catonized fatty
acetate, from triglycerides, is observed in ES tandem mass spectrometry studies with ammonium
adducts(36), but the product ions of m/z 317 and m/z 585, which both involve the neutral loss of a
fatty acid, have not. Hsu et al.(46) also reported the neutral loss of fatty acids from lithiated
triglycerides using a triple quadrupole with an electrospray interface. The spectrum also contains
hydrocarbon fragment ions at m/z 43, m/z 57, m/z 71, and m/z 85 which are derived from σbond cleavage of the fatty acid hydrocarbon chains. Also included in the lower mass region is
the product ion at m/z 99 which is the lithium adduct of the glycerol backbone, and an ion at m/z
81 derived from water loss from this glycerol backbone.
The product ion spectrum of 1,3-dipentadecanoin, Figure 5.1b, also contains the
hydrocarbon fragment ions, and a peak at m/z 63 for two water losses from the glycerol
backbone, in addition to m/z 99 and m/z 81 from glycerol. In the m/z 200 to m/z 350 region
there are two major fragment peaks which characterize this diglyceride, i.e., lithiated
pentadecanoic acid at m/z 249 [C15H30O2Li]+, and the m/z 323 fragment ion that has undergone
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Figure 5.1. Positive mode ES-MS/MS product ion spectra of the lithium adducts of the internal
acylglyceride standards used for identification and quantification of extracted lipids [MLi]+, with
peak assignments of major informative fragment ions for: (a) triheptadecanoin m/z 855, (b) 1,3dipentadecanoin m/z 547, (c) “up-front” CID-MS-MS experiment using precursor (m/z 323)
fragment ions formed from “up-front” dissociation of the 1,3-dipentadecanoin standard (m/z
547) [M + Li]+. The product ion peak at m/z 299 (inset) indicates the minor pathway of a stepwise initial “in-source” loss of ketene, followed by LiOH, in addition to production of m/z 299
from the loss of the lithium fatty acetate from m/z 547. Positive mode ES-MS/MS product ion
spectra of: (d) monopentadecanoin m/z 323, and (e) palmityl behenate m/z 571.

neutral loss of C15:0 fatty acyl chain as a ketene [MLi – C15H28O]+. Also observed are peaks at
m/z 289 from the consecutive neutral losses of H2O followed by C15:1 alpha-beta unsaturated
fatty acid [MLi – H2O – C15H28O2]+. The order of this consecutive process was ascertained by a
precursor scan of m/z 289 that showed peaks at m/z 547 for the lithiated parent ion, and m/z 529
representing loss of H2O from the m/z 547 parent. Notably the peak that would correspond to
initial C15H28O2 loss at m/z 307 was not observed, thus indicating a two-step process with H2O
loss being the first step. Fig. 5.1b also shows peaks at m/z 299 formed from the neutral loss of
C15:0 lithium fatty acetate [MLi - C15H29O2Li]+, and at m/z 305 for the neutral loss of C15:0
fatty acid [MLi – C15H30O2]+. The loss of NH4OH, then ketene, has been observed and reported
by APCI LC/MS(36), which would be analogous to the pathway leading to m/z 299 if the process
occurs in two steps, involving initial loss of C:15 fatty ketene, followed by loss of LiOH;
alternatively it could be formed through neutral loss of C15:0 lithium fatty acetate.

To

distinguish which fragment pathway was responsible for the m/z 299 product ion, an experiment
was performed where the loss of the C:15 fatty ketene from the m/z 547 precursor was produced
in the source using high cone voltage (i.e. “in-source” or “up-front” collision induced
dissociation, CID). M/z 323 was then isolated with the first quadrupole, subjected to CID in the
central hexapole, and the product ions scanned by the third quadrupole for the loss of LiOH at
m/z 299. Figure 5.1c illustrates the results of the experiment where a small peak was observed at
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m/z 299 indicating that this fragmentation pathway can occur, i.e., the loss of a fatty ketene
followed by loss of LiOH, but it is much less favored than the direct neutral loss of the C:15
lithium fatty acetate from the m/z 547 precursor. Finally, to the best of our knowledge, the
second product ion observed at m/z 323 (Fig. 5.1b) through the loss of ketene, resulting in a
lithium adduct of monoacylglycerol has not been reported.
Figure 5.1d is the product ion spectrum from the collision induced dissociation of
lithiated monopentadecanoin.

Three peaks characteristic of the fragmentation of lithiated

monoglycerides are observed in the lower molecular weight region. The major ion at m/z 99 is
the glycerol backbone derived from the neutral loss of the C15:0 fatty ketene from the parent ion
[MLi – C15H28O]+. The next two ion peaks at m/z 81 and m/z 63 are the subsequent loss of one,
and then two H2O molecules from the glycerol backbone as was observed for the tri- and
diglycerides. Figure 5.1e is the product ion spectrum of the lithium adduct of palmityl behenate,
a representative fatty acid/fatty alcohol wax ester. In the low mass region, only the hydrocarbon
fragments are observed at m/z 43, m/z 57, m/z 71, m/z 83 (one unsaturation), and m/z 85. In the
m/z 350 region there is one predominant peak appearing at m/z 347. This represents the neutral
loss of the carbon chain of the fatty alcohol [MLi – C16H32]+, leaving the lithium adduct of the
fatty acid portion of the wax ester at m/z 347 [C22H44O2Li]+.

5.3.1.2 Lipid Fragmentation Pathways
Figures 5.2, 5.3, and 5.4 are diagrams illustrating the major fragment ions produced from
CID of the lithium adducts of the acylglycerides triheptadecanoin, 1,3-dipentadecanoin, and
monopentadecanoin, respectively. Mu, et. al.(36), and Holcapek, et. al.(37), each have reported
different types of fragmentation pathways for the CID of CI-generated diglycerides employing
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ammonium adducts(36), or protonated, diglycerides with 3 or more double bonds(37). To determine
whether a different product ion spectrum would be obtained for the two types of substitution
(1,2- versus 1,3-), and whether a distinction could be made between the two substituents on a
1,2-diglyceride, a 1-stearin-2-palmitin diglyceride standard was analyzed by tandem mass
spectrometry as the lithium adduct.

Recall that in the product ion spectrum of the 1,3-

dipentadecanoin standard (Figure 5.1b), the predominant ion was the m/z 323 peak from the loss
of C15:0 fatty acyl chain as a ketene from the parent ion [MLi – C15H28O]+, followed by the peak
at m/z 299 for the neutral loss of C15:0 lithium fatty acetate [MLi – C15H29O2Li]+. In Fig. 5.5a,
the product ion spectrum of the lithium adduct of the 1,2-diglyceride, the predominant product
ions are m/z 313 and m/z 341. The m/z 313 product ion is derived from the loss of C18:0
lithium fatty acetate, which is in the 1- position, [MLi – C18H35O2Li]+. The second major
product ion at m/z 341 is derived from the loss of C16:0 lithium fatty acetate, which is in the 2position, [MLi – C16H31O2Li]+. The greater intensity of the m/z 313 peak versus m/z 341
indicates that lithium fatty acetate loss occurs with greater facility from the 1-position relative to
the analogous loss from the 2-position. Thus, when two non-identical fatty acyl substituents are
present on a 1,2- diglyceride, the higher intensity monoacyl fragment has lost the substituent that
was formerly at the 1-position. This behavior is identical to the type of selective loss of the fatty
acid from the 1-position being greater than the analogous loss from the 2-position observed with
the phosphorylated lipids(43). To verify the positional selectivity of this lithium fatty acetate loss,
the lithium adduct of 1-palmitin-2-stearin diglyceride was subjected to CID under similar
conditions. The product ion spectrum showed that the predominant neutral loss was that of
C16:0 lithium fatty acetate, from the 1-position. This behavior indicates that the principal factor
in determining the preferred neutral loss of a lithium fatty acetate is the position (i.e, 1-position is
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favored over the 2-position), rather than chain length. The spectrum (Fig. 5.5a) also contains a
low intensity peak at m/z 365 for the loss of the 2-position C16:0 fatty acyl chain as a ketene
[MLi - C16H30O]+, and a very minor peak at m/z 337 for the loss of the 1-position C18:0 fatty

Figure 5.2. Major fragment ions produced from the collisionally induced dissociation of
triheptadecanoin m/z 855 [MLi]+: the C17:0 acylium ion at m/z 253 [C17H33O]+, the lithium
adduct of heptadecanoic acid at m/z 277 [C17H34O2Li]+, the neutral loss of heptadecanoic acid,
then the neutral loss of a C17:1 alpha-beta unsaturated fatty acid, to give the m/z 317 product ion
[MLi - C17H34O2 - C17H32O2]+, the parent ion minus lithiated heptadecanoate at m/z 579 [MLi –
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C17H33O2Li]+, and the parent ion minus the neutral loss of heptadecanoic acid at m/z 585 [MLi –
C17H34O2]+.

Figure 5.3. Major fragment ions produced from the collisionally induced dissociation of 1,3dipentadecanoin m/z 547 [MLi]+: the parent ion peak minus the neutral loss of C15:0 fatty acyl
chain as ketene at m/z 323 [MLi – C15H28O]+, the neutral loss of C15:0 lithium fatty acetate at
m/z 299 [MLi – C15H29O2Li]+ (major path), or the loss of C15:0 fatty acyl chain as ketene from
the parent ion followed by LiOH at m/z 299 [MLi - C15H28O - LiOH]+ (minor path), the neutral
loss of C15:0 fatty acid at m/z 305 [MLi - C15H30O2]+, the consecutive losses of H2O followed by
C15:1 alpha-beta unsaturated fatty acid at m/z 289 [MLi - H2O - C15H28O2]+, and the lithiated
fatty acid ion, pentadecanoic acid, at m/z 249 [C15H30O2Li]+.
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Figure 5.4. Major fragment ions produced from the collisionally induced dissociation of
monopentadecanoin m/z 323 [MLi]+: the major ion at m/z 99 is the glycerol backbone derived
from the neutral loss of the C15:0 fatty acyl chain as a ketene from the parent ion [MLi –
C15H28O]+, and the m/z 81 and m/z 63 are the subsequent losses of one, and then two H2O
molecules from the lithiated glycerol backbone.
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acyl chain as a ketene [MLi - C18H34O]+. This behavior contrasts with that of a 1,3- diglyceride
in that the latter shows significant ketene loss from the 1-, or 3-position as being responsible for
the predominant product ions, whereas neutral losses of lithium fatty acetates are only minor. As
a further control, the asymmetric 1,3-diglyceride 1-palmitin-3-stearin was analyzed under similar
CID conditions. The resultant product ion spectrum confirmed that neutral losses of the fatty
acyl chains as ketenes are the favored product ion pathways for 1,3-diglycerides, and peaks
representing losses of each of the two fatty acid substituents were observed. Notably, for the
asymmetric 1,3-diglyceride, loss of the longer C18:0 fatty acyl chain as a ketene was the slightly
favored product ion as compared to the loss of the shorter C16:0 fatty acyl chain as a ketene,
suggesting that for the asymmetric 1,3-diglyceride, a longer chain length can subtly increase the
propensity for ketene loss.

Also identified in the Fig. 5.5a spectrum are peaks for the neutral

loss of C16:0 fatty acid at m/z 347 [MLi - C16H32O2]+, the neutral loss of the C18:0 fatty acid at
m/z 319 [MLi - C18H36O2]+, and the lithium adducts of stearic acid at m/z 291 [C18H36O2Li]+, and
palmitic acid at m/z 263 [C16H32O2Li]+.
Figure 5.5b is a diagram illustrating the major fragment ions produced from the collision
induced dissociation of the lithium adduct of the 1-stearin-2-palmitin diglyceride standard.
Figure 5.6 illustrates four proposed fragmentation pathways for the collisionally induced
dissociation of the lithium adduct of 1-stearin-2-palmitin diglyceride. The top two processes
(Fig. 5.6a and 5.6b) illustrate the major pathways producing product ions through the neutral loss
of a lithium fatty acetate. The bottom two processes (Fig. 5.6c and 5.6d) are minor pathways
each producing product ions through the neutral loss of a fatty ketene, followed by the loss of
LiOH. Both processes result in the same m/z product ion with 5-membered ring formation to
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Figure 5.5. (a) Product ion spectrum of 1-stearin-2-palmitin standard at m/z 603. The greater
intensity of the m/z 313 vs. m/z 341 allows the identification of the 1- position of the 1,2diglyceride. (b) Major fragment ions produced from the collisionally induced dissociation of 1stearin-2-palmitin diacylglycerol m/z 603 [MLi]+: the m/z 313 ion from the neutral loss of C18:0
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lithium fatty acetate (1- position), [MLi – C18H35O2Li]+, the ion at m/z 341 from the neutral loss
of C16:0 lithium fatty acetate (2- position), [MLi – C16H31O2Li]+, the m/z 365 ion from the loss
of the C16:0 fatty acyl chain as ketene [MLi - C16H30O]+, the neutral loss of C16:0 fatty acid at
m/z 347 [MLi - C16H32O2]+, the neutral loss of the C18:0 fatty acid at m/z 319 [MLi C18H36O2]+, the lithium adducts of stearic acid at m/z 291 [C18H36O2Li]+, the lithium adduct of
palmitic acid at m/z 263 [C16H32O2Li]+, and protonated stearic and palmitic acids at m/z 285
[C18H36O2H]+, and m/z 257 [C16H32O2H]+, respectively.
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Figure 5.6. Proposed fragmentation pathways for the collisionally induced dissociation of the
lithium adduct of 1-stearin-2-palmitin diglyceride involving the fatty acid substituent and loss of
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LiOH. In the major fragment pathway process (top set (a) and (b)), there is the neutral loss of
lithium fatty acetate (1- position or 2- position) forming the product ion. In the minor fragment
pathway (bottom set (c) and (d)), the initial step is the loss of the ketene of either the 1- position
or the 2- position fatty acid substituent, followed by the loss of LiOH forming the product ion.

make the most stable structure. The 1,3-diacylglycerides would have analogous pathways for the
two-step neutral loss of a fatty acyl chain as a ketene, followed by the loss of LiOH. However,
the neutral loss of a lithium fatty acetate for the 1,3- would be slightly more complicated,
involving a hydroxyl shift to form the final stable 5-membered ring product ion (e.g., see m/z
299 in Fig. 5.3).

5.3.1.3 Distinguishing Asymmetric 1,2-diglycerides, and 1,2- from 1,3-diglycerides
Figure 5.7 presents a general scheme that can be used in the identification of diglycerides
under low-energy (e.g., up to 100 eV ELAB) collision conditions. The top part of panel (a)
illustrates the usage of product ion intensities for determining substituent location within an
asymmetric 1,2-diglyceride. First of all, a characteristic of the 1,2-diglycerides vs. the 1,3- is
that the predominant product ions are those formed via losses of lithium fatty acetates.
Furthermore, it has been observed that the R1 substituent in the 1-position of the 1,2-diglyceride
shows a greater loss of the neutral lithium fatty acetate compared to the R2 substituent in the 2position, when both are initially present. The product ion pathways leading to losses of R1 and
R2 fatty acyl ketenes (Fig 5.7a, bottom half) are minor decomposition routes. In contrast to this
behavior, as shown in the top half of Fig. 5.7b, for decompositions of lithiated 1,3-diglycerides
the neutral losses of both the R1 and the R3 substituents as fatty acyl ketenes are observed to be
the major product ions formed. Finally, the bottom part of panel (b) illustrates that the 1,3-
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(a)

>
Loss of R1 substituent as lithium fatty acetate greater than loss of R2
substituent as lithium fatty acetate. These are the predominant product

Loss of R1 and R2 fatty acyl ketene product ions are

(b)

-

Neutral loss of R1 or R3 as fatty acyl ketenes, the most
-α, β unsat. Fatty

Neutral loss of H2O followed by neutral loss of R1 (left) or
R3 (right) as alpha-beta unsaturated fatty acids, discernable
Figure 5.7. General scheme for distinguishing asymmetric 1,2-diglycerides, and 1,2diglycerides from 1,3-diglycerides based upon MS/MS decompositions of lithium adducts. (a)
Illustrates the usage of product ion abundances for determining substituent location within an
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asymmetric 1,2-diglyceride. Loss of R1 substituent as lithium fatty acetate is greater than the R2
loss. Indicative of 1,2-diglycerides is that neutral losses of lithium fatty acetates are the
predominant product ions. Bottom half of panel (a) shows that losses of fatty acyl ketenes are
minor product ions. Top half of panel (b) illustrates that the neutral losses of the R1 or the R3
substituent as fatty acyl ketenes are observed for the 1,3-diglyceride isomer, and these are the
major product ions. Bottom part of panel (b) illustrates that the 1,3-diglyceride has a
fragmentation pathway which results in the neutral loss of H2O with subsequent loss of an alphabeta unsaturated fatty acid. This fragmentation pathway is not observed for the 1,2-diglycerides.

diglyceride has a fragment pathway which results in a consecutive neutral loss of H2O followed
by neutral loss of an alpha-beta unsaturated fatty acid (this order was established by inspection of
precursor scans of the ions shown at the bottom of Fig. 5.7b). The latter fragmentation pathway
is not observed in the 1,2-diglycerides.

5.3.2 MS of Rabbit Tear Lipids
Figure 5.8 contains the mass spectra of normal eye rabbit tears, panel (a), and dry eye
model rabbit tears, panel (b), extracted lipid lithium adducts. The spectra also contain lithium
adduct peaks of four internal standards that were used to quantify the extracted lipids which are
identified in Figure 5.8 by “IS”.

Three major envelopes are observed consisting of

monoglycerides, diglycerides, and triglycerides.

5.3.2.1 Identification of Monoglycerides
The m/z 300 to m/z 500 region contains three major peaks at m/z 337, m/z 365, and m/z
421.

The first two have been identified as monoglycerides with empirical formulas of

CnH2nO4Li+, having the single substituent of C16:0 for the m/z 337 peak, identified as
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(a)
IS

IS

IS

IS

(b)
IS

IS

IS
IS

Figure 5.8. Typical single stage MS positive mode ES scans of the lithium adducts of extracted
compounds, including the spiked internal standards (IS) of: (a) normal rabbit tear extract, and (b)
dry eye rabbit model tear extract. The internal standards include: 3.65x10-5 mg/µL
monopentadecanoin at m/z 323, 4.35x10-5 mg/µL dipentadecanoin at m/z 547, 4.8x10-5 mg/µL
palmityl behenate at m/z 571, and 5.2x10-5 mg/µL triheptadecanoin at m/z 855.

monopalmitin glyceride, and C18:0 for the m/z 365 peak, identified as monostearin glyceride
(the m/z 421 has been identified as a lithium adduct of an isoprene acetal). Figure 5.9a is the
product ion spectrum of the m/z 365 compound in the normal rabbit tear extract. Analogous to
the product ion spectrum of monopentadecanoin, the spectrum contains the glycerol backbone
lithium adduct at m/z 99 derived from the neutral loss of C18:0 stearyl fatty ketene from the
parent ion [MLi – C18H34O]+, and ions at m/z 81 and m/z 63 derived from the further loss of one,
and then two water molecules from the glycerol backbone.
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5.3.2.2 Identification of Diglycerides
The m/z 500 to m/z 800 region of the spectra contains three major peaks at m/z 575, m/z
603, and m/z 631. The m/z 575, m/z 603, and m/z 631 peaks have been identified as diglycerides
with empirical formulas of CnH2n-2O5Li+, where n = 35, 37, and 39, respectively.

5.3.2.2.1 m/z 575
The m/z 575 compound, as a diglyceride, has two possible fatty acid configurations. The
product ion spectrum of m/z 575, Fig. 5.9b, allows assignment of at least two isomeric
components having fatty acid compositions of dipalmitoyl, and stearin + myristin. For the
dipalmitoyl glyceride, the spectrum contains informative peaks at m/z 337 for the loss of C16:0
fatty acyl chain as a ketene from the parent ion [MLi – C16H30O]+, at m/z 263 for the lithium
adduct of palmitic acid [C16H32O2Li]+, at m/z 319 for the neutral loss of C16:0 fatty acid [MLi C16H32O2]+, at m/z 313 for the neutral loss of C16:0 lithium fatty acetate [MLi – C16H31O2Li]+,
and at m/z 303 for the neutral loss of H2O followed by consecutive loss of C16:1 alpha-beta
unsaturated fatty acid [MLi-H2O-C16H30O2]+. According to the identification scheme illustrated
in Fig. 5.7, the observation of the m/z 303 peak confirms the presence of the 1,3-dipalmitoyl
isomer, however, a minor presence of the 1,2-dipalmitoyl isomer cannot be ruled out
(conversely, the absence of m/z 303 could be used to rule out the 1,3- isomer). Secondly, the
identification scheme illustrated in Fig. 5.7 suggests that the greater intensity of the m/z 337
product ion (from the C16:0 fatty acyl ketene loss), as compared to the m/z 313 product ion
(from C16:0 lithium fatty acetate loss), indicates a 1,3-dipalmitoyl isomer. Concerning the
stearin, myristin diacylglyceride, the spectrum contains peaks that allow identification of both
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fatty acid substituents, including: a product ion peak at m/z 235 for C14:0 lithiated fatty acid
[C14H28O2Li]+, at m/z 347 for the neutral loss of C14:0 fatty acid [MLi – C14H28O2]+, and at m/z
291 for both C18:0 lithiated fatty acid [C18H36O2Li]+ and for the neutral loss of C18:0 fatty acid
[MLi – C18H36O2]+ (also m/z 291). Peaks at m/z 309 for the loss of C18:0 fatty acyl chain as
ketene [MLi – C18H34O]+, and at m/z 365 for the loss of C14:0 fatty acyl chain as ketene [MLi –
C14H26O]+, are observed in similar intensities, and more predominant than those of the
corresponding lithium fatty acetate losses, which is illustrative of the 1,3-isomer. However, the
spectrum does contain peaks corresponding to these lithium fatty acetate losses at m/z 285 ([MLi
– C18H35O2Li]+ ), and at m/z 341 ([MLi -C14H27O2Li]+). Because the latter peaks are found in
higher abundances than one would expect from a case where only the 1,3-diglyceride was
present, it is likely that the 1,2-isomer exists as a minor component. The intensity of the m/z 341
ion for the neutral loss of the C14:0 lithium fatty acetate is slightly greater than the m/z 285 ion
for the neutral loss of the C18:0 lithium fatty acetate suggesting that the 1,2-isomer consists
largely of 1-myristin,2-stearin. Finally, a peak at m/z 275 is observed for the neutral loss of H2O
followed by consecutive loss of C18:1 alpha-beta unsaturated fatty acid [MLi-H2O-C18H34O2]+,
also indicative of the 1,3-isomer. Thus, the parent ion contains one C14:0 fatty acid in the 3position, while the C18:0 fatty acid is in the 1-position allowing the assignment of 1-stearin,3myristin diglyceride. The spectrum also contains the low molecular weight hydrocarbon ions
m/z 43, m/z 57, m/z 71, and m/z 85, plus the m/z 99, m/z 81, and m/z 63 ions from the lithiated
glycerol backbone. The m/z 575 precursor ion was thus identified as a mixture of lithiated 1,3dipalmitin (major component), and of 1,3-stearin-myristin and 1-myristin,2-stearin (minor
components) diglyceride isomers.
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5.3.2.2.2 m/z 603
Similar characterization is found with the m/z 603 parent ion (Figure 5.9 panel (c)). A major
product ion appears at m/z 365 produced from the neutral loss of a C16:0 fatty acyl chain as a
ketene from the parent [MLi – C16H30O]+. A peak with slightly greater intensity is observed at
m/z 337 from the 1-position loss of the C18:0 fatty acyl chain as a ketene [MLi – C18H34O]+.
According to the identification scheme in Figure 5.7, the observance of the loss of these two
different fatty acid ketenes as the predominant product ions provides evidence that this
diglyceride is present as the 1,3- isomer. Moreover, the intensities of the peaks at m/z 263 for
the lithiated fatty acid ion hexadecanoic [C16H32O2Li]+ and m/z 291 from the lithiated fatty acid
ion octadecanoic [C18H36O2Li]+ are also similar in intensity, which further indicates that the
compound is composed primarily of the 1,3-isomer. Characteristic peaks for the 1,3-isomer are
also observed at m/z 303 for the consecutive neutral losses of H2O, followed by loss of C18:1
alpha-beta unsaturated fatty acid [MLi-H2O-C18H34O2]+, and at m/z 331 for the neutral losses of
H2O and C16:1 alpha-beta unsaturated fatty acid [MLi-H2O-C16H30O2]+. Also observed are
lower intensity (minor) peaks at m/z 313 from the neutral loss of C18:0 lithium fatty acetate
[MLi – C18H35O2Li]+, and at m/z 341 from the neutral loss C16:0 lithium fatty acetate [MLi –
C16H31O2Li]+. Also present in lower intensities are peaks at m/z 319 for the neutral loss of
octadecanoic acid [MLi - C18H36O2]+, and at m/z 347 for the neutral loss of hexadecanoic acid
[MLi - C16H32O2]+. The hydrocarbon ions at m/z 43, 57, 71, and 85 are present, as are the
glycerol backbone ions at m/z 99, 81 and 63. The product ion at m/z 585 is due to the loss of
water from the parent ion [MLi - H2O]+. The above evidence indicates that the m/z 603 parent
ion primarily consists of the 1-stearin,3-palmitin isomer.
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Figure 5.9. Positive mode ES tandem mass spectra illustrating informative fragment ions used
for identification of: (a) the m/z 365 lipid lithium adduct, identified as monostearyl glyceride, (b)
the m/z 575 lipid lithium adduct, identified as 1,3-dipalmitin diglyceride being the major
component, with a minor 1-stearin,3-myristin constituent, and a minor 1-myristin,2-stearin
constituent, (c) the m/z 603 lithium adduct identified as 1-stearyl,3-palmityl diglyceride, and (d)
the m/z 631 lithium adduct identified as 1,3-distearin acylglyceride.
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5.3.2.2.3 m/z 631
Finally, for the spectrum of the m/z 631 compound in Figure 5.9d a product ion at m/z
365 is observed for the neutral loss of C18:0 fatty acyl chain as a ketene [MLi – C18H34O]+, and
the ion at m/z 331 from the consecutive neutral losses of H2O and C18:1 alpha-beta unsaturated
fatty acid [MLi-H2O-C18H34O2]+ that is indicative of a 1,3-diglyceride, is also observed. The
spectrum also contains the lithium adduct of stearic acid at m/z 291 [C18H36O2Li]+, and peaks at
m/z 341 for the neutral loss of C18:0 lithium fatty acetate [MLi-C18H35O2Li]+, as well as at m/z
347, representing the neutral loss of the C18:0 fatty acid [MLi-C18H36O2]+. The spectrum is also
characterized by the low molecular weight product ions from carbon-carbon bond dissociation,
and the product ions for the glycerol backbone, and subsequent one and two water losses. The
structure is thus assigned as the 1,3-distearin diglyceride, but the presence of a minor amount of
the 1,2- isomer cannot be ruled out.

5.3.2.3 Identification of Triglycerides
The m/z 800 to m/z 1100 range consists of triesters of the empirical formula CnH2n4O6Li

+

. Figure 5.10a shows an expanded mass axis illustrating the m/z 850 to m/z 970 region.

As can be seen by the relative peak intensity of the internal standard triheptadecanoin (m/z 855),
the triesters are present in relatively low concentrations. Peaks in this area, such as the m/z 863,
the m/z 877, the m/z 905, m/z 961, etc., were analyzed by MS/MS and were found to be singly
charged Li+-bound mixed dimers primarily comprised of species from the 500 to 800 Da region
noncovalently bound with species in the 300 to 500 Da region. The product ion spectrum of the
m/z 897 peak, Figure 5.10b contains ions that are consistent with the characterization of
triglycerides, such as the m/z 267 peak for the C18:0 acylium ion [C18H35O]+, the lithium adduct
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of octadecanoic acid at m/z 291 [C18H36O2Li]+, the parent ion minus lithiated arachidinoate at
m/z 579 [MLi – C20H39O2Li]+, the parent ion minus the neutral loss of arachidinoic acid at m/z
585 [MLi – C20H40O2]+, the parent ion minus lithiated octadecanoate at m/z 607 [MLi C18H35O2Li]+, and the parent ion minus neutral loss of octadecanoic acid at m/z 613 [MLi C18H36O2Li]+. A low intensity peak is observed at m/z 641 from the loss of palmitic acid [MLi –
C16H32O2]+. The absence of more of the ions of the fatty acids is probably due to the low
concentration levels being measured. The spectrum also contains lower molecular weight ions
from the fragmentation of the fatty acids through carbon-carbon bond cleavage. The peak at m/z
897 is thus assigned as the lithium adduct of a mixture of two triglyceride isomers with the
predominant one being trioctadecanoin, and the minor being 1-arachidin,2-stearin,3-palmitin.
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Figure 5.10 (a) Expanded mass axis of the triester spectral region (m/z 850 to m/z 970) of
normal tear extract lithium adducts illustrating the occurrence of mixed dimers, and low
concentrations of triacylglycerols present in the extract. (b) Product ion spectrum with peak

116

assignments of informative product ions of the m/z 897 precursor identified as an isomeric
mixture of tristearin and 1-arachidin,2-stearin,3-palmitin.

5.3.2.4 Wax Ester Analysis
Also included in the extract is a peak at m/z 571 from the spiking addition of palmityl
behenate, a fatty acid/fatty alcohol wax ester standard (see Figure 5.1e for structure). The wax
ester was found to have a low ionization efficiency compared to the other components in the tear
extract. This was expected, as the ionization efficiency for lipids with ammonium acetate
showed greater response as the polarity of the lipid increased(28) (increase in number of alcohol
groups, one for diglyceride, two for monoglyceride, etc.), while the product ions were only of the
protonated species from the initial loss of NH3. This trend was also observed with an equimolar
mixture of lipid standards, where the monoglycerides exhibited the greatest response, followed
by the diglycerides, with the triglycerides showing the weakest response, though the product ions
were mostly lithiated, with some appearing as fragment ions (e.g., acylium). Some of the
experiments yielded good responses for the palmityl behenate wax ester standard, and peaks in
the region expected for wax esters (m/z 500 to m/z 700) were analyzed by tandem mass
spectrometry, but these peaks were not found to correspond to wax esters.

The major

components of the non-polar tear lipids have been reported in the past literature as wax esters(1014)

, such as the C27 alcohol/C15 fatty acid wax ester which would have a lithiated mass at m/z

625. None of the simple, fatty alcohol/fatty acid wax esters(58) were observed in any of the
extracts reported in this study. Previous work in our lab (unpublished results) showed that the
optimum response for lithiated phosphorylated lipids was at approximately 10 mM LiCl. A new
ionization-internal standard solution was used which contained 10 mM LiCl, instead of the 2
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mM LiCl solution which had been used in all previous experiments. While the individual wax
ester standard gave an excellent response when run with 10 mM LiCl, poor responses were still
achieved when it was present with other lipids in a mixture, suggesting that the low response for
the wax ester standard was due to suppression from the acylglycerides. However, a search for
the simple fatty alcohol/fatty acid wax esters, such as the C27 alcohol/C15 fatty acid wax ester
(lithium adduct mass at m/z 625), resulted in the conclusion that the wax esters are probably not
detectable by this method, as they are likely present below the method’s limit of detection for
wax esters (i.e., 1.4 x 10-5 mg/µL, S/N = 3) established for the spiked palmityl behenate internal
standard. This means that under the method’s conditions for ES of the lithium adducts, the wax
and cholesterol esters are not being observed. Other separation methods performed in our lab
such as TLC indicated that the wax and cholesterol esters are indeed present, but the current ESMS method suppresses their response.

5.3.2.5 Quantification of the Tear Lipids
To estimate the concentration of the lipids in the extract, standards were chosen which
were predicted to have ionization efficiencies very similar to those of the extracted lipids. For
the m/z 20 to m/z 500 region, monopentadecanoin was used with a lithium adduct mass of m/z
323, for the m/z 500 to m/z 800 region, dipentadecanoin was used with a lithium adduct mass of
m/z 547, for the m/z 800 to m/z 1100 region, triheptadecanoin was used with a lithium adduct
mass of m/z 855; for the wax esters, palmityl behenate was used with a lithium adduct mass of
m/z 571. Figure 5.8a is the spectrum of the lithium adducts of normal tear lipid extract where the
locations of the internal standards are marked with “IS”. The concentrations of the four internal
standards were chosen to be in the same approximate range as the extracted lipids, namely
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3.65x10-5 mg/µL monopentadecanoin, 4.35x10-5 mg/µL dipentadecanoin, 5.2x10-5 mg/µL
triheptadecanoin, and 4.8x10-5 mg/µL palmityl behenate, all in 50:50 chloroform/methanol with
2 mM LiCl.

To quantify the terpenoids, the response factor of the diacylglyceride

dipentadecanoin was used due to the expected similarity in ionization efficiency (one alcohol
group) for the two.
Table 5.1 shows a comparison of quantitative results of the normal and dry eye tear lipid
extracts. The total lipid extract value for the normal eye is 7.3 ± 0.7 µg µl-1, while the dry eye
total lipid extract average result was determined to be 14.0 ± 2.1 µg µl-1. This indicates that the
total lipid content in dry eye tears is much greater, approximately double, as compared to what is
observed in normal eye tears. This might be explained by the fact that the dry eye may have less
aqueous content in the tear layer compared to normal eyes, resulting in a higher concentration of
lipids per microliter of tears. In particular, the glyceryl isoprene acetals appear to have increased
in concentration the most (approximately three-fold relative to the normal eye). The relatively
large standard errors of the means (see Table 5.1) indicate variation in lipid composition from
sample to sample. The general overall pattern for the two lipid extracts is similar when
comparing each compound’s percentage of the total extract.
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Li+ Adduct

Normal Eyea

Dry Eyeb

Percent Increase

(m/z)

(mg/µL)

(mg/µL)

(%)

Free glycerol

99

9.6x10-4 ± 2.3x10-4

1.5x10-3 ± 2.7x10-4

56

Glyceryl-isoprene acetal

153

6.8x10-4 ± 2.7x10-4

1.7x10-3 ± 8.5x10-4

150

Glyceryl-isoprene acetal

287

7.5x10-4 ± 2.9x10-4

1.8x10-3 ± 9.2x10-4

140

Monopalmitin

337

7.4x10-4 ± 1.6x10-4

1.1x10-3 ± 2.0x10-4

49

Compound Identification

-3

-4

-3

2.5x10 ± 2.5x10

-4

Monostearin

365

1.6x10 ± 3.4x10

Glyceryl-isoprene acetal

421

1.2x10-3 ± 3.7x10-4

2.9x10-3 ± 1.6x10-3

142

1,3-dipalmitin (major)

575

1.4x10-4 ± 3.1x10-5

2.1x10-4 ± 2.3x10-5

50

1-stearin,3-palmitin (major)

603

5.2x10-4 ± 9.5x10-5

7.3x10-4 ± 2.7x10-5

40

1,3-distearin (major)

631

5.1x10-4 ± 9.0x10-5

7.2x10-4 ± 1.3x10-5

41

Tristearin (major) c

897

1.3x10-4 ± 5.5x10-5

1.8x10-4 ± 9.9x10-5

38

7.3x10-3 ± 7.1x10-4

1.4x10-2 ± 2.1x10-3

92

56

1-stearin,3-myristin (minor)
1-myristin,2-stearin (minor)

1-arachidin,2-stearin,
3-palmitin (minor)
TOTAL

a

Averages and standard errors of the mean reported for normal eye results were derived from
four different sets of composite rabbit tear samples, where each composite set was analyzed
separately. Tear composite volumes were 12 µL, 12 µL, 7 µL, and 7 µL.
b
Dry eye results are the average and standard error of the mean of two different composite sets
which were analyzed individually. Tear composite volumes were 6 µL, and 7 µL.
c
Reported value for the triglyceride tristearin is substantially above the method’s limit of
detection for triglycerides (i.e., 5.8 x 10-6 mg/µL).
Table 5.1. Comparison of Quantitative Results of Normal and Dry Eye Tear Lipid Extracts.

5.4 Conclusions
Tandem mass spectrometry experiments on the major components of the total chloroform
extracts identified that these compounds were more polar than the simple “fatty acid esterified to
a fatty alcohol” type of wax ester, which is what has been previously reported to make up the
majority of the non-polar lipids. Empirical formulas were derived which can be used to calculate
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the number of oxygens, and double bonds, for the species in three mass regions which primarily
indicate lipids. The first region (m/z 20 to m/z 500) consists of free glycerol, three glycerylterpene acetals, and monoacylglycerols with empirical formulas of CnH2nO4Li+. The m/z 500 to
m/z 800 region consists of diacylglycerols with empirical formulas of CnH2n-2O5Li+, and the m/z
800 to m/z 1100 region is comprised of triacylglycerols with empirical formulas of CnH2n-4O6Li+.
The work reported here using lithium adducts, combined with electrospray tandem mass
spectrometry (ES-MS-MS), for the analysis of complicated biological extracts has shown a
marked improvement over past approaches of TLC, HPLC-MS, derivative GC-MS, etc., that
have been used to characterize the tear film lipids. New, informative product ion spectra are
presented for lithiated monoacyl, 1,2- and 1,3-diacyl, and triacylglyceride standards. Newly
proposed structures and fragment pathways for the major product ions are presented for the 1,2and 1,3-diglycerides, and for the monoglyceride. The mass spectra of the lithium adducts of the
acylglycerides contain detailed and informative product ions that were successfully used to
identify the acylglycerides, and the terpenoid type compounds that were observed to be present
in the tear extracts. Through the use of ES-MS/MS, the normal and dry eye rabbit tear extracted
lipids were found to be primarily comprised of acylglycerides that exhibited high responses in
ES, whereas the wax and cholesterol esters were not detected, presumably due to ionization
suppression. Also, with this approach, separation such as HPLC, TLC, SPE, etc., was not
essential due to separation by mass. Finally, all extracted compounds that are subsequently
ionized and measured by the mass spectrometer can be quantified, and analyzed by tandem mass
spectrometry to identify their molecular structures.
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CHAPTER VI : MALDI-TOF MS OF PHOSPHORYLATED LIPIDS IN BIOLOGICAL
FLUIDS USING IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY AND A SOLID
IONIC CRYSTAL MATRIX

6.1 INTRODUCTION
Lipids are important biomolecules that are found in all living species. These include nonpolar lipids such as the acylglycerols, and the more polar phosphorylated lipids. Of the nonpolar lipids, triacylglycerols are thought to be a storage form of carbon in the cells1, while
diacylglycerols are of special importance for their role as physiological activators of protein
kinase C (PKC)2,3. Of the polar lipids, those containing phosphoryl head groups, such as the
phosphatidylcholines (PC), the phosphatidylethanolamines (PE), and the phosphatidylserines
(PS) (see Fig. 1 for structures), constitute the bilayer components of biological membranes,
determine the physical properties of these membranes, and directly participate in membrane
protein regulation and function. Other types of phosphorylated lipids are the sphingomyelins and
the glycosphingolipids which have been reported to be involved in different biological processes
such as growth and morphogenesis of cells4. Thus, analysis of this special class of biomolecules
has been of great interest to medical researchers, biologists, and chemists.
Recent analyses of phospholipids have employed HPLC5, MEKC5,6, CE-ES-MS7, ESMS-MS8-15, and to a lesser extent MALDI-FTICR16, and MALDI-TOF17-21.

The mass

spectrometric analyses of nonvolatile lipids has been reviewed by Murphy, et al.22, and it is
pointed out that the advent of soft ionization techniques such as ES-MS and MALDI-MS, has
obviated the need for derivatization of lipids. Biological samples are complex mixtures of a
wide variety of compounds that can have a negative influence on the ability to identify and
quantify lipids by mass spectrometry; effects include signal suppression, and interferences from
isomeric and isobaric compounds.
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In this paper, a MALDI-TOF MS study of the phosphorylated lipids of normal human
eye tear is reported using a novel solid ionic crystal MALDI matrix comprised of paranitroaniline and butyric acid. MALDI-TOF has become an important tool for the characterization
of complex biological extracts due to its high sensitivity, high resolution, and limited
fragmentation of the compounds of interest. Front-end isolation of the phosphorylated lipids was
achieved using immobilized metal affinity chromatography (IMAC). The chemical composition
of the human meibomian gland liquid secretions (tear) has previously been characterized by
HPLC23, P-NMR24, TLC25, and fatty acid fragment profiles have been generated by HPLC-MS26.
The newly developed methods reported in this paper enable the detection of very low-level
phosphorylated lipids in tear samples, and have the potential for use for phosphorylated lipid
determinations in other complex biological samples.

6.2 EXPERIMENTAL SECTION
6.2.1 Extraction of non-Polar and Polar Lipids
The non-polar and polar lipid fractions were extracted from tear samples with a simple
modified chloroform-water partitioning procedure27,28. The aqueous phase contained the tear
proteins, while the chloroform phase held the lipids.

6.2.2 Synthesis of Solid Ionic Crystal MALDI Matrix
Scheme 6.1 is a reaction scheme showing the synthesis of the solid ionic crystal matrix
for MALDI. 250 mg of 4-nitroaniline and 333 µL of butyric acid were added to 9.05 mL of
methanol with vortex mixing. After one minute, solvent was removed by rotovap. Upon removal
of the methanol, yellow, slightly oily, pungent crystals were formed. The MALDI matrix used
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for further studies consisted of 20 mg of the solid ionic crystal 4-nitroaniline/butyric acid
dissolved in 1 mL of ethanol.

Scheme 6.1. Synthesis of MALDI ionic crystal matrix.

6.2.3 MALDI-TOF MS Analysis
MALDI-TOF mass spectra were acquired using an Applied Biosystems Voyager Elite rToF with Delayed Extraction (Applied Biosystems, Inc., Framingham, MA).

An applied

extraction voltage of 20 kV was typically employed. Delayed extraction mode was used for all
acquisitions with a 175 ns delay time setting. The laser was operated just above the threshold
energy required to obtain desorption/ionization. Each phospholipid mass spectrum constitutes an
average of 150 to 200 traces. For sample plate spotting, 3 µL of phospholipid solution was
mixed with 3 µL of matrix and then deposited onto the MALDI plate and allowed to air dry.
All spectra were calibrated using a two-point calibration employing protonated lyso PC,
at m/z 496.34, and protonated DMPC at m/z 678.51. Phospholipids in the biological samples are

128

identified according to their MALDI-TOF MS spectral molecular weights derived from either
protonated molecules, sodiated molecules, and/or PSD product ions.

6.3 RESULTS AND DISCUSSION
6.3.1 Characterization and Optimization of the Ionic Crystal MALDI matrix
Experiments were performed in order to characterize and optimize the MALDI matrix for
the mass spectral analysis of the phosphorylated lipids extracted from tear samples. In general,
prompt fragmentation involving cleavage at the head group of phosphorylated lipids is a
common problem when analyzing biological lipid extracts by MALDI. Difficulties pertaining to
the ability to obtain quantitative29 and spatial30 information also arise when using solid MALDI
matrixes. Inhomogeneous deposits of the analyte within the matrix and non-uniformities in the
matrix layer cause variations in responses due to so-called “hot” or “sweet” spots versus the
areas that produce lower-level signals. In general, a rather complex relationship exists between
the MALDI spectral signal intensity and the amount of the measured analyte present in the
spot.31 A recent study by Rujoi et al.32, reported the use of para-nitroaniline as a matrix for the
study of the neutral phospholipids phosphatidylcholine and sphingomyelin in lens tissue, where
the obtained [M + H]+, [M + Na]+, and [M + K]+ signals appeared in greater sensitivities as
compared to the 2,5-dihydroxybenzoic acid (DHB) matrix often used for phosphorylated lipids.
Recently reported by Mank et al.29 is the use of ionic liquid matrixes which have improved shotto-shot reproducibility of signal intensities over traditional solid matrixes. This should enable
more accurate quantitative analysis by MALDI. Also reported is a reduction in fragmentation
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Figure 6.1. Structures of the main phosphorylated lipids included in this study. The left side lists
the neutral, polar, zwitterionic phosphorylated lipids. The right side lists the anionic
phosphorylated lipids as their neutral sodium adducts.
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induced by the MALDI ionization technique when using the ionic liquid matrixes. Three
examples of ionic liquid matrixes used by Mank et al.29 are illustrated in Figure 6.2: (a) 2,5dihydroxybenzoic acid butylamine, (b) alpha-cyano-4-hydroxycinnamic acid butylamine, and (c)
3,5-dimethoxy-4-hydroxycinnamic acid triethylamine. The ionic liquid matrixes are formed
through combining the appropriate viscous liquid amines with the crystal MALDI matrix, after
having dissolved both in methanol. The methanol and free amine are subsequently removed,
thus producing the ionic pair which is then mixed with a small amount of ethanol to reduce the
viscosity of the liquid matrix.
In the present study, para-nitroaniline was reacted with butyric acid as shown in Scheme
6.1. This mixture contrasts with those in Fig. 6.2 in that an ionic liquid was not produced. Rather,
upon analyte mixing and drying, a solid ionic crystal is formed that acts as a powerful gas-phase
proton donor and enhances phosphorylated lipid response. Because the final matrix preparation
is crystalline, it shows deposition (spotting) behavior similar to other widely used solid MALDI
matrixes such as sinapinic acid, DHB, or α-CHCA. Furthermore, difficult applications, such as
depositing the matrix upon tissue or other surfaces for MALDI analyses revealing twodimensional spatial distributions, will be more likely to succeed when a solid ionic crystal matrix
is used in preference to an ionic liquid matrix. Finally, acidification of the analyte environment
should not be severe with the solid ionic crystal matrix (where butyric acid is largely ion-paired
with a p-nitroaniline), in contrast to the acidic MALDI matrixes DHB or α-CHCA.
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triethylamine.
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6.3.2 Zwitterionic Phospholipid MALDI Matrix Comparison.
For the optimization of the MALDI matrix for phosphorylated lipid analyses, six matrix
preparations were evaluated in a comparison of the PNA-butyric acid matrix (with and without
TFA) to 4 standard matrix preparations. The six matrixes consisted of (1) 20 mg/mL DHB
dissolved in 1:1 MeOH:CHCl3, (2) 10 mg/mL DHB + 10 mg/mL α-CHCA + 0.1% TFA
dissolved in 2:1 CHCl3:MeOH, (3) 20 mg/mL PNA dissolved in EtOH, (4) 20 mg/mL PNA +
0.1% TFA dissolved in EtOH, (5) 20 mg/mL PNA-butyric acid ionic crystals dissolved in EtOH,
and (6) 20 mg/mL PNA-butyric acid ionic crystals + 0.1% TFA dissolved in EtOH. TFA was
included in certain preparations to either aid in analyte protonation, or to enhance the dissolution
of the lipids in the matrix17.
Table 6.1 shows the zwitterionic phosphorylated lipids’ major molecular ions observed in
the MALDI spectra for the six different matrixes; Figure 6.1 illustrates the structures of the
phosphorylated lipids used in this study. The left side of Figure 6.1 lists the neutral, polar
zwitterionic phosphorylated lipids. The right side of Figure 6.1 shows the anionic phosphorylated
lipids as their neutral sodium salts. In Table 6.1, the most striking feature found was that the
PNA-butyric acid matrix and the PNA-butyric acid plus TFA matrix both produce the protonated
form of PE as the predominant molecular ion. This is illustrated in Figure 6.3 which compares
the MALDI spectra of PE using the six separate matrixes obtained at a laser fluence just above
the threshold energy for appearance. For the DHB matrix, Fig. 6.3a, the major molecular ion
peak is the sodium adduct [PE+Na]+ at m/z 714, while the protonated molecule [PE+H]+ at m/z
692 is of considerably lower abundance in the spectrum. Also observed in the spectrum are
major ions produced through neutral head group losses at m/z 537 [PE+H-C3H10NO4P]+, at m/z
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Lipid

DHB

50/50

PNA

αCHCA/DHB

PNA

PNA +

PNA +

0.1% TFA

Butyric Acid

Butyric Acid

0.1% TFA
PE

Lyso PC

0.1% TFA

[PE+Na]+

[PE+Na]+

Very Low

[PE+H]+

[PE+H]+

[PE+H]+

[PE-HG]+

[PE-HG]+

Signal

[PE-HG]+

[PC+H]+

[PC+H]+

[PC+H]+

[PC+H]+

[PC+H]+

[PC+H]+

[SM+H]+

[SM+H]+

[SM+H]+

[SM+H]+

[SM+H]+

[PC+H]+

[PC+H]+

[PC+H]+

[PC+H]+

[PC+H]+

[PC+H]+

[PAF+H]+

[PAF+H]+

[PAF+H]+

[PAF+H]+

[PAF+H]+
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Table 6.1. Comparative Study of the Zwitterionic Phosphorylated Lipids’ Major Spectral
Molecular Ions Observed for the Six Different MALDI Matrixes.

551 [PE+H-C2H8NO4P]+, and at m/z 565 which is probably produced through post source decay
(the peak is wide and the isotopes are not resolved). The 1:1 DHB:α-CHCA plus TFA matrix,
Fig. 6.3b, produces the sodium adduct as the major MI, but there is significant head group loss
leading to m/z 551. The protonated molecule, [PE+H]+, is only a very minor peak at m/z 692.
The PNA matrix, Fig. 6.3c, did not produce any appreciable positive mode molecular ions at
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Figure 6.3. Comparison of the six MALDI matrixes for the analysis of
phosphatidylethanolamine in positive ion mode. (a) DHB matrix showing predominant sodium
adduct peak [PE+Na]+ at m/z 714, and minor [PE+H]+ at m/z 692. (b) α-CHCA/DHB plus TFA
matrix with sodium adduct at m/z 714, but significant head group loss at m/z 551 observed, and a
minor [PE+H]+ peak at m/z 692. (c) PNA matrix shows no appreciable signals for sodium
adducts or protonated molecules. (d) PNA plus TFA producing [PE+H]+ at m/z 692, but major
peaks for neutral losses of head group components at m/z 551, and m/z 605 are also observed.
(e) PNA-butyric acid solid ionic crystal matrix producing predominantly the [PE+H]+ ion at m/z
692 with only very minor amounts of the sodium adduct at m/z 714, and few fragment ions. (f)
PNA-butyric acid plus TFA matrix producing the [PE+H]+ ion at m/z 692 as a major spectral
peak, but also significant headgroup loss ions at m/z 551 and m/z 565.
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the expected m/z values of sodium or proton adducts. The PNA plus TFA matrix, Fig. 6.3d, did
produce the protonated molecule [PE+H]+ at m/z 692, but also major peaks for neutral losses of
head group components at m/z 551, and m/z 605. In general, the inclusion of TFA was observed
to promote fragmentation in the form of the loss of neutral head group components. The newly
synthesized solid ionic crystal PNA-butyric acid matrix (Fig. 6.3e) and the PNA-butyric acid
plus TFA matrix (Fig. 6.3f) were observed to produce protonated molecules as the major spectral
peaks, with only very minor amounts of sodium adducts. However, the presence of TFA was
again observed to induce significant fragmentation of the protonated molecule in the form of
head group (neutral) loss at m/z 551 (Fig. 6.3f).
The observance of the protonated molecule, MH+, as the major species in the mass
spectrum helps to simplify spectral interpretation and can help enhance the fragmentation
efficiency in tandem mass spectrometry experiments33. As illustrated in Table 6.1, the
phosphatidylcholine head group containing lipids such as lyso PC, PC, PAF, and sphingomyelin
all yield protonated molecules as the predominant molecular ion for the six matrixes studied.
However, the solid ionic crystal PNA-butyric acid matrix allows formation of the strongest
[lipid+H]+ peak, and is the least conducive to head group loss.
Figure 6.4a is a MALDI-TOF spectrum of the para-nitroaniline/butyric acid matrix
preparation illustrating the low molecular weight portion of the m/z range. The predominant
spectral PNA-related ions include: m/z 108 [PNA+H-HNO]+ and m/z 109
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Figure 6.4. (a) MALDI-TOF mass spectrum of the para-nitroaniline/butyric acid matrix
preparation illustrating the low mass region of the mass spectrum and showing background peaks
originating from the matrix. (b) MALDI-TOF mass spectrum of a two-component mixture of
lyso PC and DMPC standards showing protonated lyso PC at m/z 496, and protonated DMPC at
m/z 678, using the PNA-butyric acid matrix.

[PNA+H-NO]+ (both requiring rearrangement), m/z 122 [PNA+H-NH3]+, m/z 139 [PNA+H]+,
and m/z 229 [2PNA+H-H2NO2]+ (actually produced through a reaction between two PNA
molecules). Figure 6.4b is a MALDI-TOF spectrum of a two-component standard using the
PNA-butyric acid matrix which includes the low molecular weight range of the spectrum. The
standard consists of lyso PC and DMPC. As can be seen in Fig. 6.4b there is no interference of
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the matrix peaks with the lipid analytes. An approximate limit of detection was determined to be
1 x 10-6 M DMPC (~300 pg on sample target) using the novel solid ionic crystal as the MALDI
matrix.

6.3.3 Anionic Phospholipid MALDI Matrix Comparison
Table 6.2 shows the anionic phosphorylated lipids’ major molecular ions observed in
MALDI mass spectra for the six different matrixes (see right side of Fig. 6.1 for structures). Row
1 of Table 6.2 shows the results for MALDI-TOF MS analysis of six matrixes with the lipid
standard phosphatidylglycerol (PG) which is anionic and often present as a sodium salt. The
DHB:α-CHCA plus TFA matrix was found to produce the [PG+2Na-H]+ molecular ion as the
predominant peak, while the other five were observed to produce the sodium adduct [PG+Na]+
as the predominant molecular ion. For the PNA plus TFA matrix, the addition of TFA was
found to promote prompt head group loss from both [PG+2Na-H]+ and [PG+Na]+. Figure 6.5a is
the MALDI-TOF spectrum of PG using the PNA-butyric acid matrix showing the sodium adduct
[PG+Na]+ at m/z 771, and [PG+2Na-H]+ at m/z 793. The phosphatidylserine lipid was also
observed to suffer high degrees of head group loss with the addition of TFA as shown in Table
6.2, row 2. For the DHB:α-CHCA plus TFA matrix, PS exhibited facile prompt head group loss,
and [PS+Na]+ at m/z 784 was observed to be a very minor spectral ion. Head group loss for PS
leading to m/z 577 [PS-C3H7NO6PNa]+ as a major spectral ion was observed for the PNA plus
TFA matrix and for the PNA-butyric acid plus TFA matrix. Figure 6.5b is the MALDI-TOF
spectrum of PS using the PNA-butyric acid matrix showing [PS+Na]+ at m/z 784, and
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Table 6.2. Comparative Study of the Anionic Phosphorylated Lipids’ Major Spectral Molecular
Ions Observed for the Six Different MALDI Matrixes (for abbreviations, see text. HG = head
group).
[PS+2Na-H]+ at m/z 806. Notably, the phosphatidic acid (PA) lipid standard, Table 6.2, row 3,
did not respond well when mixed with either the PNA matrix or the PNA-butyric acid plus TFA
matrix. For PA in the PNA-butyric acid matrix (Fig. 6.5c), the predominant ion peak was
observed to be the [PA+Na]+ ion at m/z 697 which is in contrast to the DHB:α-CHCA plus TFA
matrix and the PNA plus TFA matrix where the predominant ion is [PA+2Na-H]+ (m/z 719).
With the novel solid ionic crystal matrix (PNA-butyric acid), PG and PA are found
predominantly as the sodium adducts [Phospholipid+Na]+, and not as [Phospholipid+2Na-H]+.
This suggests that the butyric acid additive in the PNA matrix is acting as a protonating agent
during MALDI analysis, displacing one of the sodium ions. This behavior is similar to that
observed for PE (Table 6.1, row 1) where the predominant molecular ion is [PE+H]+ (Fig. 6.3e),
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whereas the sodium adduct [PE+Na]+ is observed as the predominant molecular ion with the
DHB matrix (Fig. 6.3a) and the DHB:α-CHCA plus TFA matrix (Fig. 6.3b).
Other non-polar lipids that do not contain phosphate in the head group were also tested
with the new matrix. These consisted of cholesteryl stearate, monopentadecanoin, 1-palmitin-2stearin diacylglycerol, 1-palmitoyl-3-stearoyl diacylglycerol, triheptadecanoin, and the wax ester
palmityl behenate. Observed in the MALDI-TOF spectra (not shown) for all of these non-polar
lipids were sodium adducts as the predominant molecular ion peak, with minor potassium
adducts.
As compared to traditional MALDI matrixes such as DHB for the study of
phosphorylated lipids, one may summarize that the PNA-butyric acid solid ionic crystal offers:
(1) reliable appearance of only the protonated molecules of lipids containing phosphatidylcholine
head groups such as lyso PC, PC, and PAF; (2) reliable appearance of only the sodium adduct
species for anionic phospholipids such as PG, PA, and PS; and (3) the ability to simultaneously
detect all of the phosphorylated lipids represented in Figure 6.2 (including PE) in the positive
mode of MALDI-MS. These three points can greatly simplify determinations of phosphorylated
lipids present in complex biological samples and extracts.

6.3.4 PSD Fragmentation Study of Phosphatidylserine
Post source decay (PSD) analysis was performed on the phosphorylated lipid standards to
study the decompositions of [Phospholipid+H]+ for the neutral, polar zwitterionic phospholipids,
and both the [Phospholipid+Na]+ and [Phospholipid+2Na-H]+ peaks for the anionic
phospholipids. Figure 6.6a is the PSD spectrum of the sodium adduct of phosphatidylserine
[PS+Na]+ at m/z 784.
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Figure 6.5. (a) MALDI-TOF mass spectra acquired using the PNA-butyric acid matrix: (a) PG
showing [PG+Na]+ at m/z 771, and [PG+2Na-H]+ at m/z 793, (b) PS displaying [PS+Na]+ at m/z
784, and [PS+2Na-H]+ at m/z 806, and (c) PA showing [PA+Na]+ at m/z 697, and [PA+2Na-H]+
at m/z 719.
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Figure 6.6b is the PSD spectrum of [PS+2Na-H]+ at m/z 806. As can be seen in the two figures,
the two molecular ions of PS have the same fragmentation pathways producing loss of head
group fragments, but the favored pathways appear to be quite different. The phosphatidylserine
lipid undergoes three forms of head group neutral loss under PSD conditions. The three product
ion structures representing m/z 697, m/z 599, and m/z 577 are illustrated in Fig. 6.6a. As has
been previously reported by Al-Saad et al19, m/z 577 represents a six-membered ring product ion
where the sodium was lost with the head group. The m/z 599 product ion is assigned as the
sodium adduct of an alkene. The fragmentation pathway leading to the m/z 577 product ion is
clearly favored over the m/z 599 product ion (Fig. 6.6a). The m/z 577 product ion involves the
neutral loss of the sodium in the head group, while the production of the m/z 599 product ion
results in the sodium staying adducted to the acylglycerol portion of the lipid. This indicates that
for each molecular ion that contains two sodium atoms, one of the sodium ions is clearly
associated with the negatively charged oxygen in the phosphoryl group.

Secondly, the

predominant m/z 208 product ion in Fig. 6.6a, which is comprised of the neutral head group
sodium adduct, is similar to the fragmentation pathway forming m/z 577, except that a proton is
transferred to the head group, so charge is retained on the latter. This further indicates that the
predominant form of the precursor is the singly-sodiated molecule where the sodium is adducted
to the phosphoryl head group, and not the acylglycerol portion of the lipid. For [PS+2Na-H]+ the
only predominant product ion is m/z 719 (Fig. 6.6b), which is formed through the neutral loss of
C3H5O2N (87 Da). This indicates, as observed by Al-Saad et al.19, that [PS+2Na-H]+ is more
stable than [PS+Na]+. In fact, this is well known because charge on Na+ is less mobile than on H+
33

. Figure 6.6b also contains structures of the different neutral molecules involved in head group

losses.
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Figure 6.6. PSD spectra of: (a) phosphatidylserine [PS+NA]+ precursor ion at m/z 784, and (b)
phosphatidylserine [PS+2Na-H]+ precursor ion at m/z 806.

144

6.3.5 PSD Fragmentation Study of Phosphatidic Acid
Head group loss pathways similar to those observed for phosphatidylserine were also
observed in the PSD spectrum of phosphatidic acid, as illustrated in Figure 6.7a. In the spectrum
there is the six-membered ring formation for the neutral loss of the sodium-containing head
group at m/z 577 [M+Na-PO4H2Na]+, and the alkene product ion formed through neutral head
group loss at m/z 599 [M+Na-PO4H3]+. Also observed in Fig. 6.7a are product ion peaks arising
from neutral loss of the C16:0 fatty acid substituent at m/z 441 [M+Na-C16H32O2]+, neutral loss
of C18:0 sodium fatty acetate at m/z 391 [M+Na-C18H35O2Na]+, and a sodium adduct of the
phosphoric acid head group at m/z 121 [H3PO4Na]+. Figure 6.7b is the PSD spectrum of
[PA+2Na-H]+. The two predominant peaks are formed through neutral loss of the fatty acid
substituents, and can be used for identification purposes when coupled with the PSD spectrum of
[PA+Na]+ which gives head group information.

6.3.6 PSD Fragmentation Study of Lyso PC and DMPC
Figure 6.8a is the PSD spectrum of protonated lyso 1-palmitoyl choline (lyso-PC) at m/z
496. The predominant product ion in the spectrum is the expected peak
representing the protonated phosphatidylcholine head group at m/z 184. However, there are three
other peaks of interest in the spectrum.
The m/z 313 peak is derived from the neutral loss of the phosphatidylcholine head group
from the m/z 496 precursor [M+H-C5H14NO4P]+, and the m/z 258 peak from the neutral loss of a
fatty acyl chain as a ketene [M+H-C16H30O]+. The observance of these two peaks can aid in the
identification of the lyso phosphatidylcholine lipid. The third peak at m/z 104 is the head group
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Figure 6.7. PSD spectra of: (a) phosphatidic acid [PA+NA]+ precursor ion at m/z 697, (b)
phosphatidic acid [PA+2Na-H]+ precursor ion at m/z 719.

fragment ion C5H14NO+, whose structure is illustrated in Fig. 6.8a. Figure 6.8b is the PSD
spectrum of protonated dimyristyl phosphatidylcholine (DMPC) at m/z 678. In this spectrum
there is also the m/z 184 product ion for the charged phosphatidylcholine head group that has
previously been reported by Al-Saad, et al.34, and a m/z 495 product ion derived from neutral
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loss of the PC head group [M+H-C14H14NO4P]+. For fatty acid substituent identification, there is
the product ion at m/z 450 derived from the neutral loss of the C14:0 fatty acid [M+HC14H28O2]+, and a product ion at m/z 468 from the neutral loss of a C14:0 fatty acyl chain as a
ketene [M+H-C14H26O]+. At m/z 86 in the spectrum there is a PC head group product ion whose
structure is illustrated in Fig. 6.8b.
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Figure 6.8. PSD spectra of: (a) lyso 1-palmitoyl choline (lyso-PC) [LysoPC+H]+ precursor ion at
m/z 496, and (b) dimyristyl phosphatidylcholine (DMPC) [DMPC+H]+ precursor ion at m/z 678.
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6.3.7 PSD Fragmentation Study of Phosphatidylglycerol
Figure 6.9a is the PSD spectrum of the sodium adduct of 1-palmitoyl-2-oleoyl-snglycero-3-[phospho-rac-(1-glycerol)] (sodium salt) (POPG) at m/z 771. In the spectrum, there
are three predominant product ion peaks which involve the phospho-glycerol head group. At m/z
599, there is a minor peak for the neutral loss of the phospho-glycerol head group, and at m/z
577 there is the more predominant product ion peak for neutral loss of the phospho-glycerol head
group (with sodium). The intensity of the m/z 577 peak being greater than the m/z 599 peak
suggests that the departure of the neutral head group (with sodium) is the more favored
fragmentation pathway, as was also observed in the PSD of PS (Fig. 6.6a). The most
predominant product ion peak in the spectrum is the m/z 195 peak, i.e. the sodium adduct of the
phospho-glycerol head group whose structure is illustrated in Fig. 6.9a. A minor peak is also
observed at m/z 415 representing a two-step loss of a head group fragment (neutral loss of 74 Da,
see Fig. 6.9b m/z 719 structure) in conjunction with neutral loss of the C18:1 fatty acid
substituent

[M+Na-C3H6O2-C18H34O2]+,

giving

some

structural

information

for

the

phosphorylated lipid. Fig. 6.9b is the PSD spectrum of [PG+2Na-H]+ at m/z 793. This spectrum
contains information concerning both the phospho-glycerol head group, and the two fatty acid
substituents. M/z 719, m/z 217, and m/z 199 all involve the phospho-glycerol head group, and
the associated structures are represented in the spectrum. The two fatty acid substituents are
identified in the spectrum through two separate fragmentation pathways. There is a product ion
formed as a result of neutral loss of the C18:1 fatty acid at m/z 511 [M-H+2Na-C18H34O2]+, and a
product ion formed upon neutral loss of the C16:0 fatty acid at m/z 537 [M-H+2Na-C16H32O2]+.
There are also two product ion peaks at m/z 437, and m/z 463, representing the combined neutral
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Figure 6.9. PSD spectra of: (a) 1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]
(POPG) [POPG+Na]+ precursor ion at m/z 771, and (b) [POPG+2Na-H]+ precursor ion at m/z
793.
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losses of a head group fragment and a fatty acid for the C18:1 and the C16:0 fatty acid
substituents, respectively.

6.3.8 IMAC Cleanup and Preconcentration of Phosphorylated Lipids
A modified Millipore phosphopeptide enrichment method using ZipTipMC (Millipore
Inc., Bedford, MA) pipette tips containing an immobilized metal ion affinity chromatography
(IMAC) media (iminodiacetic acid, IDA resin) was used to enrich the phosphorylated lipids. The
suggested method from the manufacturer was followed except for two key solutions: the binding
solution was changed from 0.1% acetic acid (aqueous) to 0.1% acetic acid in 1:1
methanol:acetonitrile, and the elution solution was changed from 0.3 N ammonium hydroxide
(aqueous) to 0.3 N ammonium hydroxide in 1:1 methanol:acetonitrile. The immobilized metal
ion affinity chromatography (IMAC) media was found to be soluble in chloroform, therefore,
care must be taken to remove all chloroform from the extracted lipids before application of the
ZipTipMC.
Figure 6.10 is a MALDI-TOF MS spectrum illustrating the recovery of a 4-component
lipid standard mixture comprised of lyso phosphatidylcholine at m/z 496, dimyristyl
phosphatidylcholine at m/z 678, dipalmitoyl phosphatidylethanolamine at m/z 692, and
sphingomyelin at m/z 731, each detected in protonated form using the modified IMAC ZipTipMC
method.

The modified IMAC ZipTipMC method presented in this study has thus been

demonstrated to be applicable to the isolation and cleanup of phosphorylated lipids in addition to
the manufacturer’s intended use for the isolation and cleanup of phosphorylated peptides.
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Figure 6.10. Recovery of a four-component phosphorylated lipid standard mixture using the
IMAC ZipTipMC. Protonated lyso phosphatidylcholine at m/z 496, protonated dimyristyl
phosphatidylcholine at m/z 678, protonated dipalmitoyl phosphatidylethanolamine at m/z 692,
and protonated sphingomyelin at m/z 731.

6.3.9 MALDI-TOF MS Analysis of Human Tear Film Lipid Layer
A normal eye tear sample was extracted, using the modified extraction procedure above,
forming a chloroform phase containing lipids, and an aqueous phase containing proteins. The
chloroform phase was evaporated, and the phosphorylated lipids were isolated using the IMAC
ZipTipMC method. Figure 6.11a is a MALDI-TOF spectrum of the tear total chloroform
extractables collected without the use of the IMAC ZipTipMC cleanup method. Figure 6.11b is
the same extract with the use of the IMAC ZipTipMC cleanup prior to spectral collection. In Fig.
6.11a, the major peaks observed have been previously identified in our laboratory35 as sodium
adducts of monopalmitin acylglycerol at m/z 353 (not shown), monostearin acylglycerol at m/z
381 (not shown), a glyceryl-isoprene acetal at m/z 437, 1,3-dipalmitin diacylglycerol at m/z 591,
1-stearin,3-palmitin diacylglycerol at m/z 619, and 1,3-distearin diacylglycerol at m/z 647. As
has been observed previously in our laboratory with electrospray, the phosphorylated lipids
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Figure 6.11. MALDI-TOF mass spectra of the tear total chloroform extractables collected: (a)
without the use of the IMAC ZipTipMC cleanup method, and (b) with the use of the IMAC
ZipTipMC cleanup prior to spectral acquisition.
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are present in tear extracts in very low concentrations compared to the acylglycerols, and can
experience a substantial amount, or even complete, signal suppression in positive mode
electrospray. Figure 6.11a illustrates that signal suppression of the phosphorylated lipids in the
tear extract, due to the acylglycerols also present, is again occurring with the use of MALDI. By
applying the IMAC ZipTipMC isolation and cleanup procedure to the phosphorylated lipids,
removal of the acylglycerols has been achieved and the phosphorylated lipids are now
observable in Fig. 6.11b. In the ZipTipMC extract cleanup spectrum of Fig. 6.11b, m/z 659 is
postulated to be the sodium adduct of a pyrophosphate sphingomyelin with a molecular formula
of C24H50N2O13P2Na, m/z 678 is protonated 1,2- (rac) dimyristoyl phosphocholine, and m/z 719
and 747 are also postulated to be protonated pyrophosphate sphingomyelins with molecular
formulas of C31H65N2O12P2, and C33H69N2O12P2, respectively. There are also even numbered ions
at m/z 430 and 530 indicating an odd number of nitrogens in those unidentified compounds.

6.4 CONCLUSIONS
Biological extracts, such as the tear film lipid layer presented in this study, are typically
complex, multi-component mixtures. Separation schemes are usually employed to isolate the
compounds of interest to simplify the mass spectra, and to lower the limits of detection. The
novel solid ionic crystal MALDI matrix reported in this paper combines lipid detection
enhancement through the use of para-nitroaniline as the matrix’s ultraviolet light absorber with
the powerful protonating additive butyric acid. Mass spectrum complexity is reduced and
interpretation is simplified due to the phosphorylated lipids of interest existing primarily as
[M+H]+ ions for the neutral, polar zwitterionic phosphatidylcholine head group containing
species lyso PC, PC, SM, and PAF. Further simplification is obtained because one need only

153

monitor the mass spectrum for sodium adducts of the anionic phosphorylated lipids such as PG,
PA, and PS. Finally, all of the phosphorylated lipids represented in this study can be measured
simultaneously in the positive mode, including PE. It has also been demonstrated that the new
ionic crystal matrix gives PSD spectra that can be used for head group identification, and fatty
acid substituent characterization for both the nitrogen-containing phosphorylated lipids and those
devoid of nitrogen.
A new extraction, isolation, and cleanup procedure has also been reported for the
phosphorylated lipids using immobilized metal ion affinity chromatography (IMAC) media
ZipTipMC. It was shown that the ZipTipMC procedure is highly specific for recovery of the
phosphorylated lipids. The ZipTipMC procedure has been successfully applied to a complex
biological tear film lipid layer extract by removing the signal suppressing acylglycerols, thus
allowing the determination of very low levels of phosphorylated lipids.
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CHAPTER VII: IDENTIFICATION AND COMPARISON OF THE POLAR
PHOSPHORYLATED LIPIDS IN NORMAL AND DRY EYE RABBIT TEARS BY MALDITOF MASS SPECTROMETRY

7.1 Introduction
The ocular tear fluid is a dynamic and complex mixture of water, salts, mucins, and
diverse biomolecules including proteins, enzymes, and lipids, whose components interact with
one another to maintain the health and clarity of the cornea and ocular surface. The tear film acts
as a lubricant during blinking, and protects the cells of the ocular surface from damaging debris
and pathogens. Additionally, the tears transport oxygen and nutrients to the cells of the cornea
and conjunctiva. Irregularities in the tear film can cause a number of ocular problems, including
dry eye. The National Eye Institute defines dry eye syndrome as “a disorder of the tear film due
to tear deficiency or excessive evaporation that causes damage to the interpalpebral ocular
surface and is associated with symptoms of discomfort.”1 Approximately 10 to 14 million people
in the United States alone have some form of dry eye.
The development of dry eye syndrome is associated with a number of physiological and
environmental conditions, including aging,2 hormonal imbalance,3 disease,4 surgery,5,6 smoke,
wind, heat, and/or low humidity.1,7,8 However, the ability to classify dry eye patients within
specific etiological categories, except for those caused by a specific disease states such as
Sjögren's syndrome,4 is difficult because the exact effect of the various causative conditions on
the compositional structure of the tear film is unknown.
The normal tear fluid, which is approximately 7 µL in volume in both rabbits and
humans, continuously bathes the corneal and conjunctival surface of the eye. The structure of the
tear fluid is generally divided into three layers: the innermost epithelial-glycocalyx layer, an
intermediate aqueous-mucin layer,9,10 and an outermost lipid layer.11 The components of the tear
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film are supplied by a number of ocular tissues. The innermost glycocalyx layer is secreted by
the stratified squamous cells of the conjunctiva and cornea. Its primary functions are to protect
the ocular surface cells from bacterial binding and smooth out any small surface irregularities.
The aqueous-mucin layer, composed of mucins, proteins, and electrolytes, is secreted by the
main and accessory lacrimal glands and the conjunctival goblet cells. The various proteins found
in the aqueous layer perform a myriad of functions vital to maintaining the health of the ocular
surface, regulating surface cell function, and maintaining the tear film structure.12 The outer lipid
layer is secreted by the meibomian glands, which are located in the eyelids; its main function is
to retard the evaporation of the aqueous layer.13,14 Because the cells of the ocular surface
function within a narrow range of pH, osmolarity, and ionic compositions, it is vital that the tears
maintain the appropriate concentrations of constituents in each of the three layers. Alterations of
the composition of the tear film can result in development of dry eye syndrome and, ultimately,
deleterious effects on vision.
The instability of the outer lipid layer of the tear film, due to changes in the polar lipid
concentration, has been identified as a potential factor in the development of dry eye
syndrome.15,16 Previous investigations into molecular changes in tear film structure have been
hampered by the need to pool tears to make up a sample quantity large enough to allow detection
by analytical methods such as one- or two-dimensional electrophoresis.17,18,19 Another problem is
the requirement that the tear components be derivatized before they are subjected to gas
chromatography (GC), mass spectrometry (MS), or both.20,21 The chemical composition of the
human meibomian gland liquid secretions has been characterized by high pressure liquid
chromatography (HPLC),22 pico-nuclear magnetic resonance (p-NMR),23 and thin-layer
chromatography (TLC),24 and fatty acid fragment profiles have been obtained by HPLC-MS.25
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During the past several years, the analysis of phospholipids in general has been reported by
HPLC26 and micellar electrokinetic chromatography (MEKC),26,27 capillary electrophoresiselectrospray-mass spectrometry (CE-ES-MS),28 electrospray tandem mass spectrometry (ESMS/MS),29-36 and to a lesser extent matrix-assisted laser desorption/ionization-Fourier-transform
ion cyclotron resonance (MALDI-FTICR)37 and MALDI-time-of-flight (TOF) MS.38-42 Indeed
However, with the advent of soft ionization techniques such as ES-MS and MALDI-MS, the
derivatization of volatile lipids is no longer essential.43 In this paper, we report a MALDI-TOF
MS study of the phosphorylated lipids of normal and dry eye tears using an immobilized metal
ion affinity chromatography (IMAC) ZipTipMC (Millipore, Bedford, MA) clean-up method
coupled with a newly synthesized solid ionic crystal MALDI matrix to detect nanogram to
picogram quantities of phosphorylated lipids in small volume tear samples. Comparison of the
types and relative quantities of the polar phospholipids in normal and dry eye rabbit tears should
provide insight into the effect of polar lipid changes on the stability of the tear film.

7.2 Experimental
7.2.1 Animals
Six female New Zealand white rabbits (7-8 lbs body weight) purchased from Harlan
(Indianapolis, IN) were used. All animal studies were conducted in accordance with the ARVO
Statement on the Use of Animals in Ophthalmic and Vision Research.

7.2.2 Rabbit Tear Samples
The rabbit dry eye model was created in female New Zealand white rabbits by two
sequential surgical procedures. First, the main lacrimal gland was removed from the
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experimental eye; the contralateral eye was used as the normal control. Approximately 2 weeks
later, the accessory lacrimal gland and nictitating membrane were removed from the
experimental eye. Tear breakup time (TBUT) was measured daily by slit lamp with a Tearscope
(Keeler Instruments, Broomall, PA). When the TBUT of the surgical eye was half or less that of
the control eye, the surgical eye was considered to be dry. Baseline tears (representing tears
produced under non-irritating conditions) were collected daily from the normal and surgically
induced dry eyes using 5-µL silanized microcapillary pipettes.24 The tear samples were
immediately placed in Eppendorf tubes and stored at –70ºC.

7.2.3 Chemicals
Lyso 1-palmitoyl choline, dimyristoyl phosphatidylcholine, 1,2-dipalmitoyl-sn-glycero-3phosphoethanolamine, 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine, and sphingomyelin
were purchased as standards (Avanti Polar Lipids, Alabaster, AL). Methanol and chloroform
solvents of HPLC/spectroscopy grade were purchased from EM Science (Darmstadt, Germany).
All other chemicals were of analytical-reagent grade. All standards and chemicals were used as
received without further purification. Distilled and deionized (dd) water (18 MΩ, Milli-Q Water
Purification System; Millipore Inc., Bedford, MA) was used throughout standard and sample
preparations.

7.2.4 Extraction of Non-Polar and Polar Lipids
The non-polar and polar lipid fractions were extracted from tear samples with a simple
two-phase (chloroform, water) extraction technique; the resulting aqueous phase contained the
tear proteins and the chloroform phase contained the lipids.44,45 Briefly, 1 week of tears collected
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from one eye was diluted to 300 µL with dd water. The aqueous tear solution was then extracted
three times with 500 µL of chloroform. The chloroform extracts were combined and evaporated
to near dryness. At least three weeks of samples per eye were analyzed using the Zip-Tip
MALDI-TOF method described below.
To extract the phosphorylated lipids from the lacrimal glands, the gland was blended with
100 mL of chloroform. The extract was filtered and the volume of the solution was reduced to
approximately 20 mL using low heat and a gentle stream of nitrogen. Aliquots were diluted 1:10
with matrix solution (see MALDI-TOF MS below) and spotted directly onto the MALDI target
for analysis. At least three aliquots per sample type were analyzed by MALDI-TOF.

7.2.5 Zip-Tip Cleanup and Pre-concentration of Polar Lipids
A modified phosphopeptide enrichment method, previously developed in this laboratory
(Ham et al., accepted for publication), using ZipTipMC pipette tips containing an IMAC medium
(iminodiacetic acid, IDA resin) was used to concentrate the phosphorylated lipids. The suggested
method from the manufacturer (Millipore) was followed except for two key solutions: the
binding solution was changed from 0.1% acetic acid to 0.1% acetic acid in 1:1
methanol:acetonitrile, and the elution solution was changed from 0.3 N ammonium hydroxide to
0.3 N ammonium hydroxide in 1:1 methanol:acetonitrile. The IMAC medium was found to be
soluble in chloroform; therefore, care was taken to remove all chloroform from the extracted
lipids before application of the ZipTipMC. The lipids were reconstituted in 5 :l of the Zip-Tip
binding solution, aspirated through the Zip-tip matrix for binding, washed, and eluted with 3:l of
elution solution.
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7.2.6 MALDI-TOF MS
MALDI-TOF mass spectra were acquired using an Applied Biosystems Voyager Elite
MALDI-rTOF mass spectrometer with delayed extraction (Applied Biosystems, Inc.,
Framingham, MA). A UV light, 337 nm emission wavelength, nitrogen laser was used for
irradiation. A typical spectrum was collected at an extraction voltage of 20 kV. Delayed
extraction mode was used for all acquisitions with a 175 ns delay. The laser power was adjusted
to a level just above the threshold for signal appearance to minimize head group loss. Each
phospholipid mass spectrum was collected by averaging data from 250 laser shots. For sample
plate spotting, 3 µL of ZipTipMC- eluted phospholipids was mixed with 3 µL of matrix and then
deposited onto the MALDI plate and allowed to air dry. The MALDI matrix used in all studies
consisted of a recently developed solid ionic crystal matrix of 20 mg of paranitroaniline (PNA)
and butyric acid in a 1:2 molar ratio dissolved in ethanol (Ham et al., accepted for publication).
All

spectra

were

collected

using

a

two-point

calibration

of

protonated

lysophosphatidylcholine at a mass/charge ratio (m/z) of 496.34, and protonated dimyristoyl
phosphatidylcholine (DMPC) at m/z 678.51. Phospholipids in the biological samples were
assigned according to their molecular weights derived from either the monoisotopic protonated
molecules, monoisotopic sodium adducts, and/or post source decay (PSD) product ions in
MALDI-TOF mass spectra.

7.3 Results and Discussion
7.3.1 Rabbit Eyes and Tear Samples
All of the rabbit eyes remained healthy throughout the study period; the corneas and
conjunctivas of both the normal and dry eyes were healthy and showed no epithelial staining.
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The experimental dry eyes had TBUTs approximately one-third those of the corresponding
contralateral control eyes. The usual tear volume obtained from a single normal eye was 3 µL,
whereas only 1 µL was typically obtained from a dry eye.

7.3.2 MALDI-TOF MS Analysis of Tear Phospholipids
By inducing dry eye in only one eye of each rabbit, we were able to compare lipid
expression in dry eye and normal tear samples from the same animal, thereby reducing or
eliminating the effect of physiological variation from rabbit to rabbit. Samples of normal and dry
eye tears were extracted with chloroform following the modified extraction method outlined
above. The lipid-containing chloroform phase was recovered and evaporated, and the
phosphorylated lipids were isolated using the IMAC ZipTipMC method; proteins were largely left
behind in the aqueous phase. All presented mass spectra were acquired after extraction and
ZipTipMC cleanup.
Figure 7.1 a and b are representative of normal and dry eye tear mass spectra obtained by
our method. In general, the normal eye tear spectra showed six major peaks (m/z 494, 522, 550,
577, 610, 638) and seven minor peaks (m/z 637, 642, 659, 678, 695, 866, 936). The dry eye tear
spectra showed 10 major (m/z 494, 522, 550, 577, 605, 621, 637, 659, 610, 642) and four minor
(m/z 678, 695, 828, 886) peaks assignable within their mass spectra. Five of the major peaks
(m/z 494, 522, 550, 577, 610) and two of the minor peaks (m/z 678, 695) were the same for both
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Figure 7.1. Representative MALDI-TOF spectra of (A) normal eye tear and (B) dry eye tear
phosphorylated lipids. Important series include (1) C14:1-2:0 PAF (m/z 494), C16:1-2:0 PAF
(m/z 522), and C18:1-2:0 PAF (m/z 550) in the normal tears, and (2) m/z 577, 605, 621, 637, and
659 in the dry eye tears. The second series consists of SMs, which may play a role in the dry eye
response.
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types of tears. The m/z 494, 522, and 550 species in the tear mass spectra did not have reliable
post source decay (PSD) spectra for their specific identification. However, it is reasonable that
they are phosphorylated and contain one nitrogen. For the m/z 494 species, possible assignments,
based upon molecular weight alone, could be (1) a C14:1-2:0 PAF with molecular formula of
C24H48NO7P or (2) a C16:1 Lyso-PC with a molecular formula of C24H48NO7P. The m/z 522 and
550 species appear to be related to the m/z 494 species by the successive addition of two carbon
atoms of chain length (-CH2CH2-). Figure 7.2 illustrates assigned structures of some of the main
phosphorylated lipids observed in the tear extracts.
Next, as illustrated in Figure 7.3(a), we found a series of peaks which included m/z 577,
605, 621, 637, and 659. The five compounds exhibited affinities to the IMAC ZipTipMC resin,
indicating they are phosphorylated lipids, and the odd numbered m/z values pointed to an even
number of nitrogen atoms (e.g., 2) in each of the compounds. Additionally, the PSD spectra of
the m/z 577, 605, and 621 species indicated an m/z 184 head group. These three findings support
the hypothesis that the five compounds are related to sphingomyelin (SM). A similar series of
m/z 605, 621, 637, 643 and 659 species has also been observed in a C18:1 sphingomyelin
standard as impurity, Figure 7.3(b). From the sphingomyelin standard, PSD was also performed
on the m/z 605 species, Figure 7.4. The spectral informative peaks include the
phosphatidylcholine head group at m/z 184, a pyrophosphate phosphatidylcholine head group at
m/z 280, neutral loss of the long chain substituent at m/z 335 [M+H-C17H34O2]+, and loss of the
epoxide oxygen at m/z 589 [M+H-O]+. From the derived molecular weights and PSD spectra,
tentative assignments of these compounds, based upon sphingomyelin structures, can be made
(Figure 7.5). The m/z 605, 621, and 637 species are proposed to be related structures where the
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Figure 7.3. MALDI-TOF mass spectra of (a) dry eye tear extract lipids. (b) sphingomyelin
standard.
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m/z 605 is a protonated oxidized pyrophosphate sphingomyelin related compound with a
molecular formula of C24H50N2O11P2 likely resulting from epoxidation of the unsaturation on the
long chain substituent. The m/z 621 species represents a further oxidized form of the same
molecule resulting in peroxide formation with a molecular formula of C24H50N2O12P2. The m/z
637 species is a further oxidized form of m/z 605 likely resulting from formation of an epoxide
of the m/z 621 species, with a molecular formula of C24H50N2O13P2. Finally, the m/z 659 species
is the sodium adduct of the m/z 637 species with a molecular formula of C24H50N2O13P2Na.
For the m/z 610 and 638 species found within the tear spectra, PSD spectra were obtained
that indicate a relationship between the two (Figure 7.6). However, despite having a molecular
weight equal to an oxidized form of phosphatidylcholine, the species are unassigned since no
m/z 184 peak was evident. The m/z 642 species differs from the m/z 610 species by 32 Daltons,
suggesting an oxidized state of m/z 610. The M/z 678 species has been identified as C14:0-14:0
PC based off of its molecular weight and the PSD spectrum which illustrates the m/z 184 product
ion indicative of a phosphatidylcholine head group containing species (see Figure 7.7a). The
PSD spectrum of the m/z 828 species indicates that it may be a phosphatidyl serine due to a
diagnostic peak at m/z 741 (see Figure 7.7b). The m/z 695, 866, 886, and 936 species are
currently unidentified.
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Figure 7.4. Post source decay (PSD) of m/z 605 species in the Sphingomyelin standard.
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(CH2)11CH3

(a)

(b)

Figure 7.6. PSD spectrum of species found within the MALDI-TOF MS of tears. (a) PSD
spectrum of m/z 610 species. (b) PSD spectrum of m/z 638 species.
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(a)

(b)

Figure 7.7. PSD spectrum of species found within the MALDI-TOF mass spectra of tears. (a)
PSD spectrum of m/z 678 species. (b) PSD spectrum of m/z 828 species.
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Table 7.1 lists the phosphorylated lipid species observed in the tear extracts and their
relative abundances in normal versus dry eye tears. The major peak assignments corresponded to
types of platelet activating factor (PAF) and pyrophosphate sphingomyelin (SM)-related
compounds with minor peaks corresponding to phosphatidylcholine (PC) and phosphatidylserine
(PS).
Major differences in the normal and dry eye tear mass spectra were found in the peaks
corresponding to SM and PS molecules. Two major SM peaks not found in the normal tears were
present in the dry eye tears and two minor SM peaks found in the normal tears were major peaks
in the dry eye tears. A minor peaks corresponding to PS was identifiable in the dry eye tears but
was not seen in the normal tears. Additionally, a minor peak in the normal eye tears possibly
corresponding to an oxidized form the PC molecule was seen as a major peak in dry eye tears,
and two of the minor, unidentifiable peaks in the normal eye tears were not present in the mass
spectra of dry eye tears.

7.3.3 MALDI-TOF MS Analysis of Extracted Lacrimal Glands

Figure 7.8 is a representative MALDI-TOF MS spectrum of the extracted lipids from the
main lacrimal glands of the rabbits. The predominant set of phosphorylated lipids, which is
located in the region between m/z 700 and m/z 850, consists mainly of PCs, with some PEs.
Table 7.2 lists the major peaks observed in the lacrimal gland extracts and their assignments. In
addition to PC and PE molecules, peaks corresponding to PAF (m/z 496) and SM (m/z 577) were
found. No peaks corresponding to PS were identified.
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Lipid in Tear Extract

Molecular Ion
(MI)

Normal
Eye*

Dry
Eye*

C14:1-2:0 PAF C24H48NO7P (?)

[M+H]+, m/z 494

major

major

M/z 522

[M+H]+

major

major

M/z 550

[M+H]+

major

major

Pyrophosphate SM C22H46N2O11P2

[M+H]+, m/z 577

major

major

Pyrophosphate SM C24H50N2O11P2

[M+H]+, m/z 605

major

Pyrophosphate SM C24H50N2O12P2

[M+H]+, m/z 621

major

Pyrophosphate SM C24H50N2O13P2

[M+H]+, m/z 637

minor

major

Pyrophosphate SM C24H50N2O13P2Na

[M+Na]+, m/z 659

minor

major

M/z 610

[M+H]+

major

major

M/z 638

[M+H]+

major

M/z 642

[M+H]+

minor

major

C14:0-14:0 PC (DMPC)

[M+H]+, m/z 678

minor

minor

M/z 695

[M+H]+

minor

minor

16:0-20:4 PS C42H73NO10PNa

[M+2Na-H]+, m/z 828

M/z 866

[M+H]+

minor
minor

+

M/z 886
M/z 936

[M+2Na-H]
[M+H]+

minor
minor

*The assignment of a major or minor presence is qualitative and is derived from the relative
intensity abundance of the peak in the mass spectra.
TABLE 7.1. Phospholipids Peaks in MALDI-TOF Mass Spectra of Normal and Dry Eye Rabbit
Tears.
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Figure 7.8. MALDI-TOF spectrum of lacrimal gland phosphorylated lipids.
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998
0
1050

Spectral
Peak

Compound Assignment

Spectral
Peak

Compound
Assignment
16:0-18:3 PC
or 16:1-18:2
PC

M/z 413

2-N species with PC head-group,
M/z 756
possibly SM related

M/z 429

2-N species (m/z 413 oxidized) PC
M/z 758
head-group, SM related

16:0-18:2 PC

M/z 496

C14:0-2:0 PAF

M/z 760

16:0-18:1 PC

M/z 511

Unidentified

M/z 762

16:0-18:0 PC

M/z 512

1-N species with PC head-group

M/z 770

18:0-20:3 PE

M/z 518

1-N species with PC head-group

M/z 772

18:0-20:2 PE

M/z 774

18:0-20:1 PE

M/z 577
M/z 610

16:0-5:1 oxidized PC C29H56NO10P

M/z 780

16:1-20:4 PC

M/z 642

16:0-5:1 oxidized PC C29H56NO12P

M/z 782

16:0-20:4 PC

M/z 706

14:0-16:0 PC

M/z 786

18:0-18:2 PC

M/z 720

16:0-18:0 PE

M/z 788

18:0-18:1 PC

M/z 734

14:0-18:0 PC

M/z 744

18:0-18:2 PE

M/z 810

18:0-20:4 PC

M/z 746

18:0-18:1 PE

TABLE 7.2. Assignment of MALDI-TOF Mass Spectra Peaks from Rabbit Main Lacrimal
Gland
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Current tear film models suggest that a chemically stable, lamellar layer of polar
phospholipids lies anterior to the aqueous fluid and binds the non-polar meibomian oil to the
aqueous layer. The presence of this polar phospholipid interface is thought to be critical to the
spreading of the non-polar lipid film over the aqueous layer. Shine and McCulley16 found that
specific changes in the content of the polar phospholipid interface correlate directly to the
presence of dry eye in patients with chronic blepharitis.
The majority of the phospholipids are supplied to the tear film through the meibomian
glands, which are located in the eyelid. The chemical composition of the human meibomian
gland secretions is a complex mixture of cholesterol and wax esters, triacylglycerols, free fatty
acids, diesters, free cholesterol, hydrocarbons, and polar lipids.20,46-49 The polar lipids found in
the meibomian gland secretion contain 70% phospholipids and 30% sphingolipids, and the
phospholipid portion consists of 38% PC, 18% PE, 7% SM, and 39% unknowns.20 Polar lipids
make up approximately 6-16% of the compounds found in the liquid phase of the tear film.20,22,49
Based on these data, the percentages of phosphorylated lipids in the lipid phase of the tear film
would be 1.6-4% PC, 0.8-2% PE, and < 1% SM. Analysis of the rabbit meibomian gland cells
and secretions has shown the polar lipid content to be similar to that of humans, with PC, PE,
SM, and PS making up the majority of the phospholipids.23,50
Although the meibomian gland supplies the majority of the lipids to the tear film, the
lacrimal gland also provides some lipids, as well as the majority of tear proteins. An early study
performed by Stuchell et al. (Stuchell RN, et al. IOVS 1984;25:ARVO Abstract, p. 320, #2)
reported that the lipid composition of lacrimal gland secretions consisted of 55.0% glycolipids,
44.1% other neutral lipids, and 0.9% phospholipids. However, the types of phospholipids were
not reported. In our study, we found that rabbit lacrimal glands had significant amounts of the
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same polar phospholipids found in the human tear fluid, although the degree to which these
phospholipids are excreted into the tears is unknown.
In addition to the meibomian and main and accessory lacrimal glands, the rabbit has a
harderian gland that has been shown to contribute to the tear film components. The harderian
gland lies in the nasal region of the orbit with its secretions flowing through ducts within the
nictitating membrane. Analysis of the harderian gland has shown that tear proteins and lipids are
produced within the gland, although the degree to which these molecules are actively secreted is
unknown.21,51,52 In our dry eye model, both the main and accessory lacrimal glands were
removed and the ducts from the harderian gland were severed and cauterized. Only the
meibomian glands remained intact to supply lipids to the tear film.
The total chloroform extract of the tear layer constitutes a complex mixture of biological
compounds that includes non-polar and polar lipids and some lipoproteins. The polar lipid
components make up a very small fraction of the total extract, rendering their analyses difficult
by mass spectrometry alone. Combining the use of the IMAC ZipTipMC with the optimized solid
ionic crystal MALDI matrix para-nitroaniline/butyric acid allowed the identification and
comparison of the lipoprotein and phosphorylated lipid components of normal versus dry eye
rabbit tears.
Some similarities in the polar phospholipids were found in the normal and dry eye rabbit
tears. For example, three compositions of PAF, a tear lipoprotein component known to be
involved in the human lipid-mediated inflammatory response and such specific ocular conditions
as allergic conjunctivitis53 and contact lens induced acute red eye (CLARE),54 were expressed to
a similar degree in both the normal and dry eye rabbit tears. The three types of PAF lipids
differed from one another in terms of two carbon atoms of chain length (–CH2CH2–). The similar
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degree of expression of the three PAFs indicates that the inflammatory response was not
activated in our dry eye model.
Additionally, however, some significant differences in the polar phospholipids were
found in the normal and dry eye rabbit tears using our novel analytical method. The types and
concentrations of SM molecules were significantly increased in the dry eye tears compared with
the normal tears. The normal rabbit tears showed the presence of three types of SM, with one
major type present in significantly higher concentrations than the other two. The dry eye tears
showed the same three SMs as the normal tears and two additional SMs, all in significantly high
concentrations. Sphingomyelins are zwitterionic phospholipids which have been suggested to
play a significant role in maintaining the interfacial layer between the aqueous and oil layers of
the tear film. The polar head groups of zwitterionic and neutral phospholipids are known to align
themselves head-to-tail, creating an interfacial layer between meibomian oil non-polar lipids and
aqueous tears that is chemically stable and resistant to mechanical rupture.11,50 A decrease in the
percentage of SMs in the tear film was correlated with the presence of dry eye in patients with
chronic blepharitis, although the different SM species within the tear film were not identified.16
The presence of different SM species in the dry eye tears may indicate a compensation
mechanism provided by the meibomian glands to stabilize the tear film in the absence of lacrimal
and harderian gland secretions.
Previous work has shown that PE is present in human tears and may play a significant
role as a zwitterionic phospholipid in the maintenance of tear stability.16 PE was not found in
either the normal or dry eye rabbit tears examined. However, PS, a precursor in PE synthesis in
mammalian cells, was found in significant quantities in the dry eye tears. PS is an anionic
phospholipid and, as such, aids in the spreading of the meibomian oil film within the lipid
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interfacial layer through the mutual repulsion of negative charges.
Our analytical method not only allowed the assignment of the types of polar
phospholipids present in the tear film, but also allowed assignment of specific molecular
compositions within the phospholipid groups. Comparative analysis of polar phospholipids in
rabbit tears from normal and dry eyes points to the importance of SM and PS in stabilizing the
tear film in the rabbit dry eye model.

7.4 Conclusions

The combination of ZipTipMC chromatography and the solid ionic crystal matrix for
MALDI enabled the detection and assignment of phosphorylated lipids in the tears. Specific
differences between polar phospholipid levels in normal and dry eye tears were observable with
this methodology. The appearance of various SM and PS species only in the dry eye tears may
provide markers for this disease state in the future.
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CHAPTER VIII :IDENTIFICATION AND COMPARISON OF RABBIT TEAR
PROTEINS OF NORMAL VERSUS A DRY EYE MODEL BY MALDI-TOF MS

8.1 Introduction

The eye is a complex, sensitive component of the human body that has obvious
importance, thus extensive study has been conducted on the eye, and particularly the protein
components that make up the eye(1-13), for well over at least seventy years for modern testing, and
since antiquity for other. The eye structure is divided into three layers, the innermost corneal
layer, an intermediate aqueous-mucin(14,15) layer, and an outer most lipid layer(16). One of the
functions of the outer lipid layer is to retard the evaporation of the inner aqueous layer through
the functionality of the non-polar and polar lipids. The lipids are supplied to the tear film
through the meibomian gland. The proteins are supplied to the aqueous portion of the tear layer
by the main (orbital) lacrimal gland(17). Exhaustive studies have been performed on human and
rabbit tear, and less extensive for dog tear(18) and rat tear(19), for protein quantification and
identification, and also for protein expression studies concerning physiological changes that have
resulted in the symptoms of dry eye. These types of studies have been accomplished through
many standard techniques including 1-D(20) and 2-D(21) gel electrophoresis, capillary
electrophoresis(22), HPLC(23,24), immunochemistry(25-27), chip-based micro-fluidic techniques(28),
and thin layer chromatography(29). Today’s proteomic approaches to protein characterization and
identification, through the use of mass spectrometric techniques, have contributed to the
information in the study of tear proteins. Some of the mass spectrometric methods used have
been

gas

chromatography-mass

spectrometry(29),

high-pressure

liquid

chromatography/electrospray ionization mass spectrometry(30), and matrix assisted laser
desorption

ionization-time

of

flight

mass
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spectrometry(31,32).

Capillary

electrophoresis/electrospray ionization-mass spectrometry has also been applied to the analysis
of proteins in whole human blood(33).
Protein profiles, identification, and quantitation have been reported on both normal tear
protein content, and protein content for dry eye syndrome, for both human and rabbit. Reported
total protein concentrations for rabbit include 12.6 µg/µl in unstimulated tears(34), and 40.0 ± 5.3
µg/µl in lacrimal gland fluid at flow rates < 2 µl/min(35). For normal human tear, a few examples

of total reported protein concentrations include 8.1 µg/µl in stimulated tears and 22.7 µg/µl in
unstimulated tears(36), 8 ± 2.25 g/l from gentle stimulation(11), and from 6.05 ± 1.58 mg/ml to
11.48 ± 2.32 mg/ml (difference depending on which method was used for calculation, as
expressed by the authors) for tears collected by yawn reflex(37). Human tear contains numerous
proteins including serum-based proteins such as IgA and IgG, antibacteriolytic components such
as lysozyme, transferrin, albumin, lipocalin, and many more. Indeed, Fung, et al(32), recently
reported the identification of approximately 500 proteins in normal human basal tear fluid.
Rabbit tear contains many of the same types of proteins as are contained in human tear.
Boonstra, et al(26), reported the identification of transferrin in rabbit tear, but no lactoferrin, thus
indicating that rabbit tear may be substantially different from human tear. Recently, Zhou et
al(30), reported the finding of lactoferrin in rabbit tear, demonstrating the differences that may
arise from techniques and methods used. Nonetheless, there are many similarities in the types of
protein contained in both.
In the past 25 years, many advances in diagnosis, causes, and treatments of the dry eye
condition have been made(38). Many are afflicted with the condition Keratoconjunctivitis sicca
(KCS, also known as “dry eye”), which can be associated with aging, disease, smoke, surgery, or
any form of irritation of the eye. The National Eye Institute’s (NEI) definition of dry eye states
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that KCS is a disorder of the ocular tear film layer usually caused by a tear deficiency, or
excessive evaporation of the aqueous layer, resulting in damage of the ocular surface and
symptoms of discomfort(39). Some forms of dry eye may be physiologically related, perhaps from
the breakdown of the eye tear layer, or to hormones, as demonstrated in a hormone replacement
study by Schaumberg, et.al.(40), or to Sjogren syndrom(41).

In human dry eye studies, the

analytical evaluation of the dry eye condition is performed through the collection of tear samples
from individuals who are afflicted with one of the underlying causes of dry eye, and then
performing various wet chemistry and instrumental methods for compositions, tear breakup, etc.
Studies are also performed on rabbits where the rabbit has been externally given the dry eye
condition, and samples are taken and analyzed. The rabbit dry model has been produced through
sensory denervation of the lacrimal gland(17,42), and through corneal wounding(43). In this study,
the rabbit dry eye model was produced through the removal first of the main lacrimal gland from
one of the rabbit’s eyes, while the other eye is kept normal as a control.

Then, after

approximately two weeks, the accessory lacrimal gland and nictitating membrane are removed
from the same eye without the lacrimal gland. Tear samples were subsequently taken and
analyzed for protein content.

8.2 EXPERIMENTAL
8.2.1 Rabbit tear samples

Baseline tears (representing tears produced under non-irritating conditions used in normal
protection and lubrication functions) were collected from normal and surgically induced dry eyes
of New Zealand white rabbits using 5 µL silanated microcapillary pipettes(24,37). A usual volume
obtained from normal eye is 5 µL, whereas only 2 µL are typically obtained from a dry eye
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subject. Tear samples were immediately placed into Eppendorf tubes, and preserved by storage
at –70 oC. The rabbit dry eye tear model is created through two surgical procedures. First, the
main lacrimal gland is removed from one of the rabbit’s eyes, while the other eye is kept normal
as a control, and the rabbit is then allowed to heal. After approximately two weeks, the
accessory lacrimal gland and nictitating membrane are removed from the same eye without the
lacrimal gland. The tear breakup time (TBUT, measured by slit lamp and Tearscope) of the eye
is then measured and followed. The TBUT of the surgical eye must be at least half of the control
eye to be considered as “dry”. The polar and non-polar lipid fractions were extracted from tear
samples with a simple chloroform solvent modification procedure(44,45), and the proteins were
recovered from the aqueous phase of the extraction.

8.2.2 In-gel reduction, alkylation, digestion, and extraction of peptides

The protein bands that were analyzed by MALDI-TOF mass spectrometry were in-gel
digested using an in-lab procedure. The bands of interest are excised from the gel with a scalpel.
The bands are chopped into cubes (1 x 1 mm), and placed into separate 1.5 mL Eppendorf tubes.
The chopped bands are then washed with 100 – 150 µL of DD water, three times, with five min.
soakings. Between each wash, the cubes are centrifuged, and the washing removed. The gels
are then dehydrated by the addition of 100 µL of acetonitrile. After approximately 15 minutes,
the gels become white and stick together indicating dehydration. The acetonitrile is removed,
and the gels are dried in an eppendorf Vacufuge Concentrator 5301 (Brinkman Instruments,
Inc.). Reduction is then performed by swelling the gels in 50 µL of a freshly prepared solution
containing 10 mM of DTT in a 100 mM NH4HCO3 buffer solution. The gels are then incubated
for 60 minutes at 56 oC. After incubation, the gels are centrifuged and the liquid is removed.
The gels are again dehydrated in 100 µL of acetonitrile. The acetonitrile is removed and
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alkylation is performed by the addition of 50 µL of freshly prepared 55 mM iodoacetamide in
100 mM NH4HCO3 buffer. The gels are allowed to react, in the dark, for 45 minutes at room
temperature. The gels are then centrifuged, and the liquid is removed. The gels are then washed
with 100 µL of 100 mM NH4HCO3. 100 µL of acetonitrile is added, and the solution is vortexed
for 20 minutes. The gels are then centrifuged, the liquid is removed, and dried in the Vacufuge
Concentrator. The gels are rehydrated with 10-20 µL of a freshly prepared solution of 50 mM
NH4HCO3, 5 mM CaCL2, and 12 ng/µL trypsin. The gels are digested for 40 min. at 4 oC, then
overnight at 37 oC. The digestion solution is collected, and the gels are incubated for 15 min. in
30 µL 20 mM NH4HCO3 at 37 oC, the supernatent is collected, then gels are incubated 3 times
for 15 min. in 30 µL of a 60% acetonitrile, 5% formic acid solution. The supernatents are pooled
and the volume is reduced to 3 – 10 µL in the Vacufuge Concentrator. For MALDI-TOF mass
spectrometry analysis, the peptides are desalted using ZipTipC18 (Millipore, Bredford, MA). A
basic manufacturer method is followed where 1 µL of 0.1% TFA is added to the sample. The
ZipTip is wetted with 2 x 10 µL of 50% acetonitrile, and equilabrated with 3 x 10 µL of 0.1%
TFA. The sample is loaded and dispensed for 10 cycles, washed with 3 x 10 µL of 0.1% TFA,
and then eluted with 1 to 4 µL of 50% acetonitrile, 0.1% TFA, into a 0.5 mL eppendorf tube by
drawing and expelling the elution solution 10 times.

8.2.3 MALDI-TOF MS and MALDI-PSD-TOF MS

MALDI-TOF mass spectra and MALDI-PSD-TOF mass spectra were collected using a
Applied Biosystems Voyager Elite BioSpectrometry Research Station with Delayed Extraction
Technology, version 5.1 series software (Applied Biosystems, Inc., Framingham, MA). A 337
nm nitrogen laser is used. For peptide analysis, α-cyano-4-hydroxycinnamic acid (α-CHCA) as
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a saturated solution in 50:50 H2O:ACN with 0.1% TFA was used by a dry dropplet spotting
method.

For protein analysis, 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid) as a

saturated solution in 30:70 ACN:H2O with 0.1% TFA was used.

8.3 RESULTS AND DISCUSSION
8.3.1 1D gel electrophoresis

The extracted proteins from the normal-control eye rabbit tear, and the dry eye model
rabbit tear, were separated for approximate molecular weight determination using a MiniPROTEAN Electrophoresis module assembly obtained from Bio-Rad Laboratories, Inc.
(Hercules, CA). Figure 8.1 shows the results of the electrophoresis for the low molecular weight
standard, the normal-control eye rabbit tear, and the dry eye model rabbit tear, where well over
40 distinct bands are observed. The separation was performed by following the manufacturer’s
guidelines. Basically, this entails using a 1 mm thick gel with a 12% acrylamide composition. 5
µL of a LMW std and dye mixture was loaded onto the gel along with 10 µL of sample and dye

mixtures at dilutions where the second sample well contained one half the concentration of the
initial sample loading for comparative purposes (as discussed and illustrated in Figure 8.1). The
separation is performed at a constant voltage of 200V. After the electrophoresis separation is
complete, the gel is fixed in a solution of 50% methanol (v/v) and 5% acetic acid (v/v). The gel
is then rinsed and stained in a solution of 50% methanol (v/v) 5% acetic acid (v/v) and 0.1% blue
R250 (w/v). After staining, the gel is rinsed and de-stained in a solution of 5% methanol (v/v)
and 5% acetic acid (v/v). For storage, the gel is kept in a fresh solution of 5% methanol (v/v)
and 5% acetic acid (v/v). The LMW standard was used to calculate the approximate molecular
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Figure 8.1. 1D SDS-PAGE results of normal eye tear versus dry eye tear.

189

LMW
Std

5.0

Log MW = -1.13103*Rf + 5.2488
2

R = 0.990

Log MW

4.8

4.6

4.4

4.2

4.0
0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1.0

1.1

Response Factor Rf

Figure 8.2. Calibration plot used for the molecular weight determinations constructed from the
LMW standard’s Rf values.
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Molecular
Weight
(Da)

Protein ID from Literature and Mass Spectrometry

Difference in
Protein Expression
in Dry Eyes
Compared to
Normal
Increased

10,200

Lipophilin

10456

Lipophilin CL2*

11,300

ß-2 microglobulin

14,113

Apolipoprotein A-1**

14,254

Cystatin

Increased

14,390

Lysozyme

Variable

14,559

Unidentified

Increased

16,399

Lipophilin

Variable

17,310

Lipocalin (Tear specific pre-albumin)

Increased

18,500

Platelet-activating growth factor

Equal

20,500

Unidentified

Equal

25,307

T-cell-specific surface glycoprotein CD28 precursor***

30,300

Apolipoprotein D monomer

30,740

Channel protein 1 **

37,500

Unidentified

51,165

Lacrimal lipase**

Not Available

55,721

Cytochrome P450 2C14**

Not Available

56,808

Protein disulfide isomerase precursor (PDI)***

Not Available

68,915

Serum albumin precursor***

Not Available

Not Available
Equal
Not Available

Not Available
Variable
Not Available
Equal

*

Identification determined by MALDI-TOF PSD analysis which did not allow for quantitative comparison.
Identification determined by ES-MS-MS analysis which did not allow for quantitative comparison.
***
Identification determined by MALDI-TOF fingerprint analysis which did not allow for quantitative comparison.
1
Related to voltage dependent anion-selective channel protein.
**

Table 8.1. Protein Peaks Found in Rabbit Tear by MALDI-TOF MS and ES-MS-MS with
Tentative Assignments.
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weights of the extracted rabbit tear proteins. Figure 8.2 is the calibration plot used for the
molecular weight determinations constructed from the LMW standard’s Rf values. Table 8.1
lists the protein assignments for some of the major bands observed for the extracted proteins.

8.3.2 Tear total protein

Quantitation of total tear protein was determined by the Bradford Assay method (SigmaAldrich, St. Louis, MO). The protein, in solution, is complexed with the dye Brilliant Blue G
which causes a shift in the dye’s maximum absorption from 465 nm to 595 nm. The absorption
amount is directly proportional to protein concentration in a linear working range of 1-1.4
mg/mL. Figure 8.3 is a calibration curve showing the linear working range used to quantitate the
proteins in both the normal, and the dry eye model tear fluid. Table 8.2 is a tabulation of total
tear protein comparative results for normal versus dry eye tear for seven different rabbits. Also
included in the table is a 21µL composite sample of normal eye tear total protein.

8.3.3 MALDI-TOF MS of Tear Protein

In the recent literature, there have been numerous amounts of incremental optimizations
in sample pretreatment prior to MALDI-TOF MS analysis reported. These include the addition
of monobasic ammonium phosphate as a matrix enhancement, and post-crystallization washing
with dibasic ammonium citrate, both resulting in suppressing the formation of metal adducts and
matrix clusters(46). There has also been the reporting of wax coating MALDI plates prior to
sample spotting as a way of improving response(47) in peptide analysis. In the present study of
tear proteins, we have evaluated these optimization steps and incorporated certain aspects of
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abs = 0.74347x + 0.00859
2
R = 0.9996
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Figure 8.3. Calibration curve for protein quantitation.
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1.2

Table 8.2. Concentration of protein in normal and dry eye tear

Sample ID

Control Eye

Dry Model Eye

(mg/mL)

(mg/mL)

SJ-71 (06-01-04)

1.69

3.24

SJ-72 (06-01-04)

4.42

3.45

SJ-73 (06-01-04)

6.95

7.94

SJ-75 (10-09-03)

3.33

a

SJ-75 (06-01-04)

7.58

5.44

SJ-76 (10-13-03)

a

NA

3.23

SJ-76 (06-01-04)

4.70

1.43

SJ73-SJ76 21µL Comp.

3.70

NA

Average

4.62

4.12

2.05

2.26

Std Dev

a

NA: not analyzed.
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NA

them into the collection of the presently reported results. Wax coating of the Voyager MALDI
plates was observed to decrease the chemical noise in MALDI-TOF spectra, and increase the
resolution of the peaks, for the analysis of peptides. The most dramatic effect though of applying
the wax coating to the Voyager MALDI plates was observed for protein analysis in linear mode.
Figure 8.4a is the MALDI-TOF spectrum for lysozyme with an uncoated plate, and Fig. 8.4b is
the MALDI linear mode spectrum of lysozyme collected using a wax coated plate. The S/N ratio
increased from 7:1 to 65:1 with the application of the wax coating. A decrease in dimerization is
also observed at m/z 28.8 kDa. This same affect was observed with carbonic anhydrase (Figure
8.5a uncoated plate, Fig. 8.5b coated plate) where the S/N ratio increased from 12:1 to 135:1.
Figure 8.6a is the MALDI-TOF spectrum for an uncoated plate analysis of BSA (+2 at 33216 Da
and +1 at 66431 Da) giving a S/N ratio of 10:1 for the 33 kDa peak, and 15:1 for the 66 kDa
peak. Figure 8.6b is the same BSA standard collected using a wax coated plate resulting in a S/N
ratio of 39:1 for the 33 kDa peak, and 158:1 for the 66 kDa peak.
A study was performed comparing the tear protein of normal eye tear to the dry eye tear
model by depositing a 50:1 ratio of tear (neat) with matrix, and collecting the spectrum in linear
mode. Figure 8.7 shows the enhancement effect observed for the tear protein spectrum when
employing the wax coated Voyager MALDI plates. Figure 8.7a was collected using an uncoated
plate. Figure 8.7b is the MALDI-TOF spectrum collected using the wax coated Voyager plate,
illustrating a clear enhancement in the MALDI-TOF MS spectrum of the tear proteins. Because
the tear samples contain a considerable amount of salts, the matrix/sample plate spots were
washed with a 10 mM diammonium citrate H2O solution, which was observed to also enhance
the response of the proteins.
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Figure 8.4 (a) MALDI-TOF spectrum of a lysozyme (14376 Da) standard collected using a
standard, non-coated Voyager plate with a S/N ratio of 7:1. (b) Lysozyme protein standard
spectrum collected using a wax coated plate with a S/N ratio of 65:1. A decrease in dimerization
is observed at m/z 28.8 kDa.
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Figure 8.5. (a) MALDI-TOF spectrum of carbonic anhydrase (29024 Da) standard collected
using a non-coated plate with a S/N ratio of 12:1. (b) Carbonic anhydrase protein standard
spectrum collected using a wax coated plate with S/N ratio of 135:1.
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Figure 8.6. (a) MALDI-TOF spectrum of BSA (33216 Da and 66431 Da) standard collected
using a non-coated plate. The S/N ratio for the 33 kDa peak is 10:1 and S/N ratio for 66 kDa
peak is 15:1. (b) BSA spectrum collected using wax coated plate. The S/N ratio for the 33 kDa
peak is 39:1 and S/N ratio for 66 kDa peak is 158:1.
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Figures 8.8a and 8.8b are the first comparative spectra of rabbit tear fluid proteins from a
rabbit that has been given the dry eye condition. Figure 8.8a is the MALDI-TOF mass spectrum
of the left, normal eye of the rabbit. Figure 8.8b is the mass spectrum of the right, dry eye model
eye of the rabbit. Of interest in these two spectra is the observance of a decrease in the 14,390 Da
protein, a decrease in the 16,454 Da protein, and an increase in the 10,151 Da protein for Fig
8.8b, the dry eye model. From Table 1 it appears that a likely candidate for the assignment of the
14,390 Da protein may be lysozyme. The 16,454 Da protein may be lipophilin, and the 10,151
Da protein is probably the lipophilin protein. The 11,300 Da protein found in both the normal
and the dry eye extracts is assigned as a ß-2 microglobulin protein. Figure 8.9 is the post source
decay (PSD) spectrum of an m/z 1756 peptide obtained from band 1 in the 1D SDS-PAGE gel. It
has been identified as the lipophilin CL2 protein at 10,456 Da. The 1D SDS-PAGE result of the
tear proteins illustrated in Figure 8.1 shows that the majority of the proteins are the lower
molecular weight proteins ranging from approximately 10 kDa to 25 kDa (bands 1 through 4),
followed by the transferrins of bands 10 and 11. These low molecular weight proteins appear to
be comprised of many lipid-binding proteins such as the lipophilins, the apolipoproteins, and the
lipocalins, and also the globulins, cystatin and lysozyme. Therefore, it would be expected that
readily observable changes in the protein expressions would primarily involve these low
molecular weight species. Furthermore, previous work done in our lab has shown that the major
lipids in the tear film are mono and diacylglycerols(48), while other known tear lipids such as
cholesterol, the wax esters, and the phosphorylated lipids, are in much lower abundances. It
would seem likely then that the lipid binding proteins in the tear film are the fatty acid chain type
binding proteins, for example the human tear lipocalin member tear prealbumin is found in vitro
to bind retinol and fatty acids, but not cholesterol, while tear fluid apoD does bind cholesterol
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Figure 8.7. Comparison of tear protein MALDI-TOF MS spectral response enhancement using a
wax coated Voyager plate. (a) Tear protein spectrum collected using an un-coated plate. (b) Tear
protein spectrum collected using a wax coated plate.
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and the phosphorylated lipids(49) (apoD possibly bands 6 and 8 which are in low abundances).
A second set of spectra are presented in Figure 8.10 comparing the MALDI-TOF MS
protein analysis of the rabbit normal eye versus the dry eye model. The normal eye spectrum in
Fig. 8.10a shows a very large abundance of an m/z 17,408 protein which would probably
represent tear lipocalin, represented by the the predominant band #2 in Figure 1. Notably, in the
dry eye model spectrum of Fig. 8.10b, this protein is absent, but a new protein at m/z 29,002
(unidentified) is now observed. Tear lipocalin is thought to play a major role in tear stability,
being solely bound to the lipids, thus providing an anchoring effect between the tear film lipid
layer and the tear aqueous region. m/z 30,370 Da apolipoprotein D monomer as compared to the
dry eye. Secondly, the dry eye spectrum appears to have added the m/z 17,330 Da lipocalin
protein, thirdly, the m/z 11,370 Da ß-2 microglobulin protein appears to have decreased in the
dry eye spectrum, and fourthly, the 16,392 Da lipophilin protein has increased in the dry eye
spectrum. The next normal versus dry eye model is illustrated in Figure 8.11, where the normal
eye spectrum is Fig. 8.11a, and the dry eye model spectrum is Fig. 8.11b. Four differences are
observed between the spectra. First, the normal eye spectrum appears to have a more abundant
11 kDa protein expressed. In the dry eye 11b spectrum, the m/z 10 kDa, the m/z 16 kDa, and the
m/z 17 kDa protein are observed to be more greatly expressed. In Figure 8.12, the dry eye
spectrum in (b) shows an elevation of the m/z 14 kDa protein compared to the normal eye
spectrum in Fig. 8.12a. In both Figures 8.13 and 8.14, the dry eye model spectra show an
increase in the 10 kDa protein (lipophilin), and the 17 kDa (lipocalin) protein.
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Figure 8.8. MALDI-TOF MS spectra of (a) normal eye tear proteins, and (b) dry eye tear
proteins. The bottom dry eye MS spectrum shows an increase in the 10 kDa lipophilin protein,
and a decrease in both the 14 kDa lysozyme protein, and the 16 kDa lipophilin protein.
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Figure 8.9. PSD spectrum of an m/z 1756 peptide obtained from band 1 in the 1D SDS-PAGE
gel, identified as the lipophilin CL2 protein at 10,456 Da.
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Figure 8.10. MALDI-TOF MS spectra of (a) normal eye tear proteins, and (b) dry eye tear
proteins. The top normal eye spectrum contains a strong peak at 17 kDa which is probably
lipocalin. The bottom dry eye tear protein spectrum shows a predominant peak at 29 kDa of an
unidentified protein.
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Figure 8.11. MALDI-TOF MS spectra of (a) normal eye tear proteins, and (b) dry eye tear
proteins. The bottom dry eye MS spectrum shows an increase in the 17 kDa lipocalin protein, an
increase in the 16 kDa lipophilin protein and a decrease in both the 11 kDa ß-2 microglobulin
protein, and the 30 kDa apoD protein.
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8.3.4 ES Triple Quadrupole MS/MS of Digested Peptides

As a further aid in the identification of the tear proteins, Electrospray Triple Quadrupole
tandem mass spectrometry was performed on the most abundant peptides from an in-solution
digestion of the tear proteins. The lipid fraction was first removed from the tear fluid following
the above modified extraction method. The aqueous tear protein extract was then cleaned using a
ProteoPrepTM Protein Precipitation Kit (Sigma, Saint Louis, Missouri) to isolate the proteins and
wash off the tear salts. In-solution digestion was then performed on the proteins, and the
resulting peptides were infused into the electrospray source using a syringe pump. Figure 8.15a
is a single stage spectrum of the normal eye peptides. Figure 8.15b is a single stage spectrum of
the dry eye peptides. The most abundant peptides were subjected to collision induced
dissociation, and the resultant product ion spectra were searched using Protein Prospector for
possible protein identification. Figure 8.16 is a product ion spectrum from the collision induced
dissociation of the m/z 661 (+3) peptide. The important product ions include the y1-NH3 peak at
m/z 158, the y3+2 peak at m/z 187, the a2 peak at m/z 251, the y16-NH3+2 at m/z 843, the y8-NH3
peak at m/z 895, and the a12 peak at m/z 1240. The protein was identified as the T-cell receptor
alpha chain V region RL-5 precursor with a molecular weight of 14,856 Da.
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Figure 8.12. MALDI-TOF MS spectra of (a) normal eye tear proteins, and (b) dry eye tear
proteins. The bottom dry eye MS spectrum shows an increase in the 14 kDa apolipoprotein.
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Figure 8.13. MALDI-TOF MS spectra of (a) normal eye tear proteins, and (b) dry eye tear
proteins. The bottom dry eye MS spectrum shows an increase in both the 10 kDa lipophilin
protein, and the 17 kDa lipocalin protein.
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Figure 8.14. MALDI-TOF MS spectra of (a) normal eye tear proteins, and (b) dry eye tear
proteins. The bottom dry eye MS spectrum shows an increase in both the 10 kDa lipophilin
protein, and the 17 kDa lipocalin protein.
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Figure 8.15. (a) Single stage spectrum of the normal eye peptides. (b) Single stage spectrum of
the dry eye peptides.
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8.4 Conclusion

Wax coating of MALDI plates significantly enhances the response of proteins in linear
mode time-of-flight analysis.

Tears contain a considerable amount of salts that can be

effectively removed through spot washing with an aqueous solution of ammonium citrate, thus
reducing the salt suppression effects of the untreated biological sample.

Tear protein

quantitation and 1D SDS-PAGE gel analysis of the normal versus the dry eye model tears did not
show a significant difference. The MALDI-TOF MS linear mode analysis of the intact tear
proteins indicated that expression differences exist primarily in the low molecular weight range
of the lipid binding proteins. Substantial differences in the observed abundances of lipophilin
(m/z 10.2 kDa), lysozyme (14.4 kDa), and lipocalin (m/z 17.3 kDa), in normal versus dry eye
tear protein MALDI-TOF MS spectra could indicate a diseased state, and may have an
application in diagnosis of the dry eye condition.
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CHAPTER IX: SUMMARY AND CONCLUSIONS
Mass spectrometry has become a powerful tool for the chemist and the biochemist. For
the disciplines of the chemist, this includes gas phase thermochemistry studies for the physical
chemist, structural elucidation and molecular weight of organic compounds for the organic
chemist, qualitative and quantitative analysis for the analytical chemist, and even the inorganic
chemist for things such as particle size distributions. An increasingly important application of
mass spectrometry has been in the fields of proteomics, lipidomics, and metabalomics. Here, the
biologist and biochemist have also found an accurate and precise method for composition studies
of complex biological samples.
Methods have been developed by affinity capillary electrophoresis (ACE), and cation
exchange liquid chromatography (CELC), for the determination of binding strength coefficients
for complexes formed between π-delocalized lymphangitic dyes and an anti-cancer agent 4,4dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A007). In vitro trials have shown that
complexes with higher binding affinities can offer improved prospects for tumor treatment. For
the three tested carriers, the developed methods established that A007 non-covalent binding
strength was greatest for methylene green, followed by methylene blue, and lastly toluidine blue.
The developed methodology is general in nature such that it may be used to rank a wide variety
of solution binding strengths of drug:carrier pairs.
A new approach for calculating bond dissociation energies (BDE’s) from ES/MS-MS
measurements has been developed. The new method that features a “derived effective path
length” has been applied to measure BDE’s of alkali metal adducts (Li+), and halide adducts (Cl), of monoacylglycerol, 1,2-diacylglycerol, and 1,3-diacylglycerol lipids. Also studied were
lithium-bound dimers of monoacylglycerols, 1,2-diacylglycerols, and of 1,3-diacylglycerols.

216

BDE’s for the adducts and dimers of the lipids were measured using a triple quadrupole mass
spectrometer with electrospray as the ionization source. Mass spectral results were compared to
computer generated bond dissociation energies using the Becke-style 3-Parameter Density
Functional Theory (B3LYP, using the Lee-Yang-Parr correlation functional) method, with
excellent agreement between experimental and theoretical energy values. The newly developed
method is general in nature and can be used for the measurement of metal or halide ion adduct
bond dissociation energies, covalent bond dissociation energies producing fragment ions, and for
the measurement of bond energies of non-covalent interactions such as dimer dissociations. The
validity of the method has been rigorously established using a triple quadrupole, but it may also
be applied to other mass spectrometers that allow user control of the collision cell potential.
Millions of individuals suffer from a health condition known as Keratoconjunctivitis
sicca (KCS, also known as “dry eye”). Studies have indicated that the lipids in the tear film

layer, which covers the outer portion of the eye, may be directly correlated with the existence of
dry eye syndrome. By identifying and comparing the major, non-polar lipids in normal eye tear
with a dry eye model, it may be possible to identify a symptom of, or a contributing factor to, dry
eye. Electrospray tandem mass spectrometry (ES-MS/MS) was used to identify and compare the
non-polar lipids, detected as lithium adducts, from normal and dry eye tear samples obtained
from rabbits. A limited number of normal human tear samples were also examined for lipid
content, and a close resemblance to rabbit was observed. Three distinct regions were delineated
in the ES mass spectra of the non polar lipids, m/z 20 to 500, m/z 500 to 800, and m/z 800 to
1100. A common feature noted among identified lipid components was a glycerol backbone with
fatty acyl substituents attached. Product ion spectra were obtained for lithiated mono, 1,2- and
1,3-diacyl, and triacylglyceride standards. Newly proposed structures and fragment pathways for
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the major product ions are presented for the 1,2- and 1,3-diglycerides, as well as for the
monoglyceride. New approaches to distinguish asymmetric 1,2-diglycerides, and 1,2- from 1,3diglycerides are proposed. For the rabbit tear samples, the m/z 20 to 500 range contains monoester diols with empirical formulas of CnH2nO4, the m/z 500 to 800 range includes diesters with
empirical formulas of CnH2n-2O5, and the m/z 800 to 1100 range contains triesters with empirical
formulas of CnH2n-4O6. Also found in the extracts were three isoprene acetals (terpenoids).
When targeting a certain class of analytes such as the phosphorylated lipids in complex
biological extracts, interfering species can pose challenges to qualitative and quantitative
analysis. Two aspects of lipid analysis in biological extracts were optimized in order to simplify
the isolation and characterization of the phosphorylated lipids. A new solid ionic crystal MALDI
matrix was synthesized which combined the lipid response enhancing UV absorber paranitroaniline, and the strong protonating agent butyric acid. Mass spectra of the extracts
containing phosphorylated lipids were simplified by revealing only the protonated species of
phosphatidylcholine (PC) head group containing lipids such as lyso PC, PC, and plateletactivating factor (PAF) PC’s. Further spectrum simplification is obtained by the appearance of
only the sodium adduct species for other phosphorylated lipids such as phosphatidylglycerol
(PG), phosphatidic acid (PA), and phosphatidylserine (PS).

In addition, a new extraction,

isolation, and cleanup procedure has been developed to prepare the phosphorylated lipids for
MALDI-TOF analysis by the use of immobilized metal ion affinity chromatography (IMAC)
media ZipTipMC. The latter procedure was successfully applied to a complex biological tear film
lipid layer extract in preparation for MALDI-TOF analysis for phospholipid characterization.
The ocular tear fluid, like many biological fluids, is a complex mixture of biomolecules
such as proteins, non-polar lipids, and polar phosphorylated lipids whose components interact
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with one another to perform an important biological function. Irregularities in the tear film can
cause a number of ocular problems, including dry eye. Approximately 10 to 14 million people in
the United States alone suffer from some form of dry eye. However, without the ability to detect
and quantify the nano- to picogram quantities of tear components, identifying the underlying
cause of dry eye is impossible. We investigated the use of MALDI-TOF MS to identify the
phosphorylated lipids in both normal and dry eye rabbit tears. A solid ionic crystal MALDI
matrix comprised of para-nitroaniline and butyric acid was employed for enhanced spectral peak
responses of the phospholipids. Additionally, a novel phosphorylated lipid isolation, preconcentration, and clean-up method using IMAC ZipTipMC chromatography was also used. The
combination of the solid ionic crystal matrix and the ZipTipMC chromatography enabled the
detection and study of low levels of phosphorylated lipids in the complex tear fluid.
A study of a rabbit’s tear protein expression for a dry eye rabbit model was performed to
determine if a pattern in the expression of the proteins could be identified. The uniqueness of the
model allows the comparison of a normal, left eye tear protein expression to a surgically induced
dry, right eye tear protein expression. Quantitation of the tear proteins for the dry and normal
eye tears were not observed to change considerably with the dry eye condition. One dimensional
mini-gel electrophoresis of the normal versus the dry eye tear proteins did not show substantial
differences between band patterns, but was used for general identification of the major protein
bands. Specific identification of some of the predominant proteins was obtained by tandem mass
spectrometry which showed that the lower molecular weight lipid binding proteins
(approximately 10 kDa to 36 kDa) comprise a considerable amount of the observed proteins,
followed by the transferrins which have higher molecular weights ranging from 70 kDa to 85
kDa. Enhancement of MALDI-TOF MS linear mode analysis of intact proteins in neat tear fluid
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was demonstrated through the use of wax coated Voyager plates, and spot washing. MALDITOF MS analysis of the expressed tear proteins illustrated that the major differences between
normal eye tear and dry eye tear proteins is observed for the lower molecular weight lipid
binding proteins.
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